2023


  1. Georgi TW, Stoevesandt D, Kurch L, Bartelt JM, Hasenclever D, Dittmann H, Ferda J, Francis P, Franzius C, Furth C, Gräfe D, Gussew A, Hüllner M, Menezes LJ, Mustafa M, Stegger L, Umutlu L, Zöphel K, Zucchetta P, Körholz D, Sabri O, Mauz-Körholz C, Kluge R (2023). Optimized Whole-Body PET MRI Sequence Workflow in Pediatric Hodgkin Lymphoma Patients. J Nucl Med, 64(1), 96-101.
     
  2. Georgi TW, Stoevesandt D, Kurch L, Bartelt JM, Hasenclever D, Dittmann H, Ferda J, Francis P, Franzius C, Furth C, Gräfe D, Gussew A, Hüllner M, Menezes LJ, Mustafa M, Stegger L, Umutlu L, Zöphel K, Zucchetta P, Körholz D, Sabri O, Mauz-Körholz C, Kluge R (2023). Optimized Whole-Body PET MRI Sequence Workflow in Pediatric Hodgkin Lymphoma Patients. J Nucl Med, 64(1), 96-101.
     
  3. Sacher J, Zsido RG, Barth C, Zientek F, Rullmann M, Luthardt J, Patt M, Becker GA, Rusjan P, Witte AV, Regenthal R, Koushik A, Kratzsch J, Decker B, Jogschies P, Villringer A, Hesse S, Sabri O (2023). Increase in Serotonin Transporter Binding in Patients With Premenstrual Dysphoric Disorder Across the Menstrual Cycle: A Case-Control Longitudinal Neuroreceptor Ligand Positron Emission Tomography Imaging Study. Biol Psychiatry, (), 0-0.
     
  4. Messerschmidt K, Witt R, Krischer L, Sabri O, Hesse S (2023). Pulmonary Embolism Detected by Bone Scintigraphy in a Patient With Intrahepatic Cholangiocarcinoma. Clin Nucl Med, (), 0-0.
     
  5. Buchert R, Wegner F, Huppertz HJ, Berding G, Brendel M, Apostolova I, Buhmann C, Dierks A, Katzdobler S, Klietz M, Levin J, Mahmoudi N, Rinscheid A, Rogozinski S, Rumpf JJ, Schneider C, Stöcklein S, Spetsieris PG, Eidelberg D, Wattjes MP, Sabri O, Barthel H, Höglinger G (2023). Automatic covariance pattern analysis outperforms visual reading of (18) F-fluorodeoxyglucose-positron emission tomography (FDG-PET) in variant progressive supranuclear palsy. Mov Disord, (), 0-0.
     
  6. Tran-Gia J, Eberlein U, Lassmann M, Mauz-Körholz C, Körholz D, Zuccetta P, Bar-Sever Z, Rosner U, Georgi TW, Sabri O, Kluge R, Piccardo A, Kurch L (2023). Analysis of image data from the EuroNet PHL-C2 trial indicates a potential reduction in injected F-18 FDG activities in children: a proposal to update the EANM Paediatric Dosage Card. Eur J Nucl Med Mol Imaging, (), 0-0.
     
  7. Buchert R, Wegner F, Huppertz HJ, Berding G, Brendel M, Apostolova I, Buhmann C, Dierks A, Katzdobler S, Klietz M, Levin J, Mahmoudi N, Rinscheid A, Rogozinski S, Rumpf JJ, Schneider C, Stöcklein S, Spetsieris PG, Eidelberg D, Wattjes MP, Sabri O, Barthel H, Höglinger G (2023). Automatic covariance pattern analysis outperforms visual reading of (18) F-fluorodeoxyglucose-positron emission tomography (FDG-PET) in variant progressive supranuclear palsy. Mov Disord, 38(10), 1901-1913.
     
  8. Hesse S, Rullmann M, Zientek F, Schewe D, Becker GA, Patt M, Meyer PM, Juarascio AS, Frank GKW, Sabri O, Hilbert A (2023). Noradrenergic control of neurobehavior in human binge-eating disorder and obesity (NOBEAD): A smartphone-supported behavioral emotion regulation intervention study protocol integrating molecular brain imaging. Int J Eat Disord, (), 0-0.
     
  9. Pötzsch C, Kurch L, Naumann S, Georgi TW, Sabri O, Stoevesandt D, Cepelova M, Körholz D, Mauz-Körholz C, Hasenclever D, Kluge R (2023). Prevention of activated brown adipose tissue on (18)F-FDG-PET scans of young lymphoma patients: results of an ancillary study within the EuroNet-PHL-C2 trial. Sci Rep, 13(1), 21944.
     
  10. Georgi TW, Kurch L, Hasenclever D, Warbey VS, Pike L, Radford J, Sabri O, Kluge R, Barrington SF (2023). Interobserver variability in interim PET assessment in Hodgkin lymphoma-reasons and solutions. PLoS One, 18(3), e0283694.
     
  11. Georgi TW, Kurch L, Franke GN, Jentzsch M, Schwind S, Perez-Fernandez C, Petermann N, Merz M, Metzeler K, Borte G, Hoffmann S, Herling M, Denecke T, Kluge R, Sabri O, Platzbecker U, Vu?ini? V (2023). Prognostic value of baseline and early response FDG-PET/CT in patients with refractory and relapsed aggressive B-cell lymphoma undergoing CAR-T cell therapy. J Cancer Res Clin Oncol, 149(9), 6131-6138.
     
  12. Fraioli F, Albert N, Boellaard R, Galazzo IB, Brendel M, Buvat I, Castellaro M, Cecchin D, Fernandez PA, Guedj E, Hammers A, Kaplar Z, Morbelli S, Papp L, Shi K, Tolboom N, Traub-Weidinger T, Verger A, Van Weehaeghe D, Yakushev I, Barthel H (2023). Perspectives of the European Association of Nuclear Medicine on the role of artificial intelligence (AI) in molecular brain imaging. Eur J Nucl Med Mol Imaging, (), 0-0.
     
  13. Barthel H, Sébillaud S, Lorcin M, Wolff H, Viton S, Cosnier F, Gaté L, Seidel C (2023). Needlelike, short and thin multi-walled carbon nanotubes: comparison of effects on wild type and p53(+/-) rat lungs. Nanotoxicology, 17(3), 270-288.
     
  14. Barthel H (2023). Amyloid Imaging-Based Food and Drug Administration Approval of Lecanemab to Treat Alzheimer Disease-What Lasts Long Finally Becomes Good? J Nucl Med, 64(4), 503-504.
     
  15. Verger A, Yakushev I, Albert NL, van Berckel B, Brendel M, Cecchin D, Fernandez PA, Fraioli F, Guedj E, Morbelli S, Tolboom N, Traub-Weidinger T, Van Weehaeghe D, Barthel H (2023). FDA approval of lecanemab: the real start of widespread amyloid PET use? - the EANM Neuroimaging Committee perspective. Eur J Nucl Med Mol Imaging, 50(6), 1553-1555.
     
  16. Sattler B, Sharma M (2023). Editorial: Women in extreme microbiology: 2022. Front Microbiol, 14(), 1339335.
     
  17. Gattinger D, Pichler K, Weil T, Sattler B (2023). A comparative approach to confirm antibiotic-resistant microbes in the cryosphere. Front Microbiol, 14(), 1212378.
     
  18. Amiri A, Guess L, Gilder R, Showalter D, Hart L, Sattler B (2023). Using Fume Hood to Reduce Nurses' Exposure to Particulate Matters Dispersed Into the Air During Pill Crushing. Workplace Health Saf, 71(9), 412-418.
     
  19. Mauz-Körholz C, Landman-Parker J, Fernández-Teijeiro A, Attarbaschi A, Balwierz W, Bartelt JM, Beishuizen A, Boudjemaa S, Cepelova M, Ceppi F, Claviez A, Daw S, Dieckmann K, Fosså A, Gattenlöhner S, Georgi T, Hjalgrim LL, Hraskova A, Karlén J, Kurch L, Leblanc T, Mann G, Montravers F, Pears J, Pelz T, Raji? V, Ramsay AD, Stoevesandt D, Uyttebroeck A, Vordermark D, Körholz D, Hasenclever D, Wallace WH, Kluge R (2023). Response-adapted omission of radiotherapy in children and adolescents with early-stage classical Hodgkin lymphoma and an adequate response to vincristine, etoposide, prednisone, and doxorubicin (EuroNet-PHL-C1): a titration study. Lancet Oncol, 24(3), 252-261.
     
  20. Wattjes MP, Huppertz HJ, Mahmoudi N, Stöcklein S, Rogozinski S, Wegner F, Klietz M, Apostolova I, Levin J, Katzdobler S, Buhmann C, Quattrone A, Berding G, Brendel M, Barthel H, Sabri O, Höglinger G, Buchert R (2023). Brain MRI in Progressive Supranuclear Palsy with Richardson's Syndrome and Variant Phenotypes. Mov Disord, 38(10), 1891-1900.
     
  21. Meule A, Hesse S, Brähler E, Hilbert A (2023). Hedonic Overeating-Questionnaire: Exploring interactive effects between wanting, liking, and dyscontrol on body mass index. Appetite, (), 106592.
     
  22. Schönecker S, Palleis C, Franzmeier N, Katzdobler S, Ferschmann C, Schuster S, Finze A, Scheifele M, Prix C, Fietzek U, Weidinger E, Nübling G, Vöglein J, Patt M, Barthel H, Sabri O, Danek A, Höglinger GU, Brendel M, Levin J (2023). Symptomatology in 4-repeat tauopathies is associated with data-driven topology of [(18)F]-PI-2620 tau-PET signal. Neuroimage Clin, 38(), 103402.
     
  23. Wattjes MP, Huppertz HJ, Mahmoudi N, Stöcklein S, Rogozinski S, Wegner F, Klietz M, Apostolova I, Levin J, Katzdobler S, Buhmann C, Quattrone A, Berding G, Brendel M, Barthel H, Sabri O, Höglinger G, Buchert R (2023). Brain MRI in Progressive Supranuclear Palsy with Richardson's Syndrome and Variant Phenotypes. Mov Disord, (), 0-0.
     
  24. Veit-Haibach P, Ahlström H, Boellaard R, Delgado Bolton RC, Hesse S, Hope T, Huellner MW, Iagaru A, Johnson GB, Kjaer A, Law I, Metser U, Quick HH, Sattler B, Umutlu L, Zaharchuk G, Herrmann K (2023). International EANM-SNMMI-ISMRM consensus recommendation for PET/MRI in oncology. Eur J Nucl Med Mol Imaging, (), 0-0.
     
  25. Wattjes MP, Huppertz HJ, Mahmoudi N, Stöcklein S, Rogozinski S, Wegner F, Klietz M, Apostolova I, Levin J, Katzdobler S, Buhmann C, Quattrone A, Berding G, Brendel M, Barthel H, Sabri O, Höglinger G, Buchert R (2023). Brain MRI in Progressive Supranuclear Palsy with Richardson's Syndrome and Variant Phenotypes. Mov Disord, 38(10), 1891-1900.
     
  26. Sjögreen-Gleisner K, Flux G, Bacher K, Chiesa C, de Nijs R, Kagadis GC, Lima T, Georgosopoulou ML, Gabiña PM, Nekolla S, Peters S, Santos J, Sattler B, Stokke C, Tran-Gia J, Gilligan P, Bardiès M (2023). EFOMP policy statement NO. 19: Dosimetry in nuclear medicine therapy - Molecular radiotherapy. Phys Med, 116(), 103166.
     
  27. Ehrengut C, Vogt J, Leonhardi J, Carabenciov E, Teske F, Boemmel FV, Berg T, Seehofer D, Lincke T, Sabri O, Gößmann H, Denecke T, Ebel S (2023). Analysis of Periprocedural X-ray Exposure in Transarterial Radioembolization with Glass or Resin Microspheres. Diagnostics (Basel), 13(24), 0-0.
     
  28. Finze A, Biechele G, Rauchmann BS, Franzmeier N, Palleis C, Katzdobler S, Weidinger E, Guersel S, Schuster S, Harris S, Schmitt J, Beyer L, Gnörich J, Lindner S, Albert NL, Wetzel CH, Rupprecht R, Rominger A, Danek A, Burow L, Kurz C, Tato M, Utecht J, Papazov B, Zaganjori M, Trappmann LK, Goldhardt O, Grimmer T, Haeckert J, Janowitz D, Buerger K, Keeser D, Stoecklein S, Dietrich O, Morenas-Rodriguez E, Barthel H, Sabri O, Bartenstein P, Simons M, Haass C, Höglinger GU, Levin J, Perneczky R, Bre (2023). Individual regional associations between A?-, tau- and neurodegeneration (ATN) with microglial activation in patients with primary and secondary tauopathies. Mol Psychiatry, (), 0-0.
     
  29. Bergner CG, Schäfer L, Vucinic V, Schetschorke B, Lier J, Scherlach C, Rullmann M, Sabri O, Classen J, Platzbecker U, Kühl JS, Barthel H, Köhler W, Franke GN (2023). Case report: Treatment of advanced CSF1-receptor associated leukoencephalopathy with hematopoietic stem cell transplant. Front Neurol, 14(), 1163107.
     
  30. Völter F, Beyer L, Eckenweber F, Scheifele M, Bui N, Patt M, Barthel H, Katzdobler S, Palleis C, Franzmeier N, Levin J, Perneczky R, Rauchmann BS, Sabri O, Hong J, Cumming P, Rominger A, Shi K, Bartenstein P, Brendel M (2023). Assessment of perfusion deficit with early phases of [(18)F]PI-2620 tau-PET versus [(18)F]flutemetamol-amyloid-PET recordings. Eur J Nucl Med Mol Imaging, 50(5), 1384-1394.
     
  31. Tolboom N, Verger A, Albert NL, Fraioli F, Guedj E, Traub-Weidinger T, Morbelli S, Herrmann K, Zucchetta P, Plasschaert SLA, Yakushev I, Weller M, Glas M, Preusser M, Cecchin D, Barthel H, Van Weehaeghe D (2023). Theranostics in Neurooncology: Heading Toward New Horizons. J Nucl Med, (), 0-0.
     
  32. Tolboom N, Verger A, Albert NL, Brendel M, Cecchin D, Fernandez PA, Fraioli F, Guedj E, Herrmann K, Traub-Weidinger T, Morbelli S, Yakushev I, Zucchetta P, Barthel H, Van Weehaeghe D (2023). EANM position paper: theranostics in brain tumours-the present and the future. Eur J Nucl Med Mol Imaging, 51(1), 202-205.
     
  33. Tian M, Zuo C, Civelek AC, Carrio I, Watanabe Y, Kang KW, Murakami K, Garibotto V, Prior JO, Barthel H, Guan Y, Lu J, Zhou R, Jin C, Wu S, Zhang X, Zhong Y, Zhang H (2023). International Nuclear Medicine Consensus on the Clinical Use of Amyloid Positron Emission Tomography in Alzheimer's Disease. Phenomics, 3(4), 375-389.
     
  34. Weber WA, Barthel H, Bengel FM, Eiber MM, Herrmann K, Schäfers M (2023). Reply to: Not All Gatekeepers Are Theranostics. J Nucl Med, 64(10), 1662-1663.
     
  35. Weber WA, Barthel H, Bengel F, Eiber M, Herrmann K, Schäfers M (2023). What Is Theranostics? J Nucl Med, 64(5), 669-670.
     
  36. Ferrández MC, Golla SSV, Eertink JJ, de Vries BM, Lugtenburg PJ, Wiegers SE, Zwezerijnen GJC, Pieplenbosch S, Kurch L, Hüttmann A, Hanoun C, Dührsen U, de Vet HCW, Zijlstra JM, Boellaard R (2023). An artificial intelligence method using FDG PET to predict treatment outcome in diffuse large B cell lymphoma patients. Sci Rep, 13(1), 13111.
     
  37. Lückemeier P, Radujkovic A, Holtick U, Kurch L, Monecke A, Platzbecker U, Herling M, Kayser S (2023). Characterization and outcome of post-transplant lymphoproliferative disorders within a collaborative study. Front Oncol, 13(), 1208028.
     
  38. Franke FC, Damek A, Steglich J, Kurch L, Hasenclever D, Georgi TW, Wohlgemuth WA, Mauz-Körholz C, Körholz D, Kluge R, Landman-Parker J, Wallace WH, Fosså A, Vordermark D, Karlen J, Fernández-Teijeiro A, Cepelova M, Klekawka T, Attarbaschi A, Ceppi F, Hraskova A, Uyttebroeck A, Beishuizen A, Dieckmann K, Leblanc T, Moellers M, Buerke B, Stoevesandt D (2023). Differentiation between rebound thymic hyperplasia and thymic relapse after chemotherapy in pediatric Hodgkin lymphoma. Pediatr Blood Cancer, 70(8), 0-0.
     
  39. Eertink JJ, Zwezerijnen GJC, Heymans MW, Pieplenbosch S, Wiegers SE, Dührsen U, Hüttmann A, Kurch L, Hanoun C, Lugtenburg PJ, Barrington SF, Mikhaeel NG, Ceriani L, Zucca E, Czibor S, Györke T, Chamuleau MED, Hoekstra OS, de Vet HCW, Boellaard R, Zijlstra JM (2023). Baseline PET radiomics outperforms the IPI risk score for prediction of outcome in diffuse large B-cell lymphoma. Blood, 141(25), 3055-3064.
     
  40. Piccardo A, Treglia G, Fiz F, Bar-Sever Z, Bottoni G, Biassoni L, Borgwardt L, de Keizer B, Jehanno N, Lopci E, Kurch L, Massollo M, Nadel H, Roca Bielsa I, Shulkin B, Vali R, De Palma D, Cecchin D, Santos AI, Zucchetta P (2023). The evidence-based role of catecholaminergic PET tracers in Neuroblastoma. A systematic review and a head-to-head comparison with mIBG scintigraphy. Eur J Nucl Med Mol Imaging, (), 0-0.
     
  41. Körholz D, Mauz-Körholz C, Wallace WH, Landman-Parker J, Kluge R, Hasenclever D (2023). Radiotherapy for children and adolescents with early-stage classical Hodgkin lymphoma - Authors' reply. Lancet Oncol, 24(6), 0-0.
     
  42. Kroese TE, van Laarhoven HWM, Schoppman SF, Deseyne PRAJ, van Cutsem E, Haustermans K, Nafteux P, Thomas M, Obermannova R, Mortensen HR, Nordsmark M, Pfeiffer P, Elme A, Adenis A, Piessen G, Bruns CJ, Lordick F, Gockel I, Moehler M, Gani C, Liakakos T, Reynolds J, Morganti AG, Rosati R, Castoro C, Cellini F, D'Ugo D, Roviello F, Bencivenga M, de Manzoni G, van Berge Henegouwen MI, Hulshof MCCM, van Dieren J, Vollebergh M, van Sandick JW, Jeene P, Muijs CT, Slingerland M, Voncken FEM, Hartgrink H (2023). Definition, diagnosis and treatment of oligometastatic oesophagogastric cancer: A Delphi consensus study in Europe. Eur J Cancer, 185(), 28-39.
     


    43. 2022


  43. Rullmann M, Brendel M, Schroeter ML, Saur D, Levin J, Perneczky RG, Tiepolt S, Patt M, Mueller A, Villemagne VL, Classen J, Stephens AW, Sabri O, Barthel H, On Behalf Of The German Imaging Initiative For Tauopathies Gii T (2022). Multicenter 18F-PI-2620 PET for In Vivo Braak Staging of Tau Pathology in Alzheimer's Disease. Biomolecules, 12(3), 0-0.
     
  44. Renner A, Rausch I, Cal Gonzalez J, Laistler E, Moser E, Jochimsen T, Sattler T, Sabri O, Beyer T, Figl M, Birkfellner W, Sattler B (2022). Technical note: A PET/MR coil with an integrated, orbiting 511 keV transmission source for PET/MR imaging validated in an animal study. Med Phys, 49(4), 2366-2372.
     
  45. Einspänner E, Jochimsen TH, Harries J, Melzer A, Unger M, Brown R, Thielemans K, Sabri O, Sattler B (2022). Evaluating different methods of MR-based motion correction in simultaneous PET/MR using a head phantom moved by a robotic system. EJNMMI Phys, 9(1), 15.
     
  46. Jansen WJ, Janssen O, Tijms BM, Vos SJB, Ossenkoppele R, Visser PJ, Aarsland D, Alcolea D, Altomare D, von Arnim C, Baiardi S, Baldeiras I, Barthel H, Bateman RJ, Van Berckel B, Binette AP, Blennow K, Boada M, Boecker H, Bottlaender M, den Braber A, Brooks DJ, Van Buchem MA, Camus V, Carill JM, Cerman J, Chen K, Chételat G, Chipi E, Cohen AD, Daniels A, Delarue M, Didic M, Drzezga A, Dubois B, Eckerström M, Ekblad LL, Engelborghs S, Epelbaum S, Fagan AM, Fan Y, Fladby T, Fleisher AS, Van der Fli (2022). Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum. JAMA Neurol, 79(3), 228-243.
     
  47. Hendrikse H, Kiss O, Kunikowska J, Wadsak W, Decristoforo C, Patt M (2022). EANM position on the in-house preparation of radiopharmaceuticals. Eur J Nucl Med Mol Imaging, 49(4), 1095-1098.
     
  48. Villemagne VL, Barthel H (2022). Molecular Imaging of Neurodegeneration: The Way to New Horizons. J Nucl Med, 63(Suppl 1), 1S.
     
  49. Tiepolt S, Meyer PM, Patt M, Deuther-Conrad W, Hesse S, Barthel H, Sabri O (2022). PET Imaging of Cholinergic Neurotransmission in Neurodegenerative Disorders. J Nucl Med, 63(Suppl 1), 33S-44S.
     
  50. Barthel H, Villemagne VL, Drzezga A (2022). Future Directions in Molecular Imaging of Neurodegenerative Disorders. J Nucl Med, 63(Suppl 1), 68S-74S.
     
  51. Gündel D, Toussaint M, Lai TH, Deuther-Conrad W, Cumming P, Schröder S, Teodoro R, Moldovan RP, Pan-Montojo F, Sattler B, Kopka K, Sabri O, Brust P (2022). Quantitation of the A2A Adenosine Receptor Density in the Striatum of Mice and Pigs with [18F]FLUDA by Positron Emission Tomography. Pharmaceuticals (Basel), 15(5), 0-0.
     
  52. Roschke E, Kluge T, Stallkamp F, Roth A, Zajonz D, Hoffmann KT, Sabri O, Kluge R, Ghanem M (2022). Use of PET-CT in diagnostic workup of periprosthetic infection of hip and knee joints: significance in detecting additional infectious focus. Int Orthop, 46(3), 523-529.
     
  53. Messerschmidt K, Barthel H, Brendel M, Scherlach C, Hoffmann KT, Rauchmann BS, Rullmann M, Marek K, Villemagne VL, Rumpf JJ, Saur D, Schroeter ML, Schildan A, Patt M, Beyer L, Song M, Palleis C, Katzdobler S, Fietzek UM, Respondek G, Scheifele M, Nitschmann A, Zach C, Barret O, Madonia J, Russell D, Stephens AW, Koglin N, Roeber S, Herms J, Boetzel K, Bartenstein P, Levin J, Seibyl JP, Höglinger G, Classen J, Sabri O (2022). 18F-PI-2620 Tau PET Improves the Imaging Diagnosis of Progressive Supranuclear Palsy. J Nucl Med, (), 0-0.
     
  54. Georgi TW, Zieschank A, Kornrumpf K, Kurch L, Sabri O, Körholz D, Mauz-Körholz C, Kluge R, Posch S (2022). Automatic classification of lymphoma lesions in FDG-PET-Differentiation between tumor and non-tumor uptake. PLoS One, 17(4), e0267275.
     
  55. Georgi TW, Stoevesandt D, Kurch L, Bartelt JM, Hasenclever D, Dittmann H, Ferda J, Francis P, Franzius C, Furth C, Gräfe D, Gussew A, Hüllner MW, Menezes LJ, Mustafa M, Stegger L, Umutlu L, Zöphel K, Zucchetta P, Körholz D, Sabri O, Mauz-Körholz C, Kluge R (2022). Optimized whole-body positron emission tomography magnetic resonance imaging sequence workflow in pediatric Hodgkin lymphoma patients. J Nucl Med, (), 0-0.
     
  56. Aghakhanyan G, Rullmann M, Rumpf J, Schroeter ML, Scherlach C, Patt M, Brendel M, Koglin N, Stephens AW, Classen J, Hoffmann KT, Sabri O, Barthel H (2022). Interplay of tau and functional network connectivity in progressive supranuclear palsy: a [18F]PI-2620 PET/MRI study. Eur J Nucl Med Mol Imaging, (), 0-0.
     
  57. Steinhoff KG, Petersen TO, Purz S, Veelken R, Van Boemmel F, Denecke T, Berg T, Sabri O (2022). Yttrium-90 radioembolization-induced abscopal effect on hepatocellular carcinoma. J Dig Dis, 23(4), 237-239.
     
  58. Hermann W, Hesse S (2022). [Nuclear medicine diagnostics in Wilson's disease]. Nervenarzt, (), 0-0.
     
  59. Messerschmidt K, Barthel H, Brendel M, Scherlach C, Hoffmann KT, Rauchmann BS, Rullmann M, Marek K, Villemagne VL, Rumpf JJ, Saur D, Schroeter ML, Schildan A, Patt M, Beyer L, Song M, Palleis C, Katzdobler S, Fietzek UM, Respondek G, Scheifele M, Nitschmann A, Zach C, Barret O, Madonia J, Russell D, Stephens AW, Koglin N, Roeber S, Herms J, Bötzel K, Bartenstein P, Levin J, Seibyl JP, Höglinger G, Classen J, Sabri O (2022). 18F-PI-2620 Tau PET Improves the Imaging Diagnosis of Progressive Supranuclear Palsy. J Nucl Med, 63(11), 1754-1760.
     
  60. Schinke C, Rullmann M, Luthardt J, Drabe M, Preller E, Becker GA, Patt M, Regenthal R, Zientek F, Sabri O, Then Bergh F, Hesse S (2022). HPA Axis Responsiveness Associates with Central Serotonin Transporter Availability in Human Obesity and Non-Obesity Controls. Brain Sci, 12(11), 0-0.
     
  61. Griebsch NI, Kern J, Hansen J, Rullmann M, Luthardt J, Helfmeyer S, Dekorsy FJ, Soeder M, Hankir MK, Zientek F, Becker GA, Patt M, Meyer PM, Dietrich A, Blüher M, Ding YS, Hilbert A, Sabri O, Hesse S (2022). Central Serotonin/Noradrenaline Transporter Availability and Treatment Success in Patients with Obesity. Brain Sci, 12(11), 0-0.
     
  62. Rozwod K, Mauz-Körholz C, Heine P, Gattenlöhner S, Langer C, Steiner D, Krombach G, Georgi TW, Kallenberg K, Sabri O, Körholz D, Kluge R, Bartelt JM, Stoevesandt D, Kurch L (2022). Waldeyer's ring involvement in a young patient with Hodgkin lymphoma: Challenges, interdisciplinary findings, and reliability check of the image-based algorithm for diagnosis and response assessment. Pediatr Blood Cancer, 69(7), e29560.
     
  63. Schweickert de Palma E, Günnewig T, Rullmann M, Luthardt J, Hankir MK, Meyer PM, Becker GA, Patt M, Martin S, Hilbert A, Blüher M, Sabri O, Hesse S (2022). Availability of Central ?4?2* Nicotinic Acetylcholine Receptors in Human Obesity. Brain Sci, 12(12), 0-0.
     
  64. Künze G, Kümpfel R, Rullmann M, Barthel H, Brendel M, Patt M, Sabri O (2022). Molecular Simulations Reveal Distinct Energetic and Kinetic Binding Properties of [(18)F]PI-2620 on Tau Filaments from 3R/4R and 4R Tauopathies. ACS Chem Neurosci, 13(14), 2222-2234.
     
  65. Leonhardi J, Barthel H, Speerforck S, Dietzel J, Schroeter ML, Saur D, Tiepolt S, Rullmann M, Patt M, Claßen J, Schomerus G, Sabri O (2022). Differential Diagnosis Between Alzheimer's Disease-Related Depression and Pseudo-Dementia in Depression: A New Indication for Amyloid-? Imaging? J Alzheimers Dis, 88(3), 1029-1035.
     
  66. Jansen WJ, Janssen O, Tijms BM, Vos SJB, Ossenkoppele R, Visser PJ, Aarsland D, Alcolea D, Altomare D, von Arnim C, Baiardi S, Baldeiras I, Barthel H, Bateman RJ, Van Berckel B, Binette AP, Blennow K, Boada M, Boecker H, Bottlaender M, den Braber A, Brooks DJ, Van Buchem MA, Camus V, Carill JM, Cerman J, Chen K, Chételat G, Chipi E, Cohen AD, Daniels A, Delarue M, Didic M, Drzezga A, Dubois B, Eckerström M, Ekblad LL, Engelborghs S, Epelbaum S, Fagan AM, Fan Y, Fladby T, Fleisher AS, Van der Fli (2022). Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum. JAMA Neurol, 79(3), 228-243.
     
  67. Gillings N, Hjelstuen O, Behe M, Decristoforo C, Elsinga PH, Ferrari V, Kiss OC, Kolenc P, Koziorowski J, Laverman P, Mindt TL, Ocak M, Patt M, Todde S, Walte A (2022). EANM guideline on quality risk management for radiopharmaceuticals. Eur J Nucl Med Mol Imaging, (), 0-0.
     
  68. Herrmann K, Giovanella L, Santos A, Gear J, Kiratli PO, Kurth J, Denis-Bacelar AM, Hustinx R, Patt M, Wahl RL, Paez D, Giammarile F, Jadvar H, Pandit-Taskar N, Ghesani M, Kunikowska J (2022). Joint EANM, SNMMI and IAEA Enabling Guide: How to Set Up a Theranostics Centre. J Nucl Med, (), 0-0.
     
  69. Huang J, Mauche N, Rullmann M, Ulke C, Becker GA, Patt M, Zientek F, Hesse S, Sabri O, Strauß M (2022). Association between Individual Norepinephrine Transporter (NET) Availability and Response to Pharmacological Therapy in Adults with Attention-Deficit/Hyperactivity Disorder (ADHD). Brain Sci, 12(8), 0-0.
     
  70. Huang J, Mauche N, Rullmann M, Ulke C, Becker GA, Patt M, Zientek F, Hesse S, Sabri O, Strauß M (2022). Association between Individual Norepinephrine Transporter (NET) Availability and Response to Pharmacological Therapy in Adults with Attention-Deficit/Hyperactivity Disorder (ADHD). Brain Sci, 12(8), 0-0.
     
  71. Fischer J, Wellhöner S, Ebel S, Lincke T, Böhlig A, Gerhardt F, Veelken R, Goessmann H, Steinhoff KG, Denecke T, Sabri O, Berg T, Bömmel FV (2022). The Liver Maximum Capacity Test (LiMAx) Is Associated with Short-Term Survival in Patients with Early Stage HCC Undergoing Transarterial Treatment. Cancers (Basel), 14(21), 0-0.
     
  72. Mauz-Körholz C, Landman-Parker J, Balwierz W, Ammann RA, Anderson RA, Attarbaschi A, Bartelt JM, Beishuizen A, Boudjemaa S, Cepelova M, Claviez A, Daw S, Dieckmann K, Fernández-Teijeiro A, Fosså A, Gattenlöhner S, Georgi T, Hjalgrim LL, Hraskova A, Karlén J, Kluge R, Kurch L, Leblanc T, Mann G, Montravers F, Pears J, Pelz T, Raji? V, Ramsay AD, Stoevesandt D, Uyttebroeck A, Vordermark D, Körholz D, Hasenclever D, Wallace WH (2022). Response-adapted omission of radiotherapy and comparison of consolidation chemotherapy in children and adolescents with intermediate-stage and advanced-stage classical Hodgkin lymphoma (EuroNet-PHL-C1): a titration study with an open-label, embedded, multinational, non-inferiority, randomised controlled trial. Lancet Oncol, 23(1), 125-137.
     
  73. Katzdobler S, Nitschmann A, Barthel H, Bischof G, Beyer L, Marek K, Song M, Wagemann O, Palleis C, Weidinger E, Nack A, Fietzek U, Kurz C, Häckert J, Stapf T, Ferschmann C, Scheifele M, Eckenweber F, Biechele G, Franzmeier N, Dewenter A, Schönecker S, Saur D, Schroeter ML, Rumpf JJ, Rullmann M, Schildan A, Patt M, Stephens AW, van Eimeren T, Neumaier B, Drzezga A, Danek A, Classen J, Bürger K, Janowitz D, Rauchmann BS, Stöcklein S, Perneczky R, Schöberl F, Zwergal A, Höglinger GU, Bartenstein P, (2022). Additive value of [(18)F]PI-2620 perfusion imaging in progressive supranuclear palsy and corticobasal syndrome. Eur J Nucl Med Mol Imaging, (), 0-0.
     
  74. Franzmeier N, Brendel M, Beyer L, Slemann L, Kovacs GG, Arzberger T, Kurz C, Respondek G, Lukic MJ, Biel D, Rubinski A, Frontzkowski L, Hummel S, Müller A, Finze A, Palleis C, Joseph E, Weidinger E, Katzdobler S, Song M, Biechele G, Kern M, Scheifele M, Rauchmann BS, Perneczky R, Rullman M, Patt M, Schildan A, Barthel H, Sabri O, Rumpf JJ, Schroeter ML, Classen J, Villemagne V, Seibyl J, Stephens AW, Lee EB, Coughlin DG, Giese A, Grossman M, McMillan CT, Gelpi E, Molina-Porcel L, Compta Y, van S (2022). Tau deposition patterns are associated with functional connectivity in primary tauopathies. Nat Commun, 13(1), 1362.
     
  75. Koole M, Amstrong I, Krizsan AK, Stromvall A, Visvikis D, Sattler B, Nekolla SG, Dickson J (2022). EANM guidelines for PET-CT and PET-MR routine quality control. Z Med Phys, (), 0-0.
     
  76. Matheoud R, Boellaard R, Pike L, Ptacek J, Reynés-Llompart G, Soret M, Vandenberghe S, Zorz A, Julyan P, Rausch I, Sattler B, Manuel SG, Tosi G, Dalianis K, Almeida PMD, Fabbri C, Gawel J, Hadjitheodorou P, Kotzasarlidou M, Viana Miranda Lima T, O'Doherty J, Skovorodko K, Sutov D, Taher A, Valenti M, Vanzi E (2022). EFOMP's protocol quality controls in PET/CT and PET/MR. Phys Med, 105(), 102506.
     
  77. Piccardo A, Albert NL, Borgwardt L, Fahey FH, Hargrave D, Galldiks N, Jehanno N, Kurch L, Law I, Lim R, Lopci E, Marner L, Morana G, Young Poussaint T, Seghers VJ, Shulkin BL, Warren KE, Traub-Weidinger T, Zucchetta P (2022). Joint EANM/SIOPE/RAPNO practice guidelines/SNMMI procedure standards for imaging of paediatric gliomas using PET with radiolabelled amino acids and [(18)F]FDG: version 1.0. Eur J Nucl Med Mol Imaging, 49(11), 3852-3869.
     
  78. Krause A, Stocker G, Gockel I, Seehofer D, Hoffmeister A, Bläker H, Denecke T, Kluge R, Lordick F, Knödler M (2022). Guideline adherence and implementation of tumor board therapy recommendations for patients with gastrointestinal cancer. J Cancer Res Clin Oncol, (), 0-0.
     
  79. Kroese TE, van Hillegersberg R, Schoppmann S, Deseyne PRAJ, Nafteux P, Obermannova R, Nordsmark M, Pfeiffer P, Hawkins MA, Smyth E, Markar S, Hanna GB, Cheong E, Chaudry A, Elme A, Adenis A, Piessen G, Gani C, Bruns CJ, Moehler M, Liakakos T, Reynolds J, Morganti A, Rosati R, Castoro C, D'Ugo D, Roviello F, Bencivenga M, de Manzoni G, Jeene P, van Sandick JW, Muijs C, Slingerland M, Nieuwenhuijzen G, Wijnhoven B, Beerepoot LV, Kolodziejczyk P, Polkowski WP, Alsina M, Pera M, Kanonnikoff TF, Nils (2022). Definitions and treatment of oligometastatic oesophagogastric cancer according to multidisciplinary tumour boards in Europe. Eur J Cancer, 164(), 18-29.
     
  80. Claus Zippel, Johannes Ermert, Marianne Patt, Franz Josef Gildehaus, Tobias L Ross, Gerald Reischl, Torsten Kuwert, Christoph Solbach, Bernd Neumaier, Oliver Kiss, Markus Mitterhauser, Wolfgang Wadsak, Roger Schibli, Klaus Kopka (2022). Cyclotrons Operated for Nuclear Medicine and Radiopharmacy in the German Speaking D-A-CH Countries: An Update on Current Status and Trends Front. Nucl. Med., 2, 850414.
     
  81. Peira E, Poggiali D, Pardini M, Barthel H, Sabri O, Morbelli S, Cagnin A, Chincarini A, Cecchin D (2022). A comparison of advanced semi-quantitative amyloid PET analysis methods. Eur J Nucl Med Mol Imaging, 49(12), 4097-4108.
     
  82. Michalski D, Reimann W, Spielvogel E, Mages B, Biedermann B, Barthel H, Nitzsche B, Schob S, Härtig W (2022). Regionally Altered Immunosignals of Surfactant Protein-G, Vascular and Non-Vascular Elements of the Neurovascular Unit after Experimental Focal Cerebral Ischemia in Mice, Rats, and Sheep. Int J Mol Sci, 23(11), 0-0.
     
  83. Massa F, Halbgebauer S, Barba L, Oeckl P, Gómez de San José N, Bauckneht M, Lanfranchi F, Vigo T, Arnaldi D, Pardini M, Morbelli S, Chincarini A, Barthel H, Otto M, Nobili F (2022). Exploring the brain metabolic correlates of process-specific CSF biomarkers in patients with MCI due to Alzheimer's disease: preliminary data. Neurobiol Aging, 117(), 212-221.
     
  84. Guedj E, Varrone A, Boellaard R, Albert NL, Barthel H, van Berckel B, Brendel M, Cecchin D, Ekmekcioglu O, Garibotto V, Lammertsma AA, Law I, Peñuelas I, Semah F, Traub-Weidinger T, van de Giessen E, Van Weehaeghe D, Morbelli S (2022). EANM procedure guidelines for brain PET imaging using [(18)F]FDG, version 3. Eur J Nucl Med Mol Imaging, 49(2), 632-651.
     
  85. Tian M, Civelek AC, Carrio I, Watanabe Y, Kang KW, Murakami K, Garibotto V, Prior JO, Barthel H, Zhou R, Hou H, Dou X, Jin C, Zuo C, Zhang H (2022). International consensus on the use of tau PET imaging agent (18)F-flortaucipir in Alzheimer's disease. Eur J Nucl Med Mol Imaging, 49(3), 895-904.
     
  86. Verger A, Barthel H, Tolboom N, Fraioli F, Cecchin D, Albert NL, van Berckel B, Boellaard R, Brendel M, Ekmekcioglu O, Semah F, Traub-Weidinger T, van de Weehaeghe D, Morbelli S, Guedj E (2022). 2-[(18)F]-FDG PET for imaging brain involvement in patients with long COVID: perspective of the EANM Neuroimaging Committee. Eur J Nucl Med Mol Imaging, 49(11), 3599-3606.
     


    87. 2021


  87. Kurch L, Mauz-Körholz C, Fosså A, Georgi TW, Kluge R, Bartelt JM, Kunze C, Wohlgemuth WA, Pelz T, Vordermark D, Plößl S, Hasenclever D, Sabri O, Landman-Parker J, Wallace WH, Karlen J, Fernández-Teijeiro A, Cepelova M, Klekawka T, Løndalen AM, Steiner D, Krombach G, Attarbaschi A, Hoffmann M, Ceppi F, Pears J, Hraskova A, Uyttebroeck A, Beishuizen A, Dieckmann K, Leblanc T, Daw S, Körholz D, Stoevesandt D (2021). Assessment of Waldeyer's ring in pediatric and adolescent Hodgkin lymphoma patients-Importance of multimodality imaging: Results from the EuroNet-PHL-C1 trial. Pediatr Blood Cancer, 68(4), e28903.
     
  88. Patt M, Kuwert T, Luster M, Krause BJ, Solbach C (2021). Regulatorische Anforderungen an Radiopharmaka in Deutschland: die Fachgesellschaft im behördlichen Dialog. Nuklearmedizin, 60(1), 55-58.
     
  89. Patt M, Schulze R, Breitkreutz F, Vogg A, Solbach C (2021). Zum Rechtsstatus von Kits in der Herstellung von Radiopharmaka. Nuklearmedizin, 60(2), 115-120.
     
  90. Decristoforo C, Neels O, Patt M (2021). Emerging Radionuclides in a Regulatory Framework for Medicinal Products - How Do They Fit? Front Med (Lausanne), 8(), 678452.
     
  91. Patt M, Bengel F, Essler M, Krause BJ, Kuwert T, Rahbar K, Sabri O, Schäfer W, Schreckenberger M, Weber WA, Herrmann K (2021). [Fireside chat "§ 13 (2b) AMG in nuclear medicine therapy" - a follow-up event of NuklearMedizin 2020 - Digital]. Nuklearmedizin, 60(4), 262-263.
     
  92. Patt M, Bengel F, Essler M, Krause BJ, Kuwert T, Rahbar K, Sabri O, Schäfer W, Schreckenberger M, Weber WA, Herrmann K (2021). [Fireside chat "§ 13 (2b) AMG in nuclear medicine therapy" - a follow-up event of NuklearMedizin 2020 - Digital]. Nuklearmedizin, 60(4), 262-263.
     
  93. Palleis C, Brendel M, Finze A, Weidinger E, Bötzel K, Danek A, Beyer L, Nitschmann A, Kern M, Biechele G, Rauchmann BS, Häckert J, Höllerhage M, Stephens AW, Drzezga A, van Eimeren T, Villemagne VL, Schildan A, Barthel H, Patt M, Sabri O, Bartenstein P, Perneczky R, Haass C, Levin J, Höglinger GU (2021). Cortical [18 F]PI-2620 Binding Differentiates Corticobasal Syndrome Subtypes. Mov Disord, 36(9), 2104-2115.
     
  94. Soeder JM, Luthardt J, Rullmann M, Becker GA, Hankir MK, Patt M, Meyer PM, Schütz T, Ding YS, Hilbert A, Dietrich A, Sabri O, Hesse S (2021). Central Noradrenergic Neurotransmission and Weight Loss 6 Months After Gastric Bypass Surgery in Patients with Severe Obesity. Obes Surg, 31(11), 4868-4876.
     
  95. Aghakhanyan G, Saur D, Rullmann M, Weise CM, Schroeter ML, Marek K, Jamra RA, Tiepolt S, Strauss M, Scherlach C, Hoffmann KT, Sabri O, Classen J, Barthel H (2021). PET/MRI Delivers Multimodal Brain Signature in Alzheimer's Disease with De Novo PSEN1 Mutation. Curr Alzheimer Res, 18(2), 178-184.
     
  96. Kurch L, Hüttmann A, Georgi TW, Rekowski J, Sabri O, Schmitz C, Kluge R, Dührsen U, Hasenclever D (2021). Interim PET in Diffuse Large B-Cell Lymphoma. J Nucl Med, 62(8), 1068-1074.
     
  97. Kurch L, Dührsen U, Hüttmann A, Georgi TW, Sabri O, Kluge R, Hasenclever D (2021). Quantitative evaluation of interim positron emission tomography in peripheral T-cell lymphoma. EJNMMI Res, 11(1), 90.
     
  98. Kurch L, Kluge R, Sabri O, Fischer L, Wendt S, Graf Einsiedel H, Starke S, Kühl JS, Christiansen H, Hirsch FW, Sorge I, Roth C (2021). Whole-body [18F]-FDG-PET/MRI for staging of pediatric non-Hodgkin lymphoma: first results from a single-center evaluation. EJNMMI Res, 11(1), 62.
     
  99. Tiepolt S, Becker GA, Wilke S, Cecchin D, Rullmann M, Meyer PM, Barthel H, Hesse S, Patt M, Luthardt J, Wagenknecht G, Sattler B, Deuther-Conrad W, Ludwig FA, Fischer S, Gertz HJ, Smits R, Hoepping A, Steinbach J, Brust P, Sabri O (2021). (+)-[18F]Flubatine as a novel ?4?2 nicotinic acetylcholine receptor PET ligand-results of the first-in-human brain imaging application in patients with ?-amyloid PET-confirmed Alzheimer's disease and healthy controls. Eur J Nucl Med Mol Imaging, 48(3), 731-746.
     
  100. Schierz JH, Ali F, McLeod A (2021). Risk of Upstaging Due to Oncofertility Treatment Mimicking Pelvic Lymphoma on 18F-FDG PET/CT. Clin Nucl Med, 00, 1-2.
     
  101. Löser J, Luthardt J, Rullmann M, Weise D, Sabri O, Meixensberger J, Hesse S, Winkler D (2021). Striatal dopamine transporter availability and individual clinical course within the 1-year follow-up of deep brain stimulation of the subthalamic nucleus in patients with Parkinson's disease. J Neurosurg, (), 1-7.
     
  102. Kurch L, Georgi TW, Monecke A, Seehofer D, Borte G, Sabri O, Kluge R, Heyn S, Pierer M, Platzbecker U, Kayser S (2021). Vital Hepatic Lymphoma Residuum or Excessive Immune Response? Challenging Treatment Decisions in a Patient With Systemic Lupus Erythematosus and Liver-Dominant Diffuse Large B-Cell Lymphoma: Case Report. Front Oncol, 11(), 798757.
     
  103. Kurch L, Georgi TW, Monecke A, Seehofer D, Borte G, Sabri O, Kluge R, Heyn S, Pierer M, Platzbecker U, Kayser S (2021). Vital Hepatic Lymphoma Residuum or Excessive Immune Response? Challenging Treatment Decisions in a Patient With Systemic Lupus Erythematosus and Liver-Dominant Diffuse Large B-Cell Lymphoma: Case Report. Front Oncol, 11(), 798757.
     
  104. Kurch L, Georgi TW, Monecke A, Seehofer D, Borte G, Sabri O, Kluge R, Heyn S, Pierer M, Platzbecker U, Kayser S (2021). Vital Hepatic Lymphoma Residuum or Excessive Immune Response? Challenging Treatment Decisions in a Patient With Systemic Lupus Erythematosus and Liver-Dominant Diffuse Large B-Cell Lymphoma: Case Report. Front Oncol, 11(), 798757.
     
  105. Kurch L, Georgi TW, Monecke A, Seehofer D, Borte G, Sabri O, Kluge R, Heyn S, Pierer M, Platzbecker U, Kayser S (2021). Vital Hepatic Lymphoma Residuum or Excessive Immune Response? Challenging Treatment Decisions in a Patient With Systemic Lupus Erythematosus and Liver-Dominant Diffuse Large B-Cell Lymphoma: Case Report. Front Oncol, 11, 798757.
     
  106. Guntinas-Lichius O, Ihrler S, Freesmeyer M, Gühne F, Kluge R, Bräuer L, Iro H, Paulsen F, Dietz A, Bechmann I (2021). [Is there a new salivary gland? - Rather not!] Laryngorhinootologie, 100(1), 12-14.
     
  107. Rekowski J, Hüttmann A, Schmitz C, Müller SP, Kurch L, Kotzerke J, Franzius C, Weckesser M, Bengel FM, Freesmeyer M, Hertel A, Krohn T, Holzinger J, Brink I, Haberkorn U, Nyuyki F, van Assema DME, Geworski L, Hasenclever D, Jöckel KH, Dührsen U (2021). Interim PET Evaluation in Diffuse Large B-Cell Lymphoma Using Published Recommendations: Comparison of the Deauville 5-Point Scale and the ?SUVmax Method. J Nucl Med, 62(1), 37-42.
     
  108. Dukart J, Holiga S, Rullmann M, Lanzenberger R, Hawkins PCT, Mehta MA, Hesse S, Barthel H, Sabri O, Jech R, Eickhoff SB (2021). JuSpace: A tool for spatial correlation analyses of magnetic resonance imaging data with nuclear imaging derived neurotransmitter maps. Hum Brain Mapp, 42(3), 555-566.
     
  109. Guntinas-Lichius O, Ihrler S, Freesmeyer M, Gühne F, Kluge R, Bräuer L, Iro H, Paulsen F, Dietz A, Bechmann I (2021). [Is there a new salivary gland? - Rather not!] Laryngorhinootologie, 100(1), 12-14.
     
  110. Dukart J, Holiga S, Rullmann M, Lanzenberger R, Hawkins PCT, Mehta MA, Hesse S, Barthel H, Sabri O, Jech R, Eickhoff SB (2021). JuSpace: A tool for spatial correlation analyses of magnetic resonance imaging data with nuclear imaging derived neurotransmitter maps. Hum Brain Mapp, 42(3), 555-566.
     
  111. Lai TH, Toussaint M, Teodoro R, Duki?-Stefanovi? S, Gündel D, Ludwig FA, Wenzel B, Schröder S, Sattler B, Moldovan RP, Falkenburger BH, Sabri O, Deuther-Conrad W, Brust P (2021). Improved in vivo PET imaging of the adenosine A2A receptor in the brain using [18F]FLUDA, a deuterated radiotracer with high metabolic stability. Eur J Nucl Med Mol Imaging, 0, 1-10.
     
  112. Löser J, Luthardt J, Rullmann M, Weise D, Sabri O, Meixensberger J, Hesse S, Winkler D (2021). Striatal dopamine transporter availability and individual clinical course within the 1-year follow-up of deep brain stimulation of the subthalamic nucleus in patients with Parkinson's disease. J Neurosurg, (), 1-7.
     
  113. Bischof GN, Dodich A, Boccardi M, van Eimeren T, Festari C, Barthel H, Hansson O, Nordberg A, Ossenkoppele R, Sabri O, Giovanni BFG, Garibotto V, Drzezga A (2021). Clinical validity of second-generation tau PET tracers as biomarkers for Alzheimer's disease in the context of a structured 5-phase development framework. Eur J Nucl Med Mol Imaging, (), 1-11.
     
  114. Vera JH, Eftychiou N, Schuerer M, Rullmann M, Barthel H, Sabri O, Gisslen M, Zetterberg H, Blennow K, O'Brien C, Banerjee S, Dizdarevic S (2021). CLINICAL UTILITY OF ?-AMYLOID PET IMAGING IN PEOPLE LIVING WITH HIV WITH COGNITIVE SYMPTOMS. J Acquir Immune Defic Syndr, (), 1-10.
     
  115. Dukart J, Holiga S, Rullmann M, Lanzenberger R, Hawkins PCT, Mehta MA, Hesse S, Barthel H, Sabri O, Jech R, Eickhoff SB (2021). JuSpace: A tool for spatial correlation analyses of magnetic resonance imaging data with nuclear imaging derived neurotransmitter maps. Hum Brain Mapp, 42(3), 555-566.
     
  116. Dukart J, Holiga S, Rullmann M, Lanzenberger R, Hawkins PCT, Mehta MA, Hesse S, Barthel H, Sabri O, Jech R, Eickhoff SB (2021). JuSpace: A tool for spatial correlation analyses of magnetic resonance imaging data with nuclear imaging derived neurotransmitter maps. Hum Brain Mapp, 42(3), 555-566.
     
  117. Haeckert J, Brendel M, Beyer L, Barthel H, Sabri O, Hasan A, Perneczky R (2021). Effective Valproic Acid Treatment in a Patient With Delusional Parasitosis Due to Corticobasal Syndrome and Alzheimer Disease. J Clin Psychopharmacol, 41(3), 335-337.
     
  118. Cercignani M, Dipasquale O, Bogdan I, Carandini T, Scott J, Rashid W, Sabri O, Hesse S, Rullmann M, Lopiano L, Veronese M, Martins D, Bozzali M (2021). Cognitive fatigue in multiple sclerosis is associated with alterations in the functional connectivity of monoamine circuits. Brain Commun, 3(2), 1-10.
     
  119. Bullich S, Roé-Vellvé N, Marquié M, Landau SM, Barthel H, Villemagne VL, Sanabria Á, Tartari JP, Sotolongo-Grau O, Doré V, Koglin N, Müller A, Perrotin A, Jovalekic A, De Santi S, Tárraga L, Stephens AW, Rowe CC, Sabri O, Seibyl JP, Boada M (2021). Early detection of amyloid load using 18F-florbetaben PET. Alzheimers Res Ther, 13(1), 67.
     
  120. Al-Qahtani M, Behe M, Bormans G, Carlucci G, Dasilva J, Decristoforo C, Elsinga PH, Kopka K, Li XG, Mach R, Middel O, Passchier J, Patt M, Penuelas I, Rey A, Scott PJH, Todde S, Toyohara J, Vugts D (2021). Highlight selection of radiochemistry and radiopharmacy developments by editorial board (January-June 2020). EJNMMI Radiopharm Chem, 6(1), 5.
     
  121. Gillings N, Hjelstuen O, Ballinger J, Behe M, Decristoforo C, Elsinga P, Ferrari V, Peitl PK, Koziorowski J, Laverman P, Mindt TL, Neels O, Ocak M, Patt M, Todde S (2021). Guideline on current good radiopharmacy practice (cGRPP) for the small-scale preparation of radiopharmaceuticals. EJNMMI Radiopharm Chem, 6(1), 8.
     
  122. Tiepolt S, Becker GA, Wilke S, Cecchin D, Rullmann M, Meyer PM, Barthel H, Hesse S, Patt M, Luthardt J, Wagenknecht G, Sattler B, Deuther-Conrad W, Ludwig FA, Fischer S, Gertz HJ, Smits R, Hoepping A, Steinbach J, Brust P, Sabri O (2021). (+)-[18F]Flubatine as a novel ?4?2 nicotinic acetylcholine receptor PET ligand-results of the first-in-human brain imaging application in patients with ?-amyloid PET-confirmed Alzheimer's disease and healthy controls. Eur J Nucl Med Mol Imaging, 48(3), 731-746.
     
  123. Aime S, Al-Qahtani M, Behe M, Bormans G, Carlucci G, DaSilva JN, Decristoforo C, Duatti A, Elsinga PH, Kopka K, Li XG, Liu Z, Mach RH, Middel O, Passchier J, Patt M, Penuelas I, Rey A, Scott PJH, Todde S, Toyohara J, Vugts D, Yang Z (2021). Highlight selection of radiochemistry and radiopharmacy developments by editorial board. EJNMMI Radiopharm Chem, 6(1), 13.
     
  124. Grachev ID, Meyer PM, Becker GA, Bronzel M, Marsteller D, Pastino G, Voges O, Rabinovich L, Knebel H, Zientek F, Rullmann M, Sattler B, Patt M, Gerhards T, Strauss M, Kluge A, Brust P, Savola JM, Gordon MF, Geva M, Hesse S, Barthel H, Hayden MR, Sabri O (2021). Sigma-1 and dopamine D2/D3 receptor occupancy of pridopidine in healthy volunteers and patients with Huntington disease: a [18F] fluspidine and [18F] fallypride PET study. Eur J Nucl Med Mol Imaging, 48(4), 1103-1115.
     
  125. Frille A, Rullmann M, Becker GA, Patt M, Luthardt J, Tiepolt S, Wirtz H, Sabri O, Hesse S, Seyfarth HJ (2021). Increased pulmonary serotonin transporter in patients with chronic obstructive pulmonary disease who developed pulmonary hypertension. Eur J Nucl Med Mol Imaging, 48(4), 1081-1092.
     
  126. Willroider M, Roeber S, Horn AKE, Arzberger T, Scheifele M, Respondek G, Sabri O, Barthel H, Patt M, Mishchenko O, Schildan A, Mueller A, Koglin N, Stephens A, Levin J, Höglinger GU, Bartenstein P, Herms J, Brendel M, Beyer L (2021). Superiority of Formalin-Fixed Paraffin-Embedded Brain Tissue for in vitro Assessment of Progressive Supranuclear Palsy Tau Pathology With [ 18 F]PI-2620. Front Neurol, 12(), 684523.
     
  127. Palleis C, Brendel M, Finze A, Weidinger E, Bötzel K, Danek A, Beyer L, Nitschmann A, Kern M, Biechele G, Rauchmann BS, Häckert J, Höllerhage M, Stephens AW, Drzezga A, van Eimeren T, Villemagne VL, Schildan A, Barthel H, Patt M, Sabri O, Bartenstein P, Perneczky R, Haass C, Levin J, Höglinger GU (2021). Cortical [18 F]PI-2620 Binding Differentiates Corticobasal Syndrome Subtypes. Mov Disord, 36(9), 2104-2115.
     
  128. Decristoforo C, Neels O, Patt M (2021). Emerging Radionuclides in a Regulatory Framework for Medicinal Products - How Do They Fit? Front Med (Lausanne), 8(), 678452.
     
  129. Song M, Scheifele M, Barthel H, van Eimeren T, Beyer L, Marek K, Eckenweber F, Palleis C, Kaiser L, Finze A, Kern M, Nitschmann A, Biechele G, Katzdobler S, Bischof G, Hammes J, Jessen F, Saur D, Schroeter ML, Rumpf JJ, Rullmann M, Schildan A, Patt M, Neumaier B, Stephens AW, Rauchmann BS, Perneczky R, Levin J, Classen J, Höglinger GU, Bartenstein P, Boening G, Ziegler S, Villemagne V, Drzezga A, Seibyl J, Sabri O, Brendel M (2021). Feasibility of short imaging protocols for [18F]PI-2620 tau-PET in progressive supranuclear palsy. Eur J Nucl Med Mol Imaging, 48(12), 3872-3885.
     
  130. Seyfried F, Hoffmann A, Rullmann M, Schlegel N, Otto C, Hankir MK (2021). Weight loss from caloric restriction vs Roux-en-Y gastric bypass surgery differentially regulates systemic and portal vein GDF15 levels in obese Zucker fatty rats. Physiol Behav, 240(), 113534.
     
  131. Ortgies T, Rullmann M, Ziegelhöfer D, Bläser A, Thome UH (2021). The role of early-onset-sepsis in the neurodevelopment of very low birth weight infants. BMC Pediatr, 21(1), 289.
     
  132. Vali R, Alessio A, Balza R, Borgwardt L, Bar-Sever Z, Czachowski M, Jehanno N, Kurch L, Pandit-Taskar N, Parisi M, Piccardo A, Seghers V, Shulkin BL, Zucchetta P, Lim R (2021). SNMMI Procedure Standard/EANM Practice Guideline on Pediatric 18F-FDG PET/CT for Oncology 1.0. J Nucl Med, 62(1), 99-110.
     
  133. Sorge I, Georgi TW, Hirsch FW (2021). [Lymphoma in children and adolescents]. Radiologe, 61(7), 611-618.
     
  134. Zhang X, Landgraf L, Bailis N, Unger M, Jochimsen TH, Melzer A (2021). Image-Guided High-Intensity Focused Ultrasound, A Novel Application for Interventional Nuclear Medicine? J Nucl Med, 62(9), 1181-1188.
     
  135. Guntinas-Lichius O, Ihrler S, Freesmeyer M, Gühne F, Kluge R, Bräuer L, Iro H, Paulsen F, Dietz A, Bechmann I (2021). [Is there a new salivary gland? - Rather not!] Laryngorhinootologie, 100(1), 12-14.
     
  136. Gerhardt K, Jentzsch M, Georgi T, Sretenovi? A, Cross M, Bach E, Monecke A, Leiblein S, Hoffmann S, Todorovi? M, Bila J, Sabri O, Schwind S, Franke GN, Platzbecker U, Vu?ini? V (2021). Salvage Therapy With Polatuzumab Vedotin, Bendamustine, and Rituximab Prior to Allogeneic Hematopoietic Transplantation in Patients With Aggressive Lymphomas Relapsing After Therapy With Chimeric Antigen Receptor T-Cells-Report on Two Cases. Front Oncol, 11(), 0-0.
     
  137. Wichmann G, Pavlychenko M, Willner M, Halama D, Kuhnt T, Kluge R, Gradistanac T, Fest S, Wald T, Lethaus B, Dietz A, Wiegand S, Zebralla V (2021). Standardized Diagnostic Workup and Patient-Centered Decision Making for Surgery and Neck Dissection Followed by Risk-Factor Adapted Adjuvant Therapy Improve Loco-Regional Control in Local Advanced Oral Squamous Cell Carcinoma. Front Oncol, 11(), 0-0.
     
  138. Wichmann G, Willner M, Kuhnt T, Kluge R, Gradistanac T, Wald T, Fest S, Lordick F, Dietz A, Wiegand S, Zebralla V (2021). Standardized Diagnostics Including PET-CT Imaging, Bilateral Tonsillectomy and Neck Dissection Followed by Risk-Adapted Post-Operative Treatment Favoring Radio-Chemotherapy Improve Survival of Neck Squamous Cell Carcinoma of Unknown Primary Patients. Front Oncol, 11(), 0-0.
     
  139. Wang SY, Thomassen K, Kurch L, Opitz S, Franke GN, Bach E, Platzbecker U, Kayser S (2021). Combination of Tagraxofusp and Azacitidine Is an Effective Option for Relapsed Blastic Plasmacytoid Dendritic Cell Neoplasm After Allogeneic Hematopoietic Stem-Cell Transplantation. Clin Lymphoma Myeloma Leuk, 21(7), 0-0.
     
  140. Veronese M, Rizzo G, Belzunce M, Schubert J, Searle G, Whittington A, Mansur A, Dunn J, Reader A, Gunn RN (2021). Reproducibility of findings in modern PET neuroimaging: insight from the NRM2018 grand challenge. J Cereb Blood Flow Metab, 41(10), 2778-2796.
     
  141. Bischof GN, Bartenstein P, Barthel H, van Berckel B, Doré V, van Eimeren T, Foster N, Hammes J, Lammertsma AA, Minoshima S, Rowe C, Sabri O, Seibyl J, Van Laere K, Vandenberghe R, Villemagne V, Yakushev I, Drzezga A (2021). Toward a Universal Readout for 18F-Labeled Amyloid Tracers: The CAPTAINs Study. J Nucl Med, 62(7), 999-1005.
     
  142. Nuebling GS, Prix C, Brendel M, Beyer L, Wlasich E, Loosli SV, Barthel H, Sabri O, Bartenstein P, Vöglein J, Danek A, Rominger A, Edbauer D, Haass C, Levin J (2021). Low-degree trisomy 21 mosaicism promotes early-onset Alzheimer disease. Neurobiol Aging, 103(), 0-0.
     
  143. Chételat G, Arbizu J, Barthel H, Garibotto V, Lammertsma AA, Law I, Morbelli S, van de Giessen E, Drzezga A (2021). Finding our way through the labyrinth of dementia biomarkers. Eur J Nucl Med Mol Imaging, 48(8), 2320-2324.
     
  144. Garibotto V, Albert NL, Barthel H, van Berckel B, Boellaard R, Brendel M, Cecchin D, Ekmekcioglu O, van de Giessen E, Guedj E, Lammerstma AA, Semah F, Traub-Weidinger T, Van Weehaeghe D, Morbelli S (2021). The approval of a disease-modifying treatment for Alzheimer's disease: impact and consequences for the nuclear medicine community. Eur J Nucl Med Mol Imaging, 48(10), 3033-3036.
     
  145. Song M, Beyer L, Kaiser L, Barthel H, van Eimeren T, Marek K, Nitschmann A, Scheifele M, Palleis C, Respondek G, Kern M, Biechele G, Hammes J, Bischof G, Barbe M, Onur Ö, Jessen F, Saur D, Schroeter ML, Rumpf JJ, Rullmann M, Schildan A, Patt M, Neumaier B, Barret O, Madonia J, Russell DS, Stephens AW, Mueller A, Roeber S, Herms J, Bötzel K, Danek A, Levin J, Classen J, Höglinger GU, Bartenstein P, Villemagne V, Drzezga A, Seibyl J, Sabri O, Boening G, Ziegler S, Brendel M (2021). Binding characteristics of [18F]PI-2620 distinguish the clinically predicted tau isoform in different tauopathies by PET. J Cereb Blood Flow Metab, 41(11), 2957-2972.
     
  146. Brust P, Deuther-Conrad W, Donat C, Bathel H, Riss P, Paterson L, Hoepping A, Sabri O, Cumming P, (2021). Preclinical and Clinical Aspects of Nicotinic Acetylcholine Receptor Imaging. In: Diercks R, Otte A, de Vries E, van Warde A, Lammerstma AA, PET and SPECT of Neurobiological Systems (S. 593-660), Berlin Heidelberg: Springer.
     
  147. Barthel H, Zeisig V, Nitzsche B, Patt M, Patt J, Becker G, Dreyer A, Boltze J, Sabri O (2021). Cerebral Blood Flow Measurement with Oxygen-15 Water Positron Emission Tomography In: Dierckx R.A.J.O., Otte A., de Vries E.F.J., van Waarde A., Leenders K.L. (eds) , PET and SPECT of Neurobiological Systems (S. 127-152), Berlin Heidelberg: Springer.
     


    148. 2020


  148. Surov A, Meyer HJ, Höhn AK, Wienke A, Sabri O, Purz S (2020). Combined parameter SUVmax/ADCmean predicts microvessel density in head and neck squamous cell carcinoma. Preliminary results. Oral Oncol, 101(), 104355.
     
  149. Georgi TW, Kurch L, Hasenclever D, Warbey VS, Pike L, Radford J, Sabri O, Kluge R, Barrington SF (2020). Quantitative assessment of interim PET in Hodgkin lymphoma: An evaluation of the qPET method in adult patients in the RAPID trial. PLoS One, 15(4), e0231027.
     
  150. Sattler B, Kranz M, Wenzel B, Jain NT, Moldovan RP, Toussaint M, Deuther-Conrad W, Ludwig FA, Teodoro R, Sattler T, Sadeghzadeh M, Sabri O, Brust P (2020). Preclinical Incorporation Dosimetry of [18F]FACH-A Novel 18F-Labeled MCT1/MCT4 Lactate Transporter Inhibitor for Imaging Cancer Metabolism with PET. Molecules, 25(9), 2024.
     
  151. Barthel H, Seibyl J, Lammertsma AA, Villemagne VL, Sabri O (2020). Exploiting the Full Potential of ?-Amyloid and Tau PET Imaging for Drug Efficacy Testing. J Nucl Med, 61(8), 1105-1106.
     
  152. Henkelmann J, Bremicker K, Denecke T, Hoffmann KT, Henkelmann R, Heyde CE, Sabri O, Purz S (2020). Clinical suspicion of spondylodiscitis with equivocal MRI findings: does diffusion-weighted imaging prove helpful here? Acta Radiol, (), 284185120927905.
     
  153. Harries J, Jochimsen TH, Scholz T, Schlender T, Barthel H, Sabri O, Sattler B (2020). A realistic phantom of the human head for PET-MRI. EJNMMI Phys, 7(1), 52.
     
  154. Tiepolt S, Rullmann M, Jochimsen TH, Gertz HJ, Schroeter ML, Patt M, Sabri O, Barthel H (2020). Quantitative susceptibility mapping in ?-Amyloid PET-stratified patients with dementia and healthy controls - A hybrid PET/MRI study. Eur J Radiol, 131(), 109243.
     
  155. Collingridge D, Barthel H (2020). A Conversation Between David Collingridge and Henryk Barthel. J Nucl Med, 61(3), 307-310.
     
  156. Ferrara F, Zeisig V, Pietsch S, Rütten R, Dreyer AY, Pieper L, Schatzl AK, McLeod DD, Barthel H, Boltze J, Schrödl W, Nitzsche B (2020). Hypothesis and Theory: A Pathophysiological Concept of Stroke-Induced Acute Phase Response and Increased Intestinal Permeability Leading to Secondary Brain Damage. Front Neurosci, 14(), 272.
     
  157. Barthel H, Arbizu J, Drzezga A, Garibotto V, Lammertsma AA, Morbelli S (2020). Proven validity and management impact of amyloid imaging in Alzheimer's disease-repetita juvant. Eur J Nucl Med Mol Imaging, 47(8), 1787-1790.
     
  158. Barthel H (2020). First Tau PET Tracer Approved: Toward Accurate In Vivo Diagnosis of Alzheimer Disease. J Nucl Med, 61(10), 1409-1410.
     
  159. Brendel M, Barthel H, van Eimeren T, Marek K, Beyer L, Song M, Palleis C, Gehmeyr M, Fietzek U, Respondek G, Sauerbeck J, Nitschmann A, Zach C, Hammes J, Barbe MT, Onur O, Jessen F, Saur D, Schroeter ML, Rumpf JJ, Rullmann M, Schildan A, Patt M, Neumaier B, Barret O, Madonia J, Russell DS, Stephens A, Roeber S, Herms J, Bötzel K, Classen J, Bartenstein P, Villemagne V, Levin J, Höglinger GU, Drzezga A, Seibyl J, Sabri O (2020). Assessment of 18F-PI-2620 as a Biomarker in Progressive Supranuclear Palsy. JAMA Neurol, 77(11), 1408-1419.
     
  160. Rullmann M, McLeod A, Grothe MJ, Sabri O, Barthel H (2020). Reshaping the Amyloid Buildup Curve in Alzheimer Disease? Partial-Volume Effect Correction of Longitudinal Amyloid PET Data. J Nucl Med, 61(12), 1820-1824.
     
  161. Chen KT, Schürer M, Ouyang J, Koran MEI, Davidzon G, Mormino E, Tiepolt S, Hoffmann KT, Sabri O, Zaharchuk G, Barthel H (2020). Generalization of deep learning models for ultra-low-count amyloid PET/MRI using transfer learning. Eur J Nucl Med Mol Imaging, 47(13), 2998-3007.
     
  162. Barthel H, Arbizu J, Drzezga A, Garibotto V, Lammertsma AA, Morbelli S (2020). Proven validity and management impact of amyloid imaging in Alzheimer's disease-repetita juvant. Eur J Nucl Med Mol Imaging, 47(8), 1787-1790.
     
  163. Barthel H (2020). Switching on Brain PET to Light Up Amyloid Pathology In Vivo. J Nucl Med, 61(2), 227-228.
     
  164. Grundmann R, Rullmann M, Luthardt J, Zientek F, Becker GA, Patt M, Hankir MK, Blüher M, Sabri O, Hesse S (2020). Higher HbA1c levels associate with lower hippocampal serotonin transporter availability in non-diabetic adults with obesity. Sci Rep, 10(1), 21383.
     
  165. Schmidt E, Schinke C, Rullmann M, Luthardt J, Becker GA, Haars S, Stoppe M, Lobsien D, Hoffmann KT, Sabri O, Hesse S, Then Bergh F (2020). Changes of central noradrenaline transporter availability in immunotherapy-naïve multiple sclerosis patients. Sci Rep, 10(1), 14651.
     
  166. Patt M, Solbach C, Breitkreutz F, Schulze R (2020). Zur rechtlichen Einordnung diagnostischer Radiopharmaka in der nuklearmedizinischen Forschung mit gesunden Probanden. Nuklearmedizin, 59(5), 394-395.
     
  167. Essler M, Patt M (2020). Editorial: Artikelserie ?Rechtliche Grundlagen der Radiochemie?. Nuklearmedizin, 59(5), 346-347.
     
  168. Gillings N, Todde S, Behe M, Decristoforo C, Elsinga P, Ferrari V, Hjelstuen O, Peitl PK, Koziorowski J, Laverman P, Mindt TL, Ocak M, Patt M (2020). EANM guideline on the validation of analytical methods for radiopharmaceuticals. EJNMMI Radiopharm Chem, 5(1), 7.
     
  169. Henkelmann J, Bremicker K, Denecke T, Hoffmann KT, Henkelmann R, Heyde CE, Sabri O, Purz S (2020). Clinical suspicion of spondylodiscitis with equivocal MRI findings: does diffusion-weighted imaging prove helpful here? Acta Radiol, 0, 1-7.
     
  170. Kluge R, Wittig T, Georgi TW, Kurch L, Sabri O, Wallace WH, Klekawka T, Fernández-Teijeiro A, Ceppi F, Karlén J, Pears J, Cepelová M, Fosså A, Beishuizen A, Hjalgrim LL, Körholz D, Mauz-Körholz C, Hasenclever D (2020). Comparison of interim PET response to second-line vs. to first-line treatment in classical Hodgkin lymphoma - contribution to the development of response criteria for relapsed or progressive disease. J Nucl Med, 62(2), 1-21.
     
  171. Tiepolt S, Becker GA, Wilke S, Cecchin D, Rullmann M, Meyer PM, Barthel H, Hesse S, Patt M, Luthardt J, Wagenknecht G, Sattler B, Deuther-Conrad W, Ludwig FA, Fischer S, Gertz HJ, Smits R, Hoepping A, Steinbach J, Brust P, Sabri O (2020). (+)-[18F]Flubatine as a novel ?4?2 nicotinic acetylcholine receptor PET ligand-results of the first-in-human brain imaging application in patients with ?-amyloid PET-confirmed Alzheimer's disease and healthy controls. Eur J Nucl Med Mol Imaging, 0, 1-16.
     
  172. Grachev ID, Meyer PM, Becker GA, Bronzel M, Marsteller D, Pastino G, Voges O, Rabinovich L, Knebel H, Zientek F, Rullmann M, Sattler B, Patt M, Gerhards T, Strauss M, Kluge A, Brust P, Savola JM, Gordon MF, Geva M, Hesse S, Barthel H, Hayden MR, Sabri O (2020). Sigma-1 and dopamine D2/D3 receptor occupancy of pridopidine in healthy volunteers and patients with Huntington disease: a [18F] fluspidine and [18F] fallypride PET study. Eur J Nucl Med Mol Imaging, 0, 1-13.
     
  173. Steinhoff KG, Krause K, Linder N, Rullmann M, Volke L, Gebhardt C, Busse H, Stumvoll M, Blüher M, Sabri O, Hesse S, Tönjes A (2020). Effects of Hyperthyroidism on Adipose Tissue Activity and Distribution in Adults. Thyroid, 0, 1-10.
     
  174. Kurch L, Andreas H, Georgi TW, Rekowski J, Sabri O, Schmitz C, Kluge R, Duehrsen U, Hasenclever D (2020). Interim positron emission tomography in diffuse large B-cell lymphoma. J Nucl Med, 62(2), 1-36.
     
  175. Frille A, Rullmann M, Becker GA, Patt M, Luthardt J, Tiepolt S, Wirtz H, Sabri O, Hesse S, Seyfarth HJ (2020). Increased pulmonary serotonin transporter in patients with chronic obstructive pulmonary disease who developed pulmonary hypertension. Eur J Nucl Med Mol Imaging, (), 1-12.
     
  176. Reich CM, Sattler B, Jochimsen TH, Unger M, Melzer L, Landgraf L, Barthel H, Sabri O, Melzer A (2020). Practical setting and potential applications of interventions guided by PET/MRI. Q J Nucl Med Mol Imaging, (), 1-8.
     
  177. Kubasch AS, Franke GN, Aldaoud A, Weibl K, Jentzsch M, Sabri O, Horny HP, Fend F, Behre G, Platzbecker U, Vucinic V (2020). Allogeneic Hematopoietic Stem Cell Transplantation in a Rare Case of Tonsillar Mast Cell Sarcoma. Front Oncol, 10(), 219.
     
  178. Beyer L, Nitschmann A, Barthel H, van Eimeren T, Unterrainer M, Sauerbeck J, Marek K, Song M, Palleis C, Respondek G, Hammes J, Barbe MT, Onur Ö, Jessen F, Saur D, Schroeter ML, Rumpf JJ, Rullmann M, Schildan A, Patt M, Neumaier B, Barret O, Madonia J, Russell DS, Stephens AW, Roeber S, Herms J, Bötzel K, Levin J, Classen J, Höglinger GU, Bartenstein P, Villemagne V, Drzezga A, Seibyl J, Sabri O, Brendel M (2020). Early-phase [18F]PI-2620 tau-PET imaging as a surrogate marker of neuronal injury. Eur J Nucl Med Mol Imaging, 47(12), 2911-2922.
     
  179. Toussaint M, Deuther-Conrad W, Kranz M, Fischer S, Ludwig FA, Juratli TA, Patt M, Wünsch B, Schackert G, Sabri O, Brust P (2020). Sigma-1 Receptor Positron Emission Tomography: A New Molecular Imaging Approach Using (S)-(-)-[18F]Fluspidine in Glioblastoma. Molecules, 25(9), 2170.
     
  180. Dipasquale O, Martins D, Sethi A, Veronese M, Hesse S, Rullmann M, Sabri O, Turkheimer F, Harrison NA, Mehta MA, Cercignani M (2020). Unravelling the effects of methylphenidate on the dopaminergic and noradrenergic functional circuits. Neuropsychopharmacology, 45(9), 1482-1489.
     
  181. Brendel M, Catak C, Beyer L, Linn J, Wahl H, Janowitz D, Rominger A, Patt M, Barthel H, Sabri O, Bartenstein P, Wollenweber FA (2020). Colocalization of Tau but Not ?-Amyloid with Cortical Superficial Siderosis in a Case with Probable CAA. Case Rep Neurol, 12(2), 232-237.
     
  182. Schmidt E, Schinke C, Rullmann M, Luthardt J, Becker GA, Haars S, Stoppe M, Lobsien D, Hoffmann KT, Sabri O, Hesse S, Then Bergh F (2020). Changes of central noradrenaline transporter availability in immunotherapy-naïve multiple sclerosis patients. Sci Rep, 10(1), 14651.
     
  183. Hankir MK, Al-Bas S, Rullmann M, Chakaroun R, Seyfried F, Pleger B (2020). Homeostatic, reward and executive brain functions after gastric bypass surgery. Appetite, 146(), 104419.
     
  184. Desch AK, Hartung K, Botzen A, Brobeil A, Rummel M, Kurch L, Georgi T, Jox T, Bielack S, Burdach S, Classen CF, Claviez A, Debatin KM, Ebinger M, Eggert A, Faber J, Flotho C, Frühwald M, Graf N, Jorch N, Kontny U, Kramm C, Kulozik A, Kühr J, Sykora KW, Metzler M, Müller HL, Nathrath M, Nüßlein T, Paulussen M, Pekrun A, Reinhardt D, Reinhard H, Rössig C, Sauerbrey A, Schlegel PG, Schneider DT, Scheurlen W, Schweigerer L, Simon T, Suttorp M, Vorwerk P, Schmitz R, Kluge R, Mauz-Körholz C, Körholz D (2020). Genotyping circulating tumor DNA of pediatric Hodgkin lymphoma. Leukemia, 34(1), 151-166.
     
  185. Michalski D, Spielvogel E, Puchta J, Reimann W, Barthel H, Nitzsche B, Mages B, Jäger C, Martens H, Horn AKE, Schob S, Härtig W (2020). Increased Immunosignals of Collagen IV and Fibronectin Indicate Ischemic Consequences for the Neurovascular Matrix Adhesion Zone in Various Animal Models and Human Stroke Tissue. Front Physiol, 11(), 575598.
     
  186. Morbelli S, Esposito G, Arbizu J, Barthel H, Boellaard R, Bohnen NI, Brooks DJ, Darcourt J, Dickson JC, Douglas D, Drzezga A, Dubroff J, Ekmekcioglu O, Garibotto V, Herscovitch P, Kuo P, Lammertsma A, Pappata S, Peñuelas I, Seibyl J, Semah F, Tossici-Bolt L, Van de Giessen E, Van Laere K, Varrone A, Wanner M, Zubal G, Law I (2020). EANM practice guideline/SNMMI procedure standard for dopaminergic imaging in Parkinsonian syndromes 1.0. Eur J Nucl Med Mol Imaging, 47(8), 1885-1912.
     
  187. Morbelli S, Ekmekcioglu O, Barthel H, Albert NL, Boellaard R, Cecchin D, Guedj E, Lammertsma AA, Law I, Penuelas I, Semah F, Traub-Weidinger T, van de Giessen E, Varrone A, Garibotto V (2020). COVID-19 and the brain: impact on nuclear medicine in neurology. Eur J Nucl Med Mol Imaging, 47(11), 2487-2492.
     
  188. Chételat G, Arbizu J, Barthel H, Garibotto V, Law I, Morbelli S, van de Giessen E, Agosta F, Barkhof F, Brooks DJ, Carrillo MC, Dubois B, Fjell AM, Frisoni GB, Hansson O, Herholz K, Hutton BF, Jack CR Jr, Lammertsma AA, Landau SM, Minoshima S, Nobili F, Nordberg A, Ossenkoppele R, Oyen WJG, Perani D, Rabinovici GD, Scheltens P, Villemagne VL, Zetterberg H, Drzezga A (2020). Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementias. Lancet Neurol, 19(11), 951-962.
     
  189. Weber WA, Czernin J, Anderson CJ, Badawi RD, Barthel H, Bengel F, Bodei L, Buvat I, DiCarli M, Graham MM, Grimm J, Herrmann K, Kostakoglu L, Lewis JS, Mankoff DA, Peterson TE, Schelbert H, Schöder H, Siegel BA, Strauss HW (2020). The Future of Nuclear Medicine, Molecular Imaging, and Theranostics. J Nucl Med, 61(2), 263-272.
     
  190. Hagleitner MM, Metzger ML, Flerlage JE, Kelly KM, Voss SD, Kluge R, Kurch L, Cho S, Mauz-Koerholz C, Beishuizen A (2020). Liver involvement in pediatric Hodgkin lymphoma: A systematic review by an international collaboration on Staging Evaluation and Response Criteria Harmonization (SEARCH) for Children, Adolescent, and Young Adult Hodgkin Lymphoma (CAYAHL). Pediatr Blood Cancer, 67(8), 28365-9.
     
  191. Daw S, Hasenclever D, Mascarin M, Fernández-Teijeiro A, Balwierz W, Beishuizen A, Burnelli R, Cepelova M, Claviez A, Dieckmann K, Landman-Parker J, Kluge R, Körholz D, Mauz-Körholz C, Wallace WH, Leblanc T (2020). Risk and Response Adapted Treatment Guidelines for Managing First Relapsed and Refractory Classical Hodgkin Lymphoma in Children and Young People. Recommendations from the EuroNet Pediatric Hodgkin Lymphoma Group. Hemasphere, 4(1), 329-14.
     
  192. Seelisch J, De Alarcon PA, Flerlage JE, Hoppe BS, Kaste SC, Kelly KM, Kurch L, Marks LJ, Mauz-Koerholz C, McCarten K, Metzger ML, Stroevesandt D, Voss SD, Punnett A (2020). Expert consensus statements for Waldeyer's ring involvement in pediatric Hodgkin lymphoma: The staging, evaluation, and response criteria harmonization (SEARCH) for childhood, adolescent, and young adult Hodgkin lymphoma (CAYAHL) group. Pediatr Blood Cancer, 67(9), 28361-7.
     
  193. Schmitz C, Rekowski J, Müller SP, Hertenstein B, Franzius C, Ganser A, Bengel FM, Kroschinsky F, Kotzerke J, La Rosée P, Freesmeyer M, Hoeffkes HG, Hertel A, Behringer D, Mesters R, Weckesser M, Mahlmann S, Haberkorn U, Martens U, Prange-Krex G, Brenner W, Giagounidis A, Moeller R, Runde V, Sandmann M, Hautzel H, Wilop S, Krohn T, Dürk H, Heike M, Alashkar F, Brinkmann M, Trenn G, Wacker D, Kreisel-Büstgens C, Bernhard H, Heil G, Larisch R, Kurch L, Jöckel KH, Hoelzer D, Klapper W, Boellaard R, (2020). Baseline and interim PET-based outcome prediction in peripheral T-cell lymphoma: A subgroup analysis of the PETAL trial. Hematol Oncol, 38(3), 244-256.
     
  194. Georgi TW, Kurch L, Hasenclever D, Warbey VS, Pike L, Radford J, Sabri O, Kluge R, Barrington SF (2020). Quantitative assessment of interim PET in Hodgkin lymphoma: An evaluation of the qPET method in adult patients in the RAPID trial. PLoS One, 15(4), 0231027-11.
     
  195. Rösch SA, Schmidt R, Lührs M, Ehlis AC, Hesse S, Hilbert A (2020). Evidence of fNIRS-Based Prefrontal Cortex Hypoactivity in Obesity and Binge-Eating Disorder. Brain Sci, 11(1), 1-15.
     
  196. Gee AD, Andersson J, Bhalla R, Choe YS, Dick DW, Herth MM, Hostetler ED, Jáuregui-Haza UJ, Huang YY, James ML, Jeong JM, Korde A, Kuge Y, Kung HF, Lapi SE, Osso JA Jr, Parent E, Patt M, Pricile EF, Riss PJ, Santos-Oliveira R, Taylor S, Vasdev N, Vercouillie J, Wadsak W, Yang Z, Zhu H, Scott PJH (2020). Training the next generation of radiopharmaceutical scientists. Nucl Med Biol, 88, 10-13.
     
  197. Reich CM, Unger M, Melzer L, Jochimsen T, Sattler B, Sabri O, Melzer A (2020). Developing an Intuitive and Feasible Setup for In-room Control During MRI-guided Interventions Current Directions in Biomedical Engineering, 6, 1-4.
     
  198. Polito MV, Hagendorff A, Citro R, Prota C, Silverio A, De Angelis E, Klingel K, Metze M, Stöbe S, Hoffmann KT, Sabri O, Piscione F, Galasso G (2020). Loeffler's Endocarditis: An Integrated Multimodality Approach. J Am Soc Echocardiogr, 33(12), 1427-1441.
     
  199. Frille A, Rullmann M, Becker GA, Patt M, Luthardt J, Tiepolt S, Wirtz H, Sabri O, Hesse S, Seyfarth HJ (2020). Increased pulmonary serotonin transporter in patients with chronic obstructive pulmonary disease who developed pulmonary hypertension. Eur J Nucl Med Mol Imaging, 0, 1-12.
     
  200. Reich CM, Sattler B, Jochimsen TH, Unger M, Melzer L, Landgraf L, Barthel H, Sabri O, Melzer A (2020). Practical setting and potential applications of interventions guided by PET/MRI. Q J Nucl Med Mol Imaging, 0, 1-10.
     
  201. Schroeter ML, Albrecht F, Ballarini T, Leuthold D, Legler A, Hartwig S, Tiepolt S, Villringer A (2020). Capgras Delusion in Posterior Cortical Atrophy-A Quantitative Multimodal Imaging Single Case Study. Front Aging Neurosci, 12(), 133.
     
  202. Dierckx RAJO, Otte A, de Vries EFJ, van Waarde A, Leenders KL (2020). PET Imaging of the ?4?2* Nicotinic Acetylcholine Receptors in Alzheimer?s Disease In: Springer Nature, PET and SPECT in Neurology (S. 255-269), Berlin: Springer Verlag.
     
  203. Sabri O, Meyer PM, Gertz HJ, Tiepolt S, Brust P, Barthel H, Hesse S (2020). Nicotinic Acetylcholine Receptors in Alzheimer's Disease In: Dierckx R.A.J.O., Otte A., de Vries E.F.J., van Waarde A., Leenders K.L. (eds) , PET and SPECT in Neurology (S. 0-0), Cham: springer.
     


    204. 2019


  204. Surov A, Meyer HJ, Hohn AK, Sabri O, Purz S (2019). Combined Metabolo-Volumetric Parameters of 18F-FDG-PET and MRI Can Predict Tumor Cellularity, Ki67 Level and Expression of HIF 1alpha in Head and Neck Squamous Cell Carcinoma: A Pilot Study. Transl Oncol, 12(1), 8-14.
     
  205. Tiepolt S, Luthardt J, Patt M, Hesse S, Hoffmann KT, Weise D, Gertz HJ, Sabri O, Barthel H (2019). Early after Administration [11C]PiB PET Images Correlate with Cognitive Dysfunction Measured by the CERAD Test Battery. J Alzheimers Dis, 68(1), 65-76.
     
  206. Kewitz-Hempel S, Kurch L, Cepelova M, Volkmer I, Sauerbrey A, Conrad E, Knirsch S, Popperl G, Steinbach D, Beer AJ, Kramm CM, Sahlmann CO, Erdlenbruch B, Reinbold WD, Odparlik A, Sabri O, Kluge R, Staege MS (2019). Impact of rs12917 MGMT Polymorphism on [18F]FDG-PET Response in Pediatric Hodgkin Lymphoma (PHL). Mol Imaging Biol, 21(6), 1182-1191.
     
  207. Surov A, Meyer HJ, Hohn AK, Wienke A, Sabri O, Purz S (2019). 18F-FDG-PET Can Predict Microvessel Density in Head and Neck Squamous Cell Carcinoma. Cancers (Basel), 11(4), 543-552.
     
  208. Ludwig FA, Fischer S, Houska R, Hoepping A, Deuther-Conrad W, Schepmann D, Patt M, Meyer PM, Hesse S, Becker GA, Zientek FR, Steinbach J, Wunsch B, Sabri O, Brust P (2019). In vitro and in vivo Human Metabolism of (S)-[18F]Fluspidine - A Radioligand for Imaging ?1 Receptors With Positron Emission Tomography (PET). Front Pharmacol, 10, 534-.
     
  209. Tiepolt S, Patt M, Aghakhanyan G, Meyer PM, Hesse S, Barthel H, Sabri O (2019). Current radiotracers to image neurodegenerative diseases. EJNMMI Radiopharm Chem, 4(1), 17-.
     
  210. Ulke C, Rullmann M, Huang J, Luthardt J, Becker GA, Patt M, Meyer PM, Tiepolt S, Hesse S, Sabri O, Strauss M (2019). Adult attention-deficit/hyperactivity disorder is associated with reduced norepinephrine transporter availability in right attention networks: a (S,S)-O-[11C]methylreboxetine positron emission tomography study. Transl Psychiatry, 9(1), 301-.
     
  211. Nitzsche B, Boltze J, Ludewig E, Flegel T, Schmidt MJ, Seeger J, Barthel H, Brooks OW, Gounis MJ, Stoffel MH, Schulze S (2019). A stereotaxic breed-averaged, symmetric T2w canine brain atlas including detailed morphological and volumetrical data sets. Neuroimage, 187, 93-103.
     
  212. Barthel H (2019). 2019 SNMMI Highlights Lecture: Neurosciences. J Nucl Med, 60(9), 11N-18N.
     
  213. Neels O, Patt M, Decristoforo C (2019). Radionuclides: medicinal products or rather starting materials? EJNMMI Radiopharm Chem, 4(1), 22-.
     
  214. Rullmann M, Preusser S, Poppitz S, Heba S, Gousias K, Hoyer J, Schutz T, Dietrich A, Muller K, Hankir MK, Pleger B (2019). Adiposity Related Brain Plasticity Induced by Bariatric Surgery. Front Hum Neurosci, 13, 290-.
     
  215. Hankir MK, Rullmann M, Seyfried F, Preusser S, Poppitz S, Heba S, Gousias K, Hoyer J, Schutz T, Dietrich A, Muller K, Pleger B (2019). Roux-en-Y gastric bypass surgery progressively alters radiologic measures of hypothalamic inflammation in obese patients. JCI Insight, 4(19), 131329.
     
  216. Rullmann M, Preusser S, Pleger B (2019). Prefrontal and posterior parietal contributions to the perceptual awareness of touch. Sci Rep, 9(1), 16981-.
     
  217. Kurch L, Hasenclever D, Kluge R, Georgi T, Tchavdarova L, Golombeck M, Sabri O, Eggert A, Brenner W, Sykora KW, Bengel FM, Rossig C, Korholz D, Schafers M, Feuchtinger T, Bartenstein P, Ammann RA, Krause T, Urban C, Aigner R, Gattenlohner S, Klapper W, Mauz-Korholz C (2019). Only strongly enhanced residual FDG uptake in early response PET (Deauville 5 or qPET ? 2) is prognostic in pediatric Hodgkin lymphoma: Results of the GPOH-HD2002 trial. Pediatr Blood Cancer, 66(3), e27539-.
     
  218. Kurch L, Habermann B, Scholz T, Tiepolt S, Seidel P, Patt J, Winkler T, Uhlisch T, Böhm T, Geißler B, Meyer P, Messerschmidt K, Schürer M, Steinhoff K, Hesse S, Sattler B, Sabri O, Kluge R (2019). Mehr Nuklearmedizin im Studium: Option Wahlfach, dargestellt am Beispiel des Leipziger Curriculums "Nuklearmedizin universal" Der Nuklearmediziner, 42, 328-332.
     
  219. Pötzsch C, Kurch L, Naumann S, Georgi T, Körholz D, Mauz-Körholz C, Sabri O, Kluge R (2019). Maßnahmenspektrum zur Verhinderung von aktiviertem braunen Fett in der 18F-FDG-PET MTA Dialog, 12, 1070.
     
  220. Surov A, Meyer HJ, Hohn AK, Wienke A, Sabri O, Purz S (2019). Combined parameter SUVmax/ADCmean predicts microvessel density in head and neck squamous cell carcinoma. Preliminary results. Oral Oncol, 19, 30227-1.
     
  221. Kewitz-Hempel S, Kurch L, Cepelova M, Volkmer I, Sauerbrey A, Conrad E, Knirsch S, Pöpperl G, Steinbach D, Beer AJ, Kramm CM, Sahlmann CO, Erdlenbruch B, Reinbold WD, Odparlik A, Sabri O, Kluge R, Staege MS (2019). Impact of rs12917 MGMT Polymorphism on [18F]FDG-PET Response in Pediatric Hodgkin Lymphoma (PHL). Mol Imaging Biol, 21(6), 1182-1191.
     
  222. Kewitz-Hempel S, Kurch L, Cepelova M, Volkmer I, Sauerbrey A, Conrad E, Knirsch S, Pöpperl G, Steinbach D, Beer AJ, Kramm CM, Sahlmann CO, Erdlenbruch B, Reinbold WD, Odparlik A, Sabri O, Kluge R, Staege MS (2019). Impact of rs12917 MGMT Polymorphism on [18F]FDG-PET Response in Pediatric Hodgkin Lymphoma (PHL). Mol Imaging Biol, 21(6), 1182-1191.
     
  223. Boltze J, Ferrara F, Hainsworth AH, Bridges LR, Zille M, Lobsien D, Barthel H, McLeod DD, Gräßer F, Pietsch S, Schatzl AK, Dreyer AY, Nitzsche B (2019). Lesional and perilesional tissue characterization by automated image processing in a novel gyrencephalic animal model of peracute intracerebral hemorrhage. J Cereb Blood Flow Metab, 39(12), 2521-2535.
     
  224. Tatsch K, Buchert R, Bartenstein P, Barthel H, Boecker H, Brust P, Drzezga A, la Fougere C, Grunder G, Grunwald F, Krause BJ, Kuwert T, Langen KJ, Rominger A, Sabri O, Schreckenberger M, Meyer PT (2019). [Dopamine Transporter SPECT with I-123 labelled FP-CIT (DaTSCANTM)]. Nuklearmedizin, 58(1), 5-16.
     
  225. Meyer S, Mueller K, Gruenewald C, Grundl K, Marschhauser A, Tiepolt S, Barthel H, Sabri O, Schroeter ML (2019). Citalopram Improves Obsessive-Compulsive Crossword Puzzling in Frontotemporal Dementia. Case Rep Neurol, 11(1), 94-105.
     
  226. Niebisch S, Staab H, Ullrich S, Hoffmann KT, Sabri O, Thieme R, Schierle K, Wittekind C, Gockel I (2019). Retroperitoneal space-occupying lesion with displacement of the inferior vena cava. Int J Surg Case Rep, 57, 170-174.
     
  227. Hollenbach M, Feisthammel J, Mossner J, Schlosser T, Kahn T, Sabri O, Hoffmeister A (2019). Transhepatic intraductal radiofrequency ablation of a biliary papillary mucinous neoplasm. Endoscopy, 51(9), 897-898.
     
  228. Dore V, Bullich S, Rowe CC, Bourgeat P, Konate S, Sabri O, Stephens AW, Barthel H, Fripp J, Masters CL, Dinkelborg L, Salvado O, Villemagne VL, De Santi S (2019). Comparison of 18F-florbetaben quantification results using the standard Centiloid, MR-based, and MR-less CapAIBL® approaches: Validation against histopathology. Alzheimers Dement, 15(6), 807-816.
     
  229. Rosler TW, Tayaranian Marvian A, Brendel M, Nykanen NP, Hollerhage M, Schwarz SC, Hopfner F, Koeglsperger T, Respondek G, Schweyer K, Levin J, Villemagne VL, Barthel H, Sabri O, Muller U, Meissner WG, Kovacs GG, Hoglinger GU (2019). Four-repeat tauopathies. Prog Neurobiol, 180, 101644-.
     
  230. Hankir MK, Al-Bas S, Rullmann M, Chakaroun R, Seyfried F, Pleger B (2019). Homeostatic, reward and executive brain functions after gastric bypass surgery. Appetite, 146, 104419-.
     
  231. Paschke L, Lincke T, Muhlberg K, Lindner TH, Paschke R (2019). Myocardial Infarction after Long-Term Treatment with a Tyrosine Kinase Inhibitor (TKI) with Anti-VEGF Receptor Activity. Case Rep Endocrinol, 2019, 7927450-.
     
  232. Umutlu L, Beyer T, Grueneisen JS, Rischpler C, Quick HH, Veit-Haibach P, Eiber M, Purz S, Antoch G, Gatidis S, Nikolaou K, Schaefer JF, Rausch I, Herrmann K (2019). Whole-Body [18F]-FDG-PET/MRI for Oncology: A Consensus Recommendation. Rofo, 191(4), 289-297.
     
  233. Huttmann A, Rekowski J, Muller SP, Hertenstein B, Franzius C, Mesters R, Weckesser M, Kroschinsky F, Kotzerke J, Ganser A, Bengel FM, La Rosee P, Freesmeyer M, Hoffkes HG, Hertel A, Behringer D, Prange-Krex G, Griesshammer M, Holzinger J, Wilop S, Krohn T, Raghavachar A, Maschmeyer G, Brink I, Schroers R, Gaska T, Bernhard H, Giagounidis A, Schutte J, Dienst A, Hautzel H, Naumann R, Klein A, Hahn D, Popperl G, Grube M, Marienhagen J, Schwarzer A, Kurch L, Hohler T, Steiniger H, Nuckel H, Sudhoff (2019). Six versus eight doses of rituximab in patients with aggressive B cell lymphoma receiving six cycles of CHOP: results from the "Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas" (PETAL) trial. Ann Hematol, 98(4), 897-907.
     
  234. Lewis J, McCarten K, Kurch L, Flerlage JE, Kaste SC, Kluge R, Stoevesandt D, Voss SD, Kelly KM, Mauz-Korholz C, Drachtman RA, Metzger ML (2019). Definition of cortical bone involvement in the staging of newly diagnosed pediatric Hodgkin lymphoma: A report from the International Working Group on Staging Evaluation and Response Criteria Harmonization (SEARCH). Pediatr Blood Cancer, 28142, 28142-.
     
  235. Sehlin D, Syvanen S (2019). Engineered antibodies: new possibilities for brain PET? Eur J Nucl Med Mol Imaging, 46(13), 2848-2858.
     
  236. Aime S, Alberich A, Almen A, Arthurs OJ, Barthel H, Clément O, Crean M, de Souza N, Demuth F, Dewey M, Dousset V, Frangi A, Garos C, Golay X, Gordebeke P, Günther M, Hahn H, Hierath M, Hoeschen C, Hunink M, Kauczor HU, Krestin G, Krischak K, Langs G, Liu Y, Marti-Bonmati L, Matos C, Mayerhofer-Sebera U, McNulty J, Muylle K, Neeman M, Niessen W, Nikolaou K, Pereira P, Persson A, Pifferi A, Riklund K, Rockall A, Rosendahl K, Sardanelli F, Sourbron S, Speck O, Valentini V, Zolda P (2019). Strategic research agenda for biomedical imaging. Insights Imaging, 10(1), 7-.
     
  237. Law I, Albert NL, Arbizu J, Boellaard R, Drzezga A, Galldiks N, la Fougere C, Langen KJ, Lopci E, Lowe V, McConathy J, Quick HH, Sattler B, Schuster DM, Tonn JC, Weller M (2019). Joint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [18F]FDG: version 1.0. Eur J Nucl Med Mol Imaging, 46(3), 540-557.
     


    238. 2018


  238. Nitzsche B, Boltze J, Ludewig E, Flegel T, Schmidt MJ, Seeger J, Barthel H, Brooks OW, Gounis MJ, Stoffel MH, Schulze S (2018). A stereotaxic breed-averaged, symmetric T2w canine brain atlas including detailed morphological and volumetrical data sets. Neuroimage, 1053, 30066-1.
     
  239. Surov A, Meyer HJ, Hohn AK, Sabri O, Purz S (2018). Combined Metabolo-Volumetric Parameters of 18F-FDG-PET and MRI Can Predict Tumor Cellularity, Ki67 Level and Expression of HIF 1alpha in Head and Neck Squamous Cell Carcinoma: A Pilot Study. Transl Oncol, 12(1), 8-14.
     
  240. Bullich S, Barthel H, Koglin N, Becker GA, De Santi S, Jovalekic A, Stephens AW, Sabri O (2018). Validation of Noninvasive Tracer Kinetic Analysis of 18F-Florbetaben PET Using a Dual-Time-Window Acquisition Protocol. J Nucl Med, 59(7), 1104-1110.
     
  241. Ludwig FA, Fischer S, Smits R, Deuther-Conrad W, Hoepping A, Tiepolt S, Patt M, Sabri O*, Brust P* (2018). Exploring the Metabolism of (+)-18Flubatine in Vitro and in Vivo: LC-MS/MS Aided Identification of Radiometabolites in a Clinical PET Study. Molecules, 23(2), 1-15.
     
  242. Surov A, Leifels L, Meyer HJ, Winter K, Sabri O, Purz S (2018). Associations Between Histogram Analysis DCE MRI Parameters and Complex 18F-FDG-PET Values in Head and Neck Squamous Cell Carcinoma. Anticancer Res, 38(3), 1637-1642.
     
  243. Vettermann FJ, Rullmann M, Becker GA, Luthardt J, Zientek F, Patt M, Meyer PM, McLeod A, Brendel M, Bluher M, Stumvoll M, Hilbert A, Ding YS, Sabri O, Hesse S (2018). Noradrenaline transporter availability on [11C]MRB PET predicts weight loss success in highly obese adults. Eur J Nucl Med Mol Imaging, 45(9), 1618-1625.
     
  244. Sabri O, Meyer PM, Graf S, Hesse S, Wilke S, Becker GA, Rullmann M, Patt M, Luthardt J, Wagenknecht G, Hoepping A, Smits R, Franke A, Sattler B, Tiepolt S, Fischer S, Deuther-Conrad W, Hegerl U, Barthel H, Schonknecht P, Brust P (2018). Cognitive correlates of alpha4ß2 nicotinic acetylcholine receptors in mild Alzheimers dementia. Brain, 141(6), 1840-1854.
     
  245. Tiepolt S, Schafer A, Rullmann M, Roggenhofer E, Gertz HJ, Schroeter ML, Patt M, Bazin PL, Jochimsen TH, Turner R, Sabri O, Barthel H (2018). Quantitative Susceptibility Mapping of Amyloid-ß Aggregates in Alzheimers Disease with 7T MR. J Alzheimers Dis, 64(2), 393-404.
     
  246. Rullmann M, Preusser S, Poppitz S, Heba S, Hoyer J, Schutz T, Dietrich A, Muller K, Pleger B (2018). Gastric-bypass surgery induced widespread neural plasticity of the obese human brain. Neuroimage, 172, 853-863.
     
  247. Surov A, Meyer HJ, Hohn AK, Winter K, Sabri O, Purz S (2018). Associations Between [18F]FDG-PET and Complex Histopathological Parameters Including Tumor Cell Count and Expression of KI 67, EGFR, VEGF, HIF-1?, and p53 in Head and Neck Squamous Cell Carcinoma. Mol Imaging Biol, 18, 1223-1229.
     
  248. Meyer HJ, Purz S, Sabri O, Surov A (2018). Cervical Cancer: Associations between Metabolic Parameters and Whole Lesion Histogram Analysis Derived from Simultaneous 18F-FDG-PET/MRI. Contrast Media Mol Imaging, 2018, 5063285-.
     
  249. Meyer HJ, Purz S, Sabri O, Surov A (2018). Relationships between histogram analysis of ADC values and complex 18F-FDG-PET parameters in head and neck squamous cell carcinoma. PLoS One, 13(9), e0202897-.
     
  250. Boltze J, Ferrara F, Hainsworth AH, Bridges LR, Zille M, Lobsien D, Barthel H, McLeod DD, Grasser F, Pietsch S, Schatzl AK, Dreyer AY, Nitzsche B (2018). Lesional and perilesional tissue characterization by automated image processing in a novel gyrencephalic animal model of peracute intracerebral hemorrhage. J Cereb Blood Flow Metab, 2018, 271678X18802119-.
     
  251. Florek L, Tiepolt S, Schroeter ML, Berrouschot J, Saur D, Hesse S, Jochimsen T, Luthardt J, Sattler B, Patt M, Hoffmann KT, Villringer A, Classen J, Gertz HJ, Sabri O, Barthel H (2018). Dual Time-Point [18F]Florbetaben PET Delivers Dual Biomarker Information in Mild Cognitive Impairment and Alzheimer's Disease. J Alzheimers Dis, 66(3), 1105-1116.
     
  252. Barthel H (2018). 2018 SNMMI Highlights Lecture: Brain Nuclear and Molecular Imaging. J Nucl Med, 59(11), 11N-17N.
     
  253. Roth C, Sabri O, Kluge R, Fischer L, Monecke A, Wachowiak R, Hirsch FW, Kurch L (2018). Simultaneous F18-FDG-PET/MR Optimized Treatment Planning in a Young Patient with Sacro-Coccygeal Chordoma. Klin Padiatr, 230(6), 326-327.
     
  254. Schinke C, Hesse S, Rullmann M, Becker GA, Luthardt J, Zientek F, Patt M, Stoppe M, Schmidt E, Meyer K, Meyer PM, Orthgiess J, Bluher M, Kratzsch J, Ding YS, Then Bergh F, Sabri O (2018). Central noradrenaline transporter availability is linked with HPA axis responsiveness and copeptin in human obesity and non-obese controls. Stress, 29, 1-10.
     
  255. Surov A, Meyer HJ, Hohn AK, Schob S, Winter K, Sabri O, Purz S (2018). Metabolo-volumetric parameters of 18F-FDG-PET can predict expression of EGFR and HIF 1alpha in uterine cervical cancer. Cancer Biomark, 2018, 1-6.
     
  256. Solbach C, Patt M (2018). PET-Liganden für Diagnostik der Alzheimer-Demenz: Amyloid und Tau Der Nuklearmediziner, 41, 310-316.
     
  257. Schildan A, Hirschfeld J, Patt M Sabri O (2018). Arzneimittelzulassung von Radiopharmaka im klinischen Rahmen Der Nuklearmediziner, 41, 369-385.
     
  258. Georgi TW, Kluge R, Kurch L, Chavdarova L, Hasenclever D, Stoevesandt D, Pelz T, Landman-Parker J, Wallace WH, Karlen J, Fernandez-Teijeiro A, Cepelova M, Fossa A, Balwierz W, Attarbaschi A, Ammann RA, Pears J, Hraskova A, Uyttebroeck A, Beishuizen A, Dieckmann K, Leblanc T, Daw S, Baumann J, Korholz D, Sabri O, Mauz-Korholz C (2018). 18F-FDG PET Response of Skeletal (Bone Marrow and Bone) Involvement After Induction Chemotherapy in Pediatric Hodgkin Lymphoma: Are Specific Response Criteria Required? J Nucl Med, 59(10), 1524-1530.
     
  259. Hamerla G, Meyer HJ, Purz S, Surov A (2018). Rofo, 190(10), 971-972.
     
  260. Hamerla G, Meyer HJ, Purz S, Surov A (2018). Inzidentelles 18F-FDG-negatives Mammakarzinom in der Staging-18F-FDG-PET/CT bei Ösophaguskarzinom. Rofo, 190(10), 971-972.
     
  261. Bailey DL, Pichler BJ, Guckel B, Antoch G, Barthel H, Bhujwalla ZM, Biskup S, Biswal S, Bitzer M, Boellaard R, Braren RF, Brendle C, Brindle K, Chiti A, la Fougere C, Gillies R, Goh V, Goyen M, Hacker (2018). Combined PET/MRI: Global Warming-Summary Report of the 6th International Workshop on PET/MRI, March 27-29, 2017, Tübingen, Germany. Mol Imaging Biol, 20(1), 4-20.
     
  262. Mages B, Aleithe S, Altmann S, Blietz A, Nitzsche B, Barthel H, Horn AKE, Hobusch C, Hartig W, Krueger M, Michalski D (2018). Impaired Neurofilament Integrity and Neuronal Morphology in Different Models of Focal Cerebral Ischemia and Human Stroke Tissue. Front Cell Neurosci, 12, 161-.
     
  263. Wistehube T, Rullmann M, Wiacek C, Braun P, Pleger B (2018). Fat perception in the human frontal operculum, insular and somatosensory cortex. Sci Rep, 8(1), 11825-.
     
  264. Jansen WJ, Ossenkoppele R, Tijms BM, Fagan AM, Hansson O, Klunk WE, van der Flier WM, Villemagne VL, Frisoni GB, Fleisher AS, Lleo A, Mintun MA, Wallin A, Engelborghs S, Na DL, Chetelat G, Molinuevo J (2018). Association of Cerebral Amyloid-? Aggregation With Cognitive Functioning in Persons Without Dementia. JAMA Psychiatry, 75(1), 84-95.
     
  265. Steinacker P, Anderl-Straub S, Diehl-Schmid J, Semler E, Uttner I, von Arnim CAF, Barthel H, Danek A, Fassbender K, Fliessbach K, Foerstl H, Grimmer T, Huppertz HJ, Jahn H, Kassubek J, Kornhuber J, La (2018). Serum neurofilament light chain in behavioral variant frontotemporal dementia. Neurology, 91(15), 1390-1401.
     
  266. Arbizu J, Festari C, Altomare D, Walker Z, Bouwman F, Rivolta J, Orini S, Barthel H, Agosta F, Drzezga A, Nestor P, Boccardi M, Frisoni GB, Nobili F (2018). Clinical utility of FDG-PET for the clinical diagnosis in MCI. Eur J Nucl Med Mol Imaging, 45(9), 1497-1508.
     
  267. Breitkreutz F, Patt M, Solbach C (2018). Die erlaubnisfreie Herstellung und Anwendung patientenindividualisierter Arzneimittel Der Nuklearmediziner, 41, 360-368.
     
  268. Duhrsen U, Muller S, Hertenstein B, Thomssen H, Kotzerke J, Mesters R, Berdel WE, Franzius C, Kroschinsky F, Weckesser M, Kofahl-Krause D, Bengel FM, Durig J, Matschke J, Schmitz C, Poppel T, Ose C, B (2018). Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas (PETAL): A Multicenter, Randomized Phase III Trial. J Clin Oncol, 36(20), 2024-2034.
     
  269. Barthel H, Sabri O (2018). Neurodegeneration Imaging. In: Umutlu L, Herrmann K, PET/MR Imaging: Current and Emerging Applications (S. 99-106), Cham: Springer International Publishing AG.
     


    270. 2017


  270. Wichmann G, Kruger A, Boehm A, Kolb M, Hofer M, Fischer M, Muller S, Purz S, Stumpp P, Sabri O, Dietz A, Kluge R (2017). Induction chemotherapy followed by radiotherapy for larynx preservation in advanced laryngeal and hypopharyngeal cancer: Outcome prediction after one cycle induction chemotherapy by a score based on clinical evaluation, computed tomography-based volumetry and (18)F-FDG-PET/CT. Eur J Cancer, 72, 144-155.
     
  271. Hesse S, Becker GA, Rullmann M, Bresch A, Luthardt J, Hankir MK, Zientek F, Reissig G, Patt M, Arelin K, Lobsien D, Muller U, Baldofski S, Meyer PM, Bluher M, Fasshauer M, Fenske WK, Stumvoll M, Hilbert A, Ding YS, Sabri O (2017). Central noradrenaline transporter availability in highly obese, non-depressed individuals. Eur J Nucl Med Mol Imaging, 44(6), 1056-1064.
     
  272. Barthel H, Seibyl J, Sabri O (2017). Yes we can analyse amyloid images - Now What? Editorial Commentary Eur J Nucl Med Mol Imaging, 44(5), 822-824.
     
  273. Kaller S, Rullmann M, Patt M, Becker GA, Luthardt J, Girbardt J, Meyer PM, Werner P, Barthel H, Bresch A, Fritz TH, Hesse S, Sabri O (2017). Test-retest measurements of dopamine D1-type receptors using simultaneous PET/MRI imaging. Eur J Nucl Med Mol Imaging, 44(6), 1025-1032.
     
  274. Bucerius J, Barthel H, Tiepolt S, Werner P, Sluimer JC, Wildberger JE, Patt M, Hesse S, Gertz HJ, Biessen EAL, Mottaghy FM, Sabri O (2017). Feasibility of in vivo (18)F-florbetaben PET/MR imaging of human carotid amyloid-?. Eur J Nucl Med Mol Imaging, 44(7), 1119-1128.
     
  275. Hesse S, Muller U, Rullmann M, Luthardt J, Bresch A, Becker GA, Zientek F, Patt M, Meyer PM, Bluher M, Strauss M, Fenske W, Hankir M, Ding YS, Hilbert A, Sabri O (2017). The association between in vivo central noradrenaline transporter availability and trait impulsivity. Psychiatry Res, 267, 9-14.
     
  276. Hankir MK*, Patt M*, Patt JT, Becker GA, Rullmann M, Kranz M, Deuther-Conrad W, Schischke K, Seyfried F, Brust P, Hesse S, Sabri O, Krugel U, Fenske WK (2017). Suppressed Fat Appetite after Roux-en-Y Gastric Bypass Surgery Associates with Reduced Brain ?-opioid Receptor Availability in Diet-Induced Obese Male Rats. Front Neurosci, 10, 620.
     
  277. Cecchin D, Barthel H, Poggiali D, Cagnin A, Tiepolt S, Zucchetta P, Turco P, Gallo P, Frigo AC, Sabri O, Bui F (2017). A new integrated dual time-point amyloid PET/MRI data analysis method. Eur J Nucl Med Mol Imaging, 44(12), 2060-2072.
     
  278. Barthel H, Sabri O (2017). Clinical Use and Utility of Amyloid Imaging. J Nucl Med, 58(11), 1711-1717.
     
  279. Bresch A, Rullmann M, Luthardt J, Becker GA, Patt M, Ding YS, Hilbert A, Sabri O, Hesse S (2017). Hunger and disinhibition but not cognitive restraint are associated with central norepinephrine transporter availability. Appetite, 117, 270-274.
     
  280. Lucke C, Oppolzer B, Werner P, Foldyna B, Lurz P, Jochimsen T, Brenneis B, Lehmkuhl L, Sattler B, Grothoff M, Barthel H, Sabri O, Gutberlet M (2017). Comparison of volumetric and functional parameters in simultaneous cardiac PET/MR: feasibility of volumetric assessment with residual activity from prior PET/CT. Eur Radiol, 27(12), 5146-5157.
     
  281. Leifels L, Purz S, Stumpp P, Schob S, Meyer HJ, Kahn T, Sabri O, Surov A (2017). Associations between 18F-FDG-PET, DWI, and DCE Parameters in Patients with Head and Neck Squamous Cell Carcinoma Depend on Tumor Grading. Contrast Media Mol Imaging, 2017, 5369625.
     
  282. Surov A, Meyer HJ, Schob S, Hohn AK, Bremicker K, Exner M, Stumpp P, Purz S (2017). Parameters of simultaneous 18F-FDG-PET/MRI predict tumor stage and several histopathological features in uterine cervical cancer. Oncotarget, 8(17), 28285-28296.
     
  283. Sabbagh MN, Schauble B, Anand K, Richards D, Murayama S, Akatsu H, Takao M, Rowe CC, Masters CL, Barthel H, Gertz HJ, Peters O, Rasgon N, Jovalekic A, Sabri O, Schulz-Schaeffer WJ, Seibyl J (2017). Histopathology and Florbetaben PET in Patients Incorrectly Diagnosed with Alzheimers Disease. J Alzheimers Dis, 56(2), 441-446.
     
  284. Morbelli S, Arbizu J, Booij J, Chen MK, Chetelat G, Cross DJ, Djekidel M, Drzezga A, Ekmekcioglu O, Garibotto V, Hesse S, Ishii K, Jafari L, Lammertsma AA, Law I, Mathews D, Minoshima S, Mosci K, Pagani M, Pappata S, Silverman DH, Signore A, Van De Giessen E, Villemagne V, Barthel H (2017). The need of standardization and of large clinical studies in an emerging indication of [18F]FDG PET: the autoimmune encephalitis. Eur J Nucl Med Mol Imaging, 44(3), 353-357.
     
  285. Sander CY, Hesse S (2017). News and views on in-vivo imaging of neurotransmission using PET and MRI. Q J Nucl Med Mol Imaging, 61(4), 414-428.
     
  286. Bresch A, Rullmann M, Luthardt J, Becker GA, Reissig G, Patt M, Ding YS, Hilbert A, Sabri O, Hesse S (2017). Emotional eating and in vivo norepinephrine Transporter availability in obesity: A [11C]MRB PET Pilot study. Int J Eat Disord, 50(2), 152-156.
     
  287. Kluge R, Barrington S, Kurch L, Hasenclever D (2017). Reply to: Laffon and Marthan "FDG PET for therapy monitoring in Hodgkins and non-Hodgkins lymphomas: qPET versus rPET". Eur J Nucl Med Mol Imaging, 44(13), 2331-2332.
     
  288. Barrington SF, Kluge R (2017). FDG PET for therapy monitoring in Hodgkin and non-Hodgkin lymphomas. Eur J Nucl Med Mol Imaging, 44(1), 97-110.
     
  289. Kluge R, Kurch L, Georgi T, Hasenclever D (2017). Do paraneoplastic changes in diffuse FDG organ uptake predict relapse? - Wait for confirmation study : Reply to Jorgov et al. Eur J Nucl Med Mol Imaging. 2016 Jul;43(7):1220--30. Eur J Nucl Med Mol Imaging, 44(1), 170-171.
     
  290. Kluge R, Kurch L, Georgi T, Metzger M (2017). Current Role of FDG-PET in Pediatric Hodgkins Lymphoma. Semin Nucl Med, 47(3), 242-257.
     
  291. Drabe M, Rullmann M, Luthardt J, Boettcher Y, Regenthal R, Ploetz T, Becker GA, Patt M, Schinke C, Bergh FT, Zientek F, Hilbert A, Bresch A, Fenske W, Hankir MK, Sabri O, Hesse S (2017). Serotonin transporter gene promoter methylation status correlates with in vivo prefrontal 5-HTT availability and reward function in human obesity. Transl Psychiatry, 7(7), e1167.
     
  292. Fritz TH, Brummerloh B, Urquijo M, Wegner K, Reimer E, Gutekunst S, Schneider L, Smallwood J, Villringer A (2017). Blame it on the bossa nova: Transfer of perceived sexiness from music to touch. J Exp Psychol Gen, 146(9), 1360-1365.
     
  293. Mille E, Levin J, Brendel M, Zach C, Barthel H, Sabri O, Botzel K, Bartenstein P, Danek A, Rominger A (2017). Cerebral Glucose Metabolism and Dopaminergic Function in Patients with Corticobasal Syndrome. J Neuroimaging, 27(2), 255-261.
     
  294. Schipke CG, Koglin N, Bullich S, Joachim LK, Haas B, Seibyl J, Barthel H, Sabri O, Peters O (2017). Correlation of florbetaben PET imaging and the amyloid peptide Aß42 in cerebrospinal fluid. Psychiatry Res, 265, 98-101.
     
  295. Hankir MK, Seyfried F, Hintschich CA, Diep TA, Kleberg K, Kranz M, Deuther-Conrad W, Tellez LA, Rullmann M, Patt M, Teichert J, Hesse S, Sabri O, Brust P, Hansen HS, de Araujo IE, Krugel U, Fenske WK (2017). Gastric Bypass Surgery Recruits a Gut PPAR-?-Striatal D1R Pathway to Reduce Fat Appetite in Obese Rats. Cell Metab, 25(2), 335-344.
     
  296. Daerr S, Brendel M, Zach C, Mille E, Schilling D, Zacherl MJ, Burger K, Danek A, Pogarell O, Schildan A, Patt M, Barthel H, Sabri O, Bartenstein P, Rominger A (2017). Evaluation of early-phase [(18)F]-florbetaben PET acquisition in clinical routine cases. Neuroimage Clin, 14, 77-86.
     
  297. Schinke C, Hesse S, Stoppe M, Meyer K, Schmidt E, Orthgiess J, Bechmann L, Bresch A, Rullmann M, Luthardt J, Sabri O, Bluher M, Kratzsch J, Then Bergh F (2017). Post-dexamethasone serum copeptin corresponds to HPA axis responsiveness in human obesity. Psychoneuroendocrinology, 78, 39-47.
     
  298. Bullich S, Seibyl J, Catafau AM, Jovalekic A, Koglin N, Barthel H, Sabri O, De Santi S (2017). Optimized classification of (18)F-Florbetaben PET scans as positive and negative using an SUVR quantitative approach and comparison to visual assessment. Neuroimage Clin, 15, 325-332.
     
  299. Hankir MK, Kranz M, Keipert S, Weiner J, Andreasen SG, Kern M, Patt M, Kloting N, Heiker JT, Brust P, Hesse S, Jastroch M, Fenske WK (2017). Dissociation Between Brown Adipose Tissue (18)F-FDG Uptake and Thermogenesis in Uncoupling Protein 1-Deficient Mice. J Nucl Med, 58(7), 1100-1103.
     
  300. Dickson JC, Tossici-Bolt L, Sera T, Booij J, Ziebell M, Morbelli S, Assenbaum-Nan S, Borght TV, Pagani M, Kapucu OL, Hesse S, Van Laere K, Darcourt J, Varrone A, Tatsch K (2017). The impact of reconstruction and scanner characterisation on the diagnostic capability of a normal database for [(123)I]FP-CIT SPECT imaging. EJNMMI Res, 7(1), 10.
     
  301. Rausch I, Quick HH, Cal-Gonzalez J, Sattler B, Boellaard R, Beyer T (2017). Technical and instrumentational foundations of PET/MRI. Eur J Radiol, 94, A3-13.
     
  302. Aide N, Lasnon C, Veit-Haibach P, Sera T, Sattler B, Boellaard R (2017). EANM/EARL harmonization strategies in PET quantification: from daily practice to multicentre oncological studies. Eur J Nucl Med Mol Imaging, 44(S1), 17-31.
     
  303. Cecchin D, Palombit A, Castellaro M, Silvestri E, Bui F, Barthel H, Sabri O, Corbetta M, Bertoldo A (2017). Brain PET and functional MRI: why simultaneously using hybrid PET/MR systems? Q J Nucl Med Mol Imaging, 61(4), 345-359.
     
  304. Brendel M, Schnabel J, Schonecker S, Wagner L, Brendel E, Meyer-Wilmes J, Unterrainer M, Schildan A, Patt M, Prix C, Ackl N, Catak C, Pogarell O, Levin J, Danek A, Buerger K, Bartenstein P, Barthel H, (2017). Additive value of amyloid-PET in routine cases of clinical dementia work-up after FDG-PET. Eur J Nucl Med Mol Imaging, 44(13), 2239-2248.
     
  305. Schonecker S, Prix C, Raiser T, Ackl N, Wlasich E, Stenglein-Krapf G, Mille E, Brendel M, Sabri O, Patt M, Barthel H, Bartenstein P, Levin J, Rominger A, Danek A (2017). [Amyloid positron-emission-tomography with [18 F]-florbetaben in the diagnostic workup of dementia patients]. Nervenarzt, 88(2), 156-161.
     
  306. Grothe MJ, Barthel H, Sepulcre J, Dyrba M, Sabri O, Teipel SJ (2017). In vivo staging of regional amyloid deposition. Neurology, 89(20), 2031-2038.
     
  307. Hartig W, Mages B, Aleithe S, Nitzsche B, Altmann S, Barthel H, Krueger M, Michalski D (2017). Damaged Neocortical Perineuronal Nets Due to Experimental Focal Cerebral Ischemia in Mice, Rats and Sheep. Front Integr Neurosci, 11(15), 1-16.
     
  308. Decristoforo C, Penuelas I, Patt M, Todde S (2017). European regulations for the introduction of novel radiopharmaceuticals in the clinical setting. Q J Nucl Med Mol Imaging, 61(2), 135-144.
     
  309. Flerlage JE, Kelly KM, Beishuizen A, Cho S, De Alarcon PA, Dieckmann U, Drachtman RA, Hoppe BS, Howard SC, Kaste SC, Kluge R, Kurch L, Landman-Parker J, Lewis J, Link MP, McCarten K, Punnett A, Stoeve (2017). Staging Evaluation and Response Criteria Harmonization (SEARCH) for Childhood, Adolescent and Young Adult Hodgkin Lymphoma (CAYAHL): Methodology statement. Pediatr Blood Cancer, 64(7), 1-10.
     
  310. Nanni C, Cottereau AS, Lopci E, Bodet-Milin C, Coronado M, Pro B, Kim WS, Trotman J, Barrington S, Duhrsen U, Vander Borght T, Zamagni E, Kraeber-Bodere F, Messiou C, Rahmouni A, Buvat I, Andre M, Her (2017). Report of the 6th International Workshop on PET in lymphoma. Leuk Lymphoma, 58(10), 2298-2303.
     
  311. Tossici-Bolt L, Dickson JC, Sera T, Booij J, Asenbaun-Nan S, Bagnara MC, Borght TV, Jonsson C, de Nijs R, Hesse S, Koulibaly PM, Akdemir UO, Koole M, Tatsch K, Varrone A (2017). [123I]FP-CIT ENC-DAT normal database: the impact of the reconstruction and quantification methods. EJNMMI Phys, 4(1), 8.
     
  312. Mattei D, Ivanov A, Ferrai C, Jordan P, Guneykaya D, Buonfiglioli A, Schaafsma W, Przanowski P, Deuther-Conrad W, Brust P, Hesse S, Patt M, Sabri O, Ross TL, Eggen BJL, Boddeke EWGM, Kaminska B, Beule (2017). Maternal immune activation results in complex microglial transcriptome signature in the adult offspring that is reversed by minocycline treatment. Transl Psychiatry, 7(5), e1120.
     


    313. 2016


  313. Rullmann M, Dukart J, Hoffmann KT, Luthardt J, Tiepolt S, Patt M, Gertz HJ, Schroeter ML, Seibyl J, Schulz-Schaeffer WJ, Sabri O, Barthel H (2016). Partial-Volume Effect Correction Improves Quantitative Analysis of 18F-Florbetaben ?-Amyloid PET Scans. J Nucl Med, 57(2), 198-203.
     
  314. Hesse S, Rullmann M, Luthardt J, Winter K, Hankir MK, Becker GA, Zientek F, Reissig G, Regenthal R, Drabe M, Schinke C, Bresch A, Arelin K, Lobsien D, Patt M, Meyer PM, Fasshauer M, Fenske WK, Bluher M, Stumvoll M, Sabri O (2016). Central serotonin transporter availability in highly obese individuals compared with non-obese controls: A [(11)C] DASB positron emission tomography study. Eur J Nucl Med Mol Imaging, 43(6), 1096-1104.
     
  315. Tuszynski T, Rullmann M, Luthardt J, Butzke D, Tiepolt S, Gertz HJ, Hesse S, Seese A, Lobsien D, Sabri O, Barthel H (2016). Evaluation of software tools for automated identification of neuroanatomical structures in quantitative ß-amyloid PET imaging to diagnose Alzheimers disease. Eur J Nucl Med Mol Imaging, 43(6), 1077-1087.
     
  316. Bresch A, Rullmann M, Luthardt J, Arelin K, Becker GA, Patt M, Lobsien D, Baldofski S, Drabe M, Zeisig V, Regenthal R, Blüher M, Hilbert A, Sabri O, Hesse S (2016). In-vivo Serotonin Transporter availability and somatization in healthy subjects Personality and Individual Differences, 94, 354-359.
     
  317. Seibyl J, Catafau AM, Barthel H, Ishii K, Rowe CC, Leverenz JB, Ghetti B, Ironside JW, Takao M, Akatsu H, Murayama S, Bullich S, Mueller A, Koglin N, Schulz-Schaeffer WJ, Hoffmann A, Sabbagh MN, Stephens AW, Sabri O (2016). Impact of Training Method on the Robustness of the Visual Assessment of 18F-Florbetaben PET Scans: Results from a Phase-3 Study. J Nucl Med, 57(6), 900-906.
     
  318. Tiepolt S, Hesse S, Patt M, Luthardt J, Schroeter ML, Hoffmann KT, Weise D, Gertz HJ, Sabri O, Barthel H (2016). Early [(18)F]florbetaben and [(11)C]PiB PET images are a surrogate biomarker of neuronal injury in Alzheimers disease. Eur J Nucl Med Mol Imaging, 43(9), 1700-1709.
     
  319. Werner P, Saur D, Mildner T, Moller H, Classen J, Sabri O, Hoffmann KT, Barthel H (2016). Combined PET/MRI: Multimodality insights into acute stroke hemodynamics. Neurology, 86(20), 1926-1927.
     
  320. Surov A, Stumpp P, Meyer HJ, Gawlitza M, Hohn AK, Boehm A, Sabri O, Kahn T, Purz S (2016). Simultaneous (18)F-FDG-PET/MRI: Associations between diffusion, glucose metabolism and histopathological parameters in patients with head and neck squamous cell carcinoma. Oral Oncol, 58, 14-20.
     
  321. Barthel H, Meyer PT, Drzezga A, Bartenstein P, Boecker H, Brust P, Buchert R, Coenen HH, la Fougere C, Grunder G, Grunwald F, Krause BJ, Kuwert T, Schreckenberger M, Tatsch K, Langen KJ, Sabri O (2016). [German Society of Nuclear Medicine procedure guideline on beta-amyloid brain PET imaging]. Nuklearmedizin, 55(4), 129-137.
     
  322. Catafau AM, Bullich S, Seibyl JP, Barthel H, Ghetti B, Leverenz J, Ironside JW, Schulz-Schaeffer WJ, Hoffmann A, Sabri O (2016). Cerebellar Amyloid-? Plaques: How Frequent Are They, and Do They Influence 18F-Florbetaben SUV Ratios? J Nucl Med, 57(11), 1740-1745.
     
  323. Zientek F, Winter K, Muller A, Rullmann M, Luthardt J, Becker GA, Bresch A, Patt M, Sabri O, Hilbert A, Hesse S (2016). Effortful control as a dimension of temperament is negatively associated with prefrontal serotonin transporter availability in obese and non-obese individuals. Eur J Neurosci, 44(7), 2460-2466.
     
  324. Jochimsen TH, Zeisig V, Schulz J, Werner P, Patt M, Patt J, Dreyer AY, Boltze J, Barthel H, Sabri O, Sattler B (2016). Fully automated calculation of image-derived input function in simultaneous PET/MRI in a sheep model. EJNMMI Phys, 3(1), 2.
     
  325. Kluge R, Chavdarova L, Hoffmann M, Kobe C, Malkowski B, Montravers F, Kurch L, Georgi T, Dietlein M, Wallace WH, Karlen J, Fernandez-Teijeiro A, Cepelova M, Wilson L, Bergstraesser E, Sabri O, Mauz-Korholz C, Korholz D, Hasenclever D (2016). Inter-Reader Reliability of Early FDG-PET/CT Response Assessment Using the Deauville Scale after 2 Cycles of Intensive Chemotherapy (OEPA) in Hodgkins Lymphoma. PLoS One, 11(3), e0149072.
     
  326. Hinderberger P, Rullmann M, Drabe M, Luthardt J, Becker GA, Bluher M, Regenthal R, Sabri O, Hesse S (2016). The effect of serum BDNF levels on central serotonin transporter availability in obese versus non-obese adults: A [(11)C]DASB positron emission tomography study. Neuropharmacology, 110(PtA), 530-536.
     
  327. Fahnert J, Purz S, Jarvers JS, Heyde CE, Barthel H, Stumpp P, Kahn T, Sabri O, Friedrich B (2016). Use of Simultaneous 18F-FDG PET/MRI for the Detection of Spondylodiskitis. J Nucl Med, 57(9), 1396-1401.
     
  328. Werner P, Rullmann M, Bresch A, Tiepolt S, Jochimsen T, Lobsien D, Schroeter ML, Sabri O, Barthel H (2016). Impact of attenuation correction on clinical [(18)F]FDG brain PET in combined PET/MRI. EJNMMI Res, 6(1), 47-56.
     
  329. Frille A, Steinhoff KG, Hesse S, Grachtrup S, Wald A, Wirtz H, Sabri O, Seyfarth HJ (2016). Thoracic [18F]fluorodeoxyglucose uptake measured by positron emission tomography/computed tomography in pulmonary hypertension. Medicine (Baltimore), 95(25), e3976.
     
  330. Schutz L, Lobsien D, Fritzsch D, Tiepolt S, Werner P, Schroeter ML, Berrouschot J, Saur D, Hesse S, Jochimsen T, Rullmann M, Sattler B, Patt M, Gertz HJ, Villringer A, Classen J, Hoffmann KT, Sabri O, Barthel H (2016). Feasibility and acceptance of simultaneous amyloid PET/MRI. Eur J Nucl Med Mol Imaging, 43(12), 2236-2243.
     
  331. Dickhuth K, Hesse S, Purz S, Habermann B, Lincke Th, Fahnert J, Stumpp P, Do HM, Stolzenburg U, Kahn Th, Sabri O, Kluge R (2016). Frühe Rezidivdiagnostik des Prostatakarzinoms mittels PET/CT und simultaner PET/MRT und dem neuen Radiotracer [68Ga]PSMA-Ligand. Aerzteblatt Sachsen, 8, 339-343.
     
  332. Kranz M, Sattler B, Wust N, Deuther-Conrad W, Patt M, Meyer PM, Fischer S, Donat CK, Wunsch B, Hesse S, Steinbach J, Brust P, Sabri O (2016). Evaluation of the Enantiomer Specific Biokinetics and Radiation Doses of [(18)F]Fluspidine-A New Tracer in Clinical Translation for Imaging of ?? Receptors. Molecules, 21(9), E1164.
     
  333. Kranz M, Sattler B, Tiepolt S, Wilke S, Deuther-Conrad W, Donat CK, Fischer S, Patt M, Schildan A, Patt J, Smits R, Hoepping A, Steinbach J, Sabri O, Brust P (2016). Radiation dosimetry of the ?4?2 nicotinic receptor ligand (+)-[(18)F]flubatine, comparing preclinical PET/MRI and PET/CT to first-in-human PET/CT results. EJNMMI Phys, 3(1), 25.
     
  334. Melasch J, Rullmann M, Hilbert A, Luthardt J, Becker GA, Patt M, Villringer A, Arelin K, Meyer PM, Lobsien D, Ding YS, Muller K, Sabri O, Hesse S, Pleger B (2016). The central nervous norepinephrine network links a diminished sense of emotional well-being to an increased body weight. Int J Obes (Lond), 40(5), 779-787.
     
  335. Melasch J, Rullmann M, Hilbert A, Luthardt J, Becker GA, Patt M, Stumvoll M, Bluher M, Villringer A, Arelin K, Meyer PM, Bresch A, Sabri O, Hesse S, Pleger B (2016). Sex differences in serotonin-hypothalamic connections underpin a diminished sense of emotional well-being with increasing body weight. Int J Obes (Lond), 40(8), 1268-1277.
     
  336. Morbelli S, Djekidel M, Hesse S, Pagani M, Barthel H (2016). Role of (18)F-FDG-PET imaging in the diagnosis of autoimmune encephalitis. Lancet Neurol, 15(10), 1009-1010.
     
  337. Hankir MK, Patt M, Patt JT, Becker GA, Rullmann M, Kranz M, Deuther-Conrad W, Schischke K, Seyfried F, Brust P, Hesse S, Sabri O, Krugel U, Fenske WK (2016). Suppressed Fat Appetite after Roux-en-Y Gastric Bypass Surgery Associates with Reduced Brain ?-opioid Receptor Availability in Diet-Induced Obese Male Rats. Front Neurosci, 10, 620.
     
  338. Schunter JA, Kunz M, Pierer M, Simon JC, Oppolzer AB, Sabri O, Ziemer M (2016). Extracranial cutaneous manifestation of temporal arteritis - a case of erythematous plaques on the legs. J Dtsch Dermatol Ges, 14(1), 66-71.
     
  339. Albert NL, Unterrainer M, Diemling M, Xiong G, Bartenstein P, Koch W, Varrone A, Dickson JC, Tossici-Bolt L, Sera T, Asenbaum S, Booij J, Kapucu LO, Kluge A, Ziebell M, Darcourt J, Nobili F, Pagani M, (2016). Implementation of the European multicentre database of healthy controls for [(123)I]FP-CIT SPECT increases diagnostic accuracy in patients with clinically uncertain parkinsonian syndromes. Eur J Nucl Med Mol Imaging, 43(7), 1315-1322.
     
  340. Buchert R, Kluge A, Tossici-Bolt L, Dickson J, Bronzel M, Lange C, Asenbaum S, Booij J, Atay Kapucu LO, Svarer C, Koulibaly PM, Nobili F, Pagani M, Sabri O, Sera T, Tatsch K, Vander Borght T, Van Laer (2016). Reduction in camera-specific variability in [(123)I]FP-CIT SPECT outcome measures by image reconstruction optimized for multisite settings: impact on age-dependence of the specific binding ratio in the ENC-DAT database of healthy controls. Eur J Nucl Med Mol Imaging, 43(7), 1323-1336.
     
  341. Hankir MK, Kranz M, Gnad T, Weiner J, Wagner S, Deuther-Conrad W, Bronisch F, Steinhoff K, Luthardt J, Kloting N, Hesse S, Seibyl JP, Sabri O, Heiker JT, Bluher M, Pfeifer A, Brust P, Fenske WK (2016). A novel thermoregulatory role for PDE10A in mouse and human adipocytes. EMBO Mol Med, 8(7), 796-812.
     
  342. Minoshima S, Drzezga AE, Barthel H, Bohnen N, Djekidel M, Lewis DH, Mathis CA, Mc Conathy J, Nordberg A, Sabri O, Seibyl JP, Stokes MK, Van Laere K (2016). SNMMI Procedure Standard/EANM Practice Guideline for Amyloid PET Imaging of the Brain 1.0. J Nucl Med , 57(8), 1316-1322.
     
  343. Weiner J, Kranz M, Kloting N, Kunath A, Steinhoff K, Rijntjes E, Kohrle J, Zeisig V, Hankir M, Gebhardt C, Deuther-Conrad W, Heiker JT, Kralisch S, Stumvoll M, Bluher M, Sabri O, Hesse S, Brust P, Ton (2016). Thyroid hormone status defines brown adipose tissue activity and browning of white adipose tissues in mice. Sci Rep, 6, 38124.
     
  344. Stumpp P, Purz S, Sabri O, Kahn T (2016). [Molecular imaging of head and neck cancers : Perspectives of PET/MRI]. Radiologe, 56(7), 588-596.
     
  345. Kewitz S, Kurch L, Volkmer I, Staege MS (2016). Stimulation of the hypoxia pathway modulates chemotherapy resistance in Hodgkins lymphoma cells. Tumour Biol, 37(6), 8229-8237.
     
  346. Boltze J, Wagner DC, Barthel H, Gounis MJ (2016). Academic-industry Collaborations in Translational Stroke Research. Transl Stroke Res, 7(4), 343-353.
     
  347. Bailey DL, Pichler BJ, Guckel B, Barthel H, Beer AJ, Botnar R, Gillies R, Goh V, Gotthardt M, Hicks RJ, Lanzenberger R, la Fougere C, Lentschig M, Nekolla SG, Niederdraenk T, Nikolaou K, Nuyts J, Oleg (2016). Combined PET/MRI: from Status Quo to Status Go. Summary Report of the Fifth International Workshop on PET/MR Imaging; February 15-19, 2016; Tübingen, Germany. Mol Imaging Biol, 18(5), 637-650.
     
  348. Mozet C, Kuhnt T, Sattler B, Remmele J, Thome U, Stepan H, Kluge R, Dietz A, Knoedler M (2016). [Head and Neck Cancer in Pregnancy - Recommendations for Diagnosis and Therapy With Case Report]. Laryngorhinootologie, 95(10), 674-683.
     
  349. Beyer T, Lassen ML, Boellaard R, Delso G, Yaqub M, Sattler B, Quick HH (2016). Investigating the state-of-the-art in whole-body MR-based attenuation correction: an intra-individual, inter-system, inventory study on three clinical PET/MR systems. MAGMA, 29(1), 75-87.
     
  350. Hering K, Bresch A, Lobsien D, Mueller W, Kortmann RD, Seidel C (2016). Primary Intradural Extramedullary Spinal Melanoma in the Lower Thoracic Spine. Case Rep Oncol Med, 2016, 3815280.
     
  351. Kurch L, Körholz D, Kluge R (2016). Pädiatrisches Hodgkin-Lymphome. In: Mohnike W, Hör G. Hertel A, Schelbert H, PET/CT-Atlas - Interdisziplinäre PET/CT- und PET/MR-Diagnostik und Therapie. (S. 415-433), Heidelberg: Springer Veralg.
     
  352. Sabri O, Meyer PM, Hesse S, Barthel H, Tiepolt S (2016). Neuronuklearmedizin: Neue Targets und In-vivo-PET-Biomarker für neurologische und psychiatrische Erkrankungen. In: Wolf KJ, Knapp WH, Herrmann T, Strahlenforschung in der Medizin - Relevanz und Perspektiven. (S. 309-322), Halle: Leopoldina.
     
  353. Nitzsche B, Barthel H, Lobsien D, Boltze J, Zeisig V, Dreyer AY (2016). Focal Cerebral Ischemia by Permanent Middle Cerebral Artery Occlusion in Sheep: Surgical Technique, Clinical Imaging, and Histopathological Results. In: Janowski M, Experimental Neurosurgery in Animal Models. (S. 195-225), Berlin Heidelberg: Springer.
     


    354. 2015


  354. Kluge R, Kurch L, Georgi T, Körholz D (2015). Current Status of FDG-PET/CT in the Treatment Setting of Hodgkins lymphoma in childhood and adolescence Clin Transl Imaging, 3(4), 309-319.
     
  355. Senda M, Sasaki M, Yamane T, Shimizu K, Patt M, Barthel H, Sattler B, Nagasawa T, Schultze-Mosgau M, Aitoku Y, Dinkelborg L, Sabri O (2015). Ethnic comparison of pharmacokinetics of (18)F-florbetaben, a PET tracer for beta-amyloid imaging, in healthy Caucasian and Japanese subjects. Eur J Nucl Med Mol Imaging, 42(1), 89-96.
     
  356. Werner P, Barthel H, Drzezga A, Sabri O (2015). Current Status and future role of brain PET/MRI in clinical and research settings Eur J Nucl Med Mol Imaging, 42(3), 512-526.
     
  357. Sabri O, Seibyl J, Rowe C, Barthel H (2015). Beta-amyloid imaging with florbetaben. Clin Transl Imaging, 3(1), 13-26.
     
  358. Barthel H, Schroeter ML, Hoffmann KT, Sabri O (2015). PET/MR in Dementia and Other Neurodegenerative Diseases. Semin Nucl Med, 45(3), 224-233.
     
  359. Barthel H, Seibyl J, Sabri O (2015). The role of positron emission tomography imaging in understanding Alzheimers disease. Expert Rev Neurother, 15(4), 395-406.
     
  360. Bailey DL, Antoch G, Bartenstein P, Barthel H, Beer AJ, Bisdas S, Bluemke DA, Boellaard R, Claussen CD, Franzius C, Hacker M, Hricak H, la Fougere C, Guckel B, Nekolla SG, Pichler BJ, Purz S, Quick HH, Sabri O, Sattler B, Schafer J, Schmidt H, van den Hoff J, Voss S, Weber W, Wehrl HF, Beyer T (2015). Combined PET/MR: The Real Work Has Just Started. Summary Report of the Third International Workshop on PET/MR Imaging; February 17-21, 2014, Tübingen, Germany. Mol Imaging Biol, 17(3), 297-312.
     
  361. Jochimsen TH, Schulz J, Busse H, Werner P, Schaudinn A, Zeisig V, Kurch L, Seese A, Barthel H, Sattler B, Sabri O (2015). Lean body mass correction of standardized uptake value in simultaneous whole-body positron emission tomography and magnetic resonance imaging. Phys Med Biol, 60(12), 4651-4664.
     
  362. Sabri O, Becker GA, Meyer PM, Hesse S, Wilke S, Graef S, Patt M, Luthardt J, Wagenknecht G, Hoepping A, Smits R, Franke A, Sattler B, Habermann B, Neuhaus P, Fischer S, Tiepolt S, Deuther-Conrad W, Barthel H, Schonknecht P, Brust P (2015). First-in-human PET quantification study of cerebral alpha4ß2* nicotinic acetylcholine receptors using the novel specific radioligand (-)-[(18)F]Flubatine. Neuroimage, 118(9), 199-208.
     
  363. Sabri O, Sabbagh MN, Seibyl J, Barthel H, Akatsu H, Ouchi Y, Senda K, Murayama S, Ishii K, Takao M, Beach TG, Rowe CC, Leverenz JB, Ghetti B, Ironside JW, Catafau AM, Stephens AW, Mueller A, Koglin N, Hoffmann A, Roth K, Reininger C, Schulz-Schaeffer WJ (2015). Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer disease: Phase 3 study. Alzheimers Dement, 11(8), 964-974.
     
  364. Steinhoff KG, Hankir M, Krause K, Tönjes A, Fenske WK, Sabri O (2015). Interaction of thyroid hormone with brown adipose tissue. Nuklearmedizin, 54(3), 82-87.
     
  365. Schroeter ML, Tiepolt S, Marschhauser A, Thone-Otto A, Hoffmann KT, Barthel H, Obrig H, Sabri O (2015). Dissociation of amyloid biomarkers in PET and CSF in Alzheimers disease: a case report. BMC Neurol, 15, 152.
     
  366. Werner P, Saur D, Zeisig V, Ettrich B, Patt M, Sattler B, Jochimsen T, Lobsien D, Meyer PM, Bergh FT, Dreyer A, Boltze J, Classen J, Fritzsch D, Hoffmann KT, Sabri O, Barthel H (2015). Simultaneous PET/MRI in stroke: a case series. J Cereb Blood Flow Metab, 35(9), 1421-1425.
     
  367. Tiepolt S, Patt M, Hoffmann KT, Schroeter ML, Sabri O, Barthel H (2015). Alzheimers Disease FDG PET Imaging Pattern in an Amyloid-Negative Mild Cognitive Impairment Subject. J Alzheimers Dis, 47(3), 539-543.
     
  368. Gawlitza M, Purz S, Kubiessa K, Boehm A, Barthel H, Kluge R, Kahn T, Sabri O, Stumpp P (2015). In Vivo Correlation of Glucose Metabolism, Cell Density and Microcirculatory Parameters in Patients with Head and Neck Cancer: Initial Results Using Simultaneous PET/MRI. PLoS One, 10(8), e0134749.
     
  369. Brandmaier P, Purz S, Bremicker K, Hockel M, Barthel H, Kluge R, Kahn T, Sabri O, Stumpp P (2015). Simultaneous [18F]FDG-PET/MRI: Correlation of Apparent Diffusion Coefficient (ADC) and Standardized Uptake Value (SUV) in Primary and Recurrent Cervical Cancer. PLoS One, 10(11), e0141684.
     
  370. Fritz TH, Vogt M, Lederer A, Schneider L, Fomicheva E, Schneider M, Villringer A (2015). Benefits of listening to a recording of euphoric joint music making in polydrug abusers. Front Hum Neurosci, 9, 300.
     
  371. Fritz TH, Steixner A, Boettger J, Villringer A (2015). Losing track of time through delayed body representations. Front Psychol, 6, 405.
     
  372. Boellaard R, Rausch I, Beyer T, Delso G, Yaqub M, Quick HH, Sattler B (2015). Quality control for quantitative multicenter whole-body PET/MR studies: A NEMA image quality phantom study with three current PET/MR systems. Med Phys, 42(10), 5961-5969.
     
  373. Bailey DL, Pichler BJ, Guckel B, Barthel H, Beer AJ, Bremerich J, Czernin J, Drzezga A, Franzius C, Goh V, Hartenbach M, Iida H, Kjaer A, la Fougere C, Ladefoged CN, Law I, Nikolaou K, Quick HH, Sabri O, Schafer J, Schafers M, Wehrl HF, Beyer T (2015). Combined PET/MRI: Multi-modality Multi-parametric Imaging Is Here: Summary Report of the 4th International Workshop on PET/MR Imaging; February 23-27, 2015, Tübingen, Germany. Mol Imaging Biol, 17(5), 595-608.
     
  374. Jansen WJ, Ossenkoppele R, Knol DL, Tijms BM, Scheltens P, Verhey FR, Visser PJ, Aalten P, Aarsland D, Alcolea D, Alexander M, Almdahl IS, Arnold SE, Baldeiras I, Barthel H, van Berckel BN, Bibeau K, (2015). Prevalence of Cerebral Amyloid Pathology in Persons Without Dementia: A Meta-analysis. JAMA, 313(19), 1924-1938.
     
  375. Ossenkoppele R, Jansen WJ, Rabinovici GD, Knol DL, van der Flier WM, van Berckel BN, Scheltens P, Visser PJ, Verfaillie SC, Zwan MD, Adriaanse SM, Lammertsma AA, Barkhof F, Jagust WJ, Miller BL, Rosen (2015). Prevalence of Amyloid PET Positivity in Dementia Syndromes: A Meta-analysis. JAMA, 313(19), 1939-1949.
     
  376. Barthel C, Sorger D, Deuther-Conrad W, Scheunemann M, Schweiger S, Jackel P, Roghani A, Steinbach J, Schuurmann G, Sabri O, Brust P, Wenzel B (2015). New systematically modified vesamicol analogs and their affinity and selectivity for the vesicular acetylcholine transporter - A critical examination of the lead structure. Eur J Med Chem, 100, 50-67.
     
  377. Lange C, Kurth J, Seese A, Schwarzenbock S, Steinhoff K, Umland-Seidler B, Krause BJ, Brenner W, Sabri O, Hesse S, Buchert R (2015). Robust, fully automatic delineation of the head contour by stereotactical normalization for attenuation correction according to Chang in dopamine transporter scintigraphy. Eur Radiol, 25(9), 2709-2717.
     
  378. Paschke R, Lincke T, Muller SP, Kreissl MC, Dralle H, Fassnacht M (2015). The Treatment of Well-Differentiated Thyroid Carcinoma. Dtsch Arztebl Int, 112(26), 452-458.
     
  379. Hankir MK, Ashrafian H, Hesse S, Horstmann A, Fenske WK (2015). Distinctive striatal dopamine signaling after dieting and gastric bypass. Trends Endocrinol Metab, 26(5), 223-230.
     
  380. Zajonz D, Wuthe L, Tiepolt S, Brandmeier P, Prietzel T, von Salis-Soglio GF, Roth A, Josten C, Heyde CE, Ghanem M (2015). Diagnostic work-up strategy for periprosthetic joint infections after total hip and knee arthroplasty: a 12-year experience on 320 consecutive cases. Patient Saf Surg, 9, 20.
     
  381. Weise D, Tiepolt S, Awissus C, Hoffmann KT, Lobsien D, Kaiser T, Barthel H, Sabri O, Gertz HJ (2015). Critical Comparison of Different Biomarkers for Alzheimer s Disease in a Clinical Setting. J Alzheimers Dis, 48(2), 425-432.
     
  382. Zajonz D, Pfranger J, Fuchs J, Tiepolt S, Lindscheidt T, Farag M, Prietzel T (2015). [Cardiac fibromyxosarcoma with bone metastases : palliative surgical treatment]. Orthopade, 44(1), 80-84.
     
  383. Mauz-Korholz C, Metzger ML, Kelly KM, Schwartz CL, Castellanos ME, Dieckmann K, Kluge R, Korholz D (2015). Pediatric Hodgkin Lymphoma. J Clin Oncol, 33(27), 2975-2985.
     
  384. Mauz-Korholz C, Lange T, Hasenclever D, Burkhardt B, Feller AC, Dorffel W, Kluge R, Vordermark D, Korholz D (2015). Pediatric Nodular Lymphocyte-predominant Hodgkin Lymphoma: Treatment Recommendations of the GPOH-HD Study Group. Klin Padiatr, 227(6-7), 314-321.
     
  385. Krause K, Weiner J, Hones S, Kloting N, Rijntjes E, Heiker JT, Gebhardt C, Kohrle J, Fuhrer D, Steinhoff K, Hesse S, Moeller LC, Tonjes A (2015). The Effects of Thyroid Hormones on Gene Expression of Acyl-Coenzyme A Thioesterases in Adipose Tissue and Liver of Mice. Eur Thyroid J, 4(Suppl1), 59-66.
     
  386. Morbelli S, Garibotto V, Van De Giessen E, Arbizu J, Chetelat G, Drezgza A, Hesse S, Lammertsma AA, Law I, Pappata S, Payoux P, Pagani M (2015). A Cochrane review on brain [18-F]FDG PET in dementia: limitations and future perspectives. Eur J Nucl Med Mol Imaging, 42(10), 1487-1491.
     
  387. Mueller K, Fritz T, Mildner T, Richter M, Schulze K, Lepsien J, Schroeter ML, Moller HE (2015). Investigating the dynamics of the brain response to music: A central role of the ventral striatum/nucleus accumbens. Neuroimage, 116, 68-79.
     
  388. Jacobsen JH, Stelzer J, Fritz TH, Chetelat G, La Joie R, Turner R (2015). Why musical memory can be preserved in advanced Alzheimers disease. Brain, 138(Pt8), 2438-2450.
     
  389. Teodoro R, Scheunemann M, Deuther-Conrad W, Wenzel B, Fasoli FM, Gotti C, Kranz M, Donat CK, Patt M, Hillmer A, Zheng MQ, Peters D, Steinbach J, Sabri O, Huang Y, Brust P (2015). A Promising PET Tracer for Imaging of ?? Nicotinic Acetylcholine Receptors in the Brain: Design, Synthesis, and in Vivo Evaluation of a Dibenzothiophene-Based Radioligand. Molecules, 20(10), 18387-18421.
     
  390. Teipel S, Drzezga A, Grothe MJ, Barthel H, Chetelat G, Schuff N, Skudlarski P, Cavedo E, Frisoni GB, Hoffmann W, Thyrian JR, Fox C, Minoshima S, Sabri O, Fellgiebel A (2015). Multimodal imaging in Alzheimers disease: validity and usefulness for early detection. Lancet Neurol, 14(10), 1037-1053.
     
  391. Arbizu Lostao J, Barthel H, Boehm T, Calapaqui-Teran A, Delgado-Bolton R, Garibotto V, Grmek M, Hacken E, Hoffmann KT, Law I, Lucena F, Morbelli S, Pagani M, Payoux P, Pepe G, Pestean C, Sabri O, Soca (2015). Chapter & PET/MRI for Brain Imaging In: Fragoso Costa P, Santos A, Vidovic B, Brain Imaging - A Technologists Guide (S. 100-109), Vienna, Austria: Eirpüeam Association of Nuclear Medicine.
     


    392. 2014


  392. Hesse S, Moeller F, Petroff D, Lobsien D, Luthardt J, Regenthal R, Becker GA, Patt M, Thomae E, Seese A, Meyer PM, Bergh FT, Sabri O (2014). Altered serotonin transporter availability in patients with multiple sclerosis. Eur J Nucl Med Mol Imaging, 41(5), 827-835.
     
  393. Hasenclever D, Kurch L, Mauz-Korholz C, Elsner A, Georgi T, Wallace H, Landman-Parker J, Moryl-Bujakowska A, Cepelova M, Karlen J, Alvarez Fernandez-Teijeiro A, Attarbaschi A, Fossa A, Pears J, Hraskova A, Bergstrasser E, Beishuizen A, Uyttebroeck A, Schomerus E, Sabri O, Korholz D, Kluge R (2014). qPET - a quantitative extension of the Deauville scale to assess response in interim FDG-PET scans in lymphoma. Eur J Nucl Med Mol Imaging, 41(7), 1301-1308.
     
  394. Preuss M, Werner P, Barthel H, Nestler U, Christiansen H, Hirsch FW, Fritzsch D, Hoffmann KT, Bernhard MK, Sabri O (2014). Integrated PET/MRI for planning navigated biopsies in pediatric brain tumors. Childs Nerv Syst, 30(8), 1399-1403.
     
  395. Purz S, Sabri O, Viehweger A, Barthel H, Kluge R, Sorge I, Hirsch FW (2014). Potential Pediatric Applications of PET/MR. J Nucl Med, 55(Suppl.2), S32-39.
     
  396. Patt M, Becker GA, Grossmann U, Habermann B, Schildan A, Wilke S, Deuther-Conrad W, Graef S, Fischer S, Smits R, Hoepping A, Wagenknecht G, Steinbach J, Gertz HJ, Hesse S, Schonknecht P, Brust P, Sabri O (2014). Evaluation of metabolism, plasma protein binding and other biological parameters after administration of (-)-[(18)F]Flubatine in humans. Nucl Med Biol, 41(6), 489-494.
     
  397. Drzezga A, Barthel H, Minoshima S, Sabri O (2014). Potential Clinical Applications of PET/MR Imaging in Neurodegenerative Diseases. J Nucl Med, 55(Suppl.2), S47-55.
     
  398. Brust P, Deuther-Conrad W, Becker G, Patt M, Donat CK, Stittsworth S, Fischer S, Hiller A, Wenzel B, Dukic-Stefanovic S, Hesse S, Steinbach J, Wunsch B, Lever SZ, Sabri O (2014). Distinctive in vivo kinetics of the new ?1 receptor ligands (R)-(+)- and (S)-(-)-18F-fluspidine in porcine brain. J Nucl Med, 55(10), 1730-1736.
     
  399. Werner P, Fritzsch D, Holland H, Bauer M, Krupp W, Hoffmann KT, Saur D, Then Bergh F, Sabri O, Barthel H (2014). Definition of primary and secondary glioblastoma-letter. Clin Cancer Res, 20(7), 2011-2012.
     
  400. Sattler B, Kranz M, Starke A, Wilke S, Donat CK, Deuther-Conrad W, Patt M, Schildan A, Patt J, Smits R, Hoepping A, Schoenknecht P, Steinbach J, Brust P, Sabri O (2014). Internal Dose Assessment of (-)-18F-Flubatine, Comparing Animal Model Datasets of Mice and Piglets with First-in-Human Results. J Nucl Med, 55(11), 1885-1892.
     
  401. Fritz TH, Ciupek M, Kirkland A, Ihme K, Guha A, Hoyer J, Villringer A (2014). Enhanced response to music in pregnancy. Psychophysiology, 51(9), 905-911.
     
  402. Hesse S, van de Giessen E, Zientek F, Petroff D, Winter K, Dickson JC, Tossici-Bolt L, Sera T, Asenbaum S, Darcourt J, Akdemir UO, Knudsen GM, Nobili F, Pagani M, Vander Borght T, Van Laere K, Varrone A, Tatsch K, Sabri O, Booij J (2014). Association of central serotonin transporter availability and body mass index in healthy Europeans. Eur Neuropsychopharmacol, 24(8), 1240-1247.
     
  403. Drzezga A, Sabri O, Fellgiebel A (2014). Amyloid-Bildgebung: Reif für die Routine? Deutsches Aerzteblatt, 111(26), A1206.
     
  404. Hasenclever D, Kurch L, Kluge R (2014). Sources of variability in FDG PET imaging and the qPET value: reply to Laffon and Marthan. Eur J Nucl Med Mol Imaging, 41(11), 2155-2157.
     
  405. Steinhoff K, Pierer M, Siegert J, Pigla U, Laub R, Hesse S, Seidel W, Sorger D, Seese A, Kuenstler JU, Pietzsch HJ, Lincke T, Rullmann M, Emmrich F, Sabri O (2014). Visualizing inflammation activity in rheumatoid arthritis with Tc-99 m anti-CD4-mAb fragment scintigraphy. Nucl Med Biol, 41(4), 350-354.
     
  406. Kurch L, Körholz D, Georgi T, Kluge R (2014). FDG-PET/CT bzw. FDG-PET/MRT als integraler Bestandteil der Therapiesteuerung beim pädiatrischen Hodgkin-Lymphom Der Nuklearmediziner, 37, 258-263.
     
  407. Kurch L, Sabri O, Christiansen H, Bühlingen U, Preuss M, Werner P, Barthel H, Kluge R, Sorge I (2014). Einsatz der PET/MRT in der Kinder-Onkologie. Der Nuklearmediziner, 37(4), 264-268.
     
  408. Meyer PM, Tiepolt S, Barthel H, Hesse S, Sabri O (2014). Radioligand imaging of ?4ß2* nicotinic acetylcholine receptors in Alzheimers disease and Parkinsons disease. Q J Nucl Med Mol Imaging, 58(4), 376-386.
     
  409. Bailey DL, Barthel H, Beuthin-Baumann B, Beyer T, Bisdas S, Boellaard R, Czernin J, Drzezga A, Ernemann U, Franzius C, Guckel B, Handgretinger R, Hartenbach M, Hellwig D, Nadel H, Nekolla SG, Pfluger T, Pichler BJ, Quick HH, Sabri O, Sattler B, Schafer J, Schick F, Siegel BA, Schlemmer HP, Schwenzer NF, van den Hoff J, Veit-Haibach P, Wehrl HF (2014). Combined PET/MR: Where are we now? Summary report of the second international workshop on PET/MR imaging April 8-12, 2013, Tubingen, Germany. Mol Imaging Biol, 16(3), 295-310.
     
  410. Kubiessa K*, Purz S*, Gawlitza M, Kuhn A, Fuchs J, Steinhoff KG, Boehm A, Sabri O, Kluge R, Kahn T, Stumpp P (2014). Initial clinical results of simultaneous 18F-FDG PET/MRI in comparison to 18F-FDG PET/CT in patients with head and neck cancer. Eur J Nucl Med Mol Imaging, 41(4), 639-648.
     
  411. Smits R, Fischer S, Hiller A, Deuther-Conrad W, Wenzel B, Patt M, Cumming P, Steinbach J, Sabri O, Brust P, Hoepping A (2014). Synthesis and biological evaluation of both enantiomers of [(18)F]flubatine, promising radiotracers with fast kinetics for the imaging of ?4?2-nicotinic acetylcholine receptors. Bioorg Med Chem, 22(2), 804-812.
     
  412. Rotering S, Deuther-Conrad W, Cumming P, Donat CK, Scheunemann M, Fischer S, Xiong G, Steinbach J, Peters D, Sabri O, Bucerius J, Brust P (2014). Imaging of ?7 nicotinic acetylcholine receptors in brain and cerebral vasculature of juvenile pigs with [(18)F]NS14490. EJNMMI Res, 4, 43.
     
  413. Gallezot JD, Esterlis I, Bois F, Zheng MQ, Lin SF, Kloczynski T, Krystal JH, Huang Y, Sabri O, Carson RE, Cosgrove KP (2014). Evaluation of the sensitivity of the novel ?4?2* nicotinic acetylcholine receptor PET radioligand 18F-(-)-NCFHEB to increases in synaptic acetylcholine levels in rhesus monkeys. Synapse, 68(11), 556-564.
     
  414. Lange C, Seese A, Schwarzenbock S, Steinhoff K, Umland-Seidler B, Krause BJ, Brenner W, Sabri O, Kurth J, Hesse S, Buchert R (2014). CT-based attenuation correction in I-123-ioflupane SPECT. PLoS One, 9(9), e108328.
     
  415. Gesing J, Pfaeffle R, Christiansen H, Keller A, Lincke T, Lamesch P, Sabri O, Kiess W (2014). Papillary Thyroid Carcinoma in an Adolescent Girl with Graves Disease. Klin Padiatr, 226(6-7), 379-381.
     
  416. Parker JA, Christian P, Jadvar H, Sattler B, Wallis JW (2014). The SNMMI and EANM practice guideline for tele-nuclear medicine 2.0. J Nucl Med Technol, 42(1), 15-19.
     
  417. Kobe C, Kuhnert G, Kahraman D, Haverkamp H, Eich HT, Franke M, Persigehl T, Klutmann S, Amthauer H, Bockisch A, Kluge R, Wolf HH, Maintz D, Fuchs M, Borchmann P, Diehl V, Drzezga A, Engert A, Dietlein (2014). Assessment of tumor size reduction improves outcome prediction of positron emission tomography/computed tomography after chemotherapy in advanced-stage Hodgkin lymphoma. J Clin Oncol, 32(17), 1776-1781.
     
  418. Zajonz D, Werner M, Panzert S, Strubing AS, Tiepolt S, Fabsits E, Brandmaier P, Heyde CE, Prietzel T (2014). [Secondary telangiectatic osteosarcoma of the left femur. A case presentation of an unusual course of disease]. Orthopade, 43(5), 467-472.
     
  419. Zajonz D, von der Hoh NH, Tiemann AH, Zaage J, Brandmaier P, Tiepolt S, Heyde CE, Ghanem M (2014). [Superinfected epidermal inclusion cyst of the thigh with development of squamous cell carcinoma--case report of a rare complication]. Z Orthop Unfall, 152(3), 265-269.
     
  420. Beyer T, Flux G, Sattler B, Bischof Delaloye A, Carrio I (2014). EJNMMI Physics--access is open for open access. Editorial. Eur J Nucl Med Mol Imaging, 41(2), 197-198.
     
  421. Maier FC, Wehrl HF, Schmid AM, Mannheim JG, Wiehr S, Lerdkrai C, Calaminus C, Stahlschmidt A, Ye L, Burnet M, Stiller D, Sabri O, Reischl G, Staufenbiel M, Garaschuk O, Jucker M, Pichler BJ (2014). Longitudinal PET-MRI reveals ß-amyloid deposition and rCBF dynamics and connects vascular amyloidosis to quantitative loss of perfusion. Nat Med, 20(12), 1485-1492.
     
  422. Zeisig V, Patt M, Becker G, Boltze J, Sabri O, Barthel H (2014). Cerebral blood flow measurement with Oxygen-15 water Positron Emission tomography. In: Dierckx R, Otte A, de Vries E, van Warde A, eds., PET and SPECT of neurobiological systems. (S. 103-124), Heidelberg: Springer Berlin.
     
  423. Brust P, Deuther-Conrad W, Donat CK, Barthel H, Riss P, Paterson L, Höpping A, Sabri O, Cumming P (2014). Preclinical aspects of nicotinic acetylcholine receptor imaging. In: Dierckx R, Otte A, de Vries E, van Warde A, eds., PET and SPECT of neurobiological systems. (S. 456-512), Berlin Heidelberg: Springer.
     
  424. Sabri O, Meyer P M, Gertz H-J, Brust P, Barthel H, Hesse S (2014). PET Imaging of the alpha4beta2 Nicotinic Acetylcholine Receptors in Alzheimers Disease. In: R.A.J.O. Dierckx et al., PET and SPECT in Neurology. (S. 255-269), Berlin Heidelberg: Springer-Verlag.
     


    425. 2013


  425. van de Giessen E, Hesse S, Caan MW, Zientek F, Dickson JC, Tossici-Bolt L, Sera T, Asenbaum S, Guignard R, Akdemir UO, Knudsen GM, Nobili F, Pagani M, Vander Borght T, Van Laere K, Varrone A, Tatsch K (2013). No association between striatal dopamine transporter binding and body mass index: A multi-center European study in healthy volunteers. Neuroimage, 64, 61-67.
     
  426. Purz S, Kluge R, Barthel H, Steinert F, Stumpp P, Kahn T, Sabri O (2013). Visualization of ectopic parathyroid adenomas. N Engl J Med, 369(21), 2067-2069.
     
  427. Patt M, Schildan A, Habermann B, Fischer S, Hiller A, Deuther-Conrad W, Wilke S, Smits R, Hoepping A, Wagenknecht G, Steinbach J, Brust P, Sabri O (2013). Fully automated radiosynthesis of both enantiomers of [18F]Flubatine under GMP conditions for human application. Appl Radiat Isot, 80, 7-11.
     
  428. Becker GA, Ichise M, Barthel H, Luthardt J, Patt M, Seese A, Schultze-Mosgau M, Rohde B, Gertz HJ, Reininger C, Sabri O (2013). PET quantification of 18F-florbetaben binding to β-amyloid deposits in human brains. J Nucl Med, 54(5), 723-731.
     
  429. Hirsch FW, Sattler B, Sorge I, Kurch L, Viehweger A, Ritter L, Werner P, Jochimsen T, Barthel H, Bierbach U, Till H, Sabri O, Kluge R (2013). PET/MR in children. Initial clinical experience in paediatric oncology using an integrated PET/MR scanner. Pediatr Radiol, 43(7), 860-875.
     
  430. Tiepolt S, Barthel H, Butzke D, Hesse S, Patt M, Gertz HJ, Reininger C, Sabri O (2013). Influence of scan duration on the accuracy of ß-amyloid PET with florbetaben in patients with Alzheimer's disease and healthy volunteers. Eur J Nucl Med Mol Imaging, 40(2), 238-244.
     
  431. Booij J, van de Giessen E, Hesse S, Sabri O (2013). Comments on Eusebio et al.: Voxel-based analysis of whole-brain effects of age and gender on dopamine transporter SPECT imaging in healthy subjects. Eur J Nucl Med Mol Imaging, 40(1), 143-144.
     
  432. Sattler B, Jochimsen T, Barthel H, Sommerfeld K, Stumpp P, Hoffmann KT, Gutberlet M, Villringer A, Kahn T, Sabri O (2013). Physical and organizational provision for installation, regulatory requirements and implementation of a simultaneous hybrid PET/MR-imaging system in an integrated research and clinical setting. MAGMA, 26(1), 159-171.
     
  433. Patt M, Solbach C, Habermann B, Schildan A, Baur B, Sabri O (2013). Influence of additives to the formulation of n.c.a. [(11)C]PiB on sterile filter performance. Appl Radiat Isot, 82, 289-292.
     
  434. Kurch L, Mauz-Korholz C, Bertling S, Wallinder M, Kaminska M, Marwede D, Tchavdarova L, Georgi TW, Elsner A, Barthel A, Stoevesandt D, Hasenclever D, Sattler B, Sabri O, Korholz D, Kluge R (2013). The EuroNet paediatric hodgkin network - modern imaging data management for real time central review in multicentre trials. Klin Padiatr, 225(6), 357-361.
     
  435. Kluge R, Kurch L, Montravers F, Mauz-Korholz C (2013). FDG PET/CT in children and adolescents with lymphoma. Pediatr Radiol, 43(4), 406-417.
     
  436. Kurch L, Sabri O, Kluge R (2013). Die Rolle der FDG-PET/CT bei malignen Lymphomen im Kindes- und Jugendalter unter besonderer Berücksichtigung des Hodgkin-Lymphoms Der Nuklearmediziner, 36(2), 96-106.
     
  437. Fritz TH, Halfpaap J, Grahl S, Kirkland A, Villringer A (2013). Musical feedback during exercise machine workout enhances mood. Front Psychol, 4, 921.
     
  438. Fritz TH, Hardikar S, Demoucron M, Niessen M, Demey M, Giot O, Li Y, Haynes JD, Villringer A, Leman M (2013). Musical agency reduces perceived exertion during strenuous physical performance. Proc Natl Acad Sci , 110(44), 17784-17789.
     
  439. Fritz TH, Schmude P, Jentschke S, Friederici AD, Koelsch S (2013). From understanding to appreciating music cross-culturally. PLoS One, 8(9), e72500.
     
  440. Fritz TH (2013). The Dock-in Model of Music Culture and Cross-cultural Perception. Music Perception, 30(5), 513-518.
     
  441. Woost TB, Dukart J, Frisch S, Barthel H, Sabri O, Mueller K, Schroeter ML (2013). Neural correlates of the DemTect in Alzheimer's disease and frontotemporal lobar degeneration - A combined MRI & FDG-PET study. Neuroimage Clin, 2, 746-758.
     
  442. Thomsen G, Knudsen GM, Jensen PS, Ziebell M, Holst KK, Asenbaum S, Booij J, Darcourt J, Dickson JC, Kapucu OL, Nobili F, Sabri O, Sera T, Tatsch K, Tossici-Bolt L, Laere KV, Borght TV, Varrone A, Paga (2013). No difference in striatal dopamine transporter availability between active smokers, ex-smokers and non-smokers using [123I]FP-CIT (DaTSCAN) and SPECT. EJNMMI Res, 3(1), 39.
     
  443. Bailey DL, Barthel H, Beyer T, Boellaard R, Guckel B, Hellwig D, Herzog H, Pichler BJ, Quick HH, Sabri O, Scheffler K, Schlemmer HP, Schwenzer NF, Wehrl HF (2013). Summary report of the First International Workshop on PET/MR imaging, March 19-23, 2012, Tübingen, Germany. Mol Imaging Biol, 15(4), 361-371.
     
  444. Soderlund TA, Dickson JC, Prvulovich E, Ben-Haim S, Kemp P, Booij J, Nobili F, Thomsen G, Sabri O, Koulibaly PM, Akdemir OU, Pagani M, van Laere K, Asenbaum-Nan S, George J, Sera T, Tatsch K, Bomanji (2013). Value of semiquantitative analysis for clinical reporting of 123I-2-ß-carbomethoxy-3ß-(4-iodophenyl)-N-(3-fluoropropyl)nortropane SPECT studies. J Nucl Med, 54(5), 714-722.
     
  445. Frisch S, Dukart J, Vogt B, Horstmann A, Becker G, Villringer A, Barthel H, Sabri O, Muller K, Schroeter ML (2013). Dissociating memory networks in early Alzheimer's disease and frontotemporal lobar degeneration - a combined study of hypometabolism and atrophy. PLoS One, 8(2), 55251.
     
  446. Dukart J, Perneczky R, Forster S, Barthel H, Diehl-Schmid J, Draganski B, Obrig H, Santarnecchi E, Drzezga A, Fellgiebel A, Frackowiak R, Kurz A, Muller K, Sabri O, Schroeter ML, Yakushev I (2013). Reference cluster normalization improves detection of frontotemporal lobar degeneration by means of FDG-PET. PLoS One, 8(2), e55415.
     
  447. Fischer S, Hiller A, Smits R, Hoepping A, Funke U, Wenzel B, Cumming P, Sabri O, Steinbach J, Brust P (2013). Radiosynthesis of racemic and enantiomerically pure (-)-[18F]flubatine--a promising PET radiotracer for neuroimaging of α4β2 nicotinic acetylcholine receptors. Appl Radiat Isot, 74, 128-136.
     
  448. Nobili F, Naseri M, De Carli F, Asenbaum S, Booij J, Darcourt J, Ell P, Kapucu O, Kemp P, Svarer C, Morbelli S, Pagani M, Sabri O, Tatsch K, Tossici-Bolt L, Sera T, Vander Borght T, Van Laere K, Varro (2013). Automatic semi-quantification of [123I]FP-CIT SPECT scans in healthy volunteers using BasGan version 2: results from the ENC-DAT database. Eur J Nucl Med Mol Imaging, 40(4), 565-573.
     
  449. Varrone A, Dickson JC, Tossici-Bolt L, Sera T, Asenbaum S, Booij J, Kapucu OL, Kluge A, Knudsen GM, Koulibaly PM, Nobili F, Pagani M, Sabri O, Vander Borght T, Van Laere K, Tatsch K (2013). European multicentre database of healthy controls for [123I]FP-CIT SPECT (ENC-DAT): age-related effects, gender differences and evaluation of different methods of analysis. Eur J Nucl Med Mol Imaging, 40(2), 213-227.
     
  450. Dukart J, Mueller K, Barthel H, Villringer A, Sabri O, Schroeter ML (2013). Meta-analysis based SVM classification enables accurate detection of Alzheimer's disease across different clinical centers using FDG-PET and MRI. Psychiatry Res, 212(3), 230-236.
     
  451. Teipel SJ, Sabri O, Grothe M, Barthel H, Prvulovic D, Buerger K, Bokde AL, Ewers M, Hoffmann W, Hampel H (2013). Perspectives for multimodal neurochemical and imaging biomarkers in Alzheimer's disease. J Alzheimers Dis, 33(Suppl 1), 329-347.
     
  452. Knausl B, Lutgendorf-Caucig C, Hopfgartner J, Dieckmann K, Kurch L, Pelz T, Potter R, Georg D (2013). Can treatment of pediatric Hodgkin's lymphoma be improved by PET imaging and proton therapy? Strahlenther Onkol, 189(1), 54-61.
     
  453. Kranert T, Menzel C, Bartenstein P, Brust P, Coenen HH, Krause BJ, Kuwert T, Sabri O, Schreckenberger M, Tatsch K, Grunwald F (2013). [Perfusion brain imaging with SPECT-technique. German Guideline S1]. Nuklearmedizin, 52(5), 157-62.
     
  454. Booij J, Arbizu J, Darcourt J, Hesse S, Nobili F, Payoux P, Pappata S, Tatsch K, Walker Z, Pagani M (2013). Appropriate use criteria for amyloid PET imaging cannot replace guidelines: on behalf of the European Association of Nuclear Medicine. Eur J Nucl Med Mol Imaging, 40(7), 1122-1125.
     
  455. Machann J, Horstmann A, Born M, Hesse S, Hirsch FW (2013). Diagnostic imaging in obesity. Best Pract Res Clin Endocrinol Metab, 27(2), 261-277.
     
  456. Zajonz D, Moche M, Tiepold S, von Salis-Soglio G, Pretzsch M (2013). [Acute hip pseudoparalysis with calcific tendinitis at the insertion of the psoas muscle. Case report and first description of an atypical location]. Z Rheumatol, 72(2), 178-183.
     
  457. Fritz T, Koelsch S (2013). Emotional Communication as a cross-species homology underlying music processing. In: Altenmüller E, Schmidt S, Zimmermann E, Emotional Communication. (S. 300-312), Oxford: OXFORD UNIVERSITY PRESS.
     
  458. Seifert U, Verschure P, Arbib M, Cohen A, Fogassi L, Fritz T, Kuperberg G, Manzolli J, Rickard N (2013). Semantics of Internal and External Worlds. In: Arbib M, Language, Music, and the Brain. (S. 203-232), Cambridge: Strüngmann Forum Reports.
     


    459. 2012


  459. Schroeter ML, Vogt B, Frisch S, Becker G, Barthel H, Mueller K, Villringer A, Sabri O (2012). Executive deficits are related to the inferior frontal junction in early dementia. Brain, 135(Pt 1), 201-15.
     
  460. Hesse S, Brust P, Mading P, Becker GA, Patt M, Seese A, Sorger D, Zessin J, Meyer PM, Lobsien D, Laudi S, Habermann B, Fuchtner F, Luthardt J, Bresch A, Steinbach J, Sabri O (2012). Imaging of the brain serotonin transporters (SERT) with 18F-labelled fluoromethyl-McN5652 and PET in humans. Eur J Nucl Med Mol Imaging, 39(6), 1001-1011.
     
  461. Djang DS, Janssen MJ, Bohnen N, Booij J, Henderson TA, Herholz K, Minoshima S, Rowe CC, Sabri O, Seibyl J, Van Berckel BN, Wanner M (2012). SNM Practice Guideline for Dopamine Transporter Imaging with 123I-Ioflupane SPECT 1.0. J Nucl Med, 53(1), 154-163.
     
  462. Wenzel B, Li Y, Kraus W, Sorger D, Sabri O, Brust P, Steinbach J (2012). Pyrrolovesamicols-synthesis, structure and VAChT binding of two 4-fluorobenzoyl regioisomers. Bioorg Med Chem Lett, 22(6), 2163-2166.
     
  463. Huster D, Kuhne A, Bhattacharjee A, Raines L, Jantsch V, Noe J, Schirrmeister W, Sommerer I, Sabri O, Berr F, Mossner J, Stieger B, Caca K, Lutsenko S (2012). Diverse functional properties of Wilson disease ATP7B variants. Gastroenterology, 142(4), 947-956.
     
  464. Schipke CG, Peters O, Heuser I, Grimmer T, Sabbagh MN, Sabri O, Hock C, Kunz M, Kuhlmann J, Reininger C, Blankenburg M (2012). Impact of beta-amyloid-specific florbetaben PET imaging on confidence in early diagnosis of Alzheimer's disease. Dement Geriatr Cogn Disord, 33(6), 416-422.
     
  465. Singer S, Lincke T, Gamper E, Bhaskaran K, Schreiber S, Hinz A, Schulte T (2012). Quality of life in patients with thyroid cancer compared with the general population. Thyroid, 22(2), 117-124.
     
  466. Mozet C, Schwabe K, Fischer M, Quaeschling U, Lincke T, Dietz A (2012). [Dysphagia and globus sensation in a young woman]. Laryngorhinootologie, 91(9), 577-580.
     
  467. Knausl B, Lutgendorf-Caucig C, Hopfgartner J, Dieckmann K, Kurch L, Pelz T, Potter R, Georg D (2012). Can treatment of pediatric Hodgkin\'s lymphoma be improved by PET imaging and proton therapy? Strahlenther Onkol, 189(1), 54-61.
     
  468. Engert A, Haverkamp H, Kobe C, Markova J, Renner C, Ho A, Zijlstra J, Kral Z, Fuchs M, Hallek M, Kanz L, Dohner H, Dorken B, Engel N, Topp M, Klutmann S, Amthauer H, Bockisch A, Kluge R, Kratochwil C, (2012). Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial. Lancet, 379(9828), 1791-1799.
     
  469. Haase R, Vilser C, Mauz-Korholz C, Hasenclever D, Kluge R, Ruschke K, Borkhardt A, Seeger K, Lehrnbecher T, Kulozik A, Rossler J, Burdach S, Jurgens H, Korholz D (2012). Evaluation of the prognostic meaning of C-reactive protein (CRP) in children and adolescents with classical Hodgkin's lymphoma (HL). Klin Padiatr, 224(6), 377-381.
     
  470. Terpolilli NA, Kim SW, Thal SC, Kataoka H, Zeisig V, Nitzsche B, Klaesner B, Zhu C, Schwarzmaier S, Meissner L, Mamrak U, Engel DC, Drzezga A, Patel RP, Blomgren K, Barthel H, Boltze J, Kuebler WM, Pl (2012). Inhalation of nitric oxide prevents ischemic brain damage in experimental stroke by selective dilatation of collateral arterioles. Circ Res, 110(5), 727-738.
     
  471. Thorwarth D, Beyer T, Boellaard R, de Ruysscher D, Grgic A, Lee JA, Pietrzyk U, Sattler B, Schaefer A, van Elmpt W, Vogel W, Oyen WJ, Nestle U (2012). Integration of FDG-PET/CT into external beam radiation therapy planning: technical aspects and recommendations on methodological approaches. Nuklearmedizin, 51(4), 140-153.
     
  472. Hodler J, von Schulthess GK, Zollikofer C (2012). PET Imaging of Dementia. In: Hodler J, Diseases of the Brain, Head & Neck, Spine 2012-2015 (S. 244-250), Milano: Springer Verlag.
     


    473. 2011


  473. Kendziorra K, Wolf H, Meyer PM, Barthel H, Hesse S, Becker GA, Luthardt J, Schildan A, Patt M, Sorger D, Seese A, Gertz HJ, Sabri O (2011). Decreased cerebral a4ß2* nicotinic acetylcholine receptor availability in patients with mild cognitive impairment and Alzheimer's disease assessed with positron emission tomography. Eur J Nucl Med Mol Imaging, 38(3), 515-525.
     
  474. Strecker K, Wegner F, Hesse S, Becker GA, Patt M, Meyer PM, Lobsien D, Schwarz J, Sabri O (2011). Preserved serotonin transporter binding in de novo Parkinson's disease: negative correlation with the dopamine transporter. J Neurol, 258(1), 19-26.
     
  475. Dukart J, Mueller K, Horstmann A, Barthel H, Moller HE, Villringer A, Sabri O, Schroeter ML (2011). Combined evaluation of FDG-PET and MRI improves detection and differentiation of dementia. PLoS One, 6(3), e22193.
     
  476. Hesse S, Stengler K, Regenthal R, Patt M, Becker GA, Franke A, Knupfer H, Meyer PM, Luthardt J, Jahn I, Lobsien D, Heinke W, Brust P, Hegerl U, Sabri O (2011). The serotonin transporter availability in untreated early-onset and late-onset patients with obsessive-compulsive disorder. Int J Neuropsychopharmacol, 14(5), 606-617.
     
  477. Guenther T, Schonknecht P, Becker G, Olbrich S, Sander C, Hesse S, Meyer PM, Luthardt J, Hegerl U, Sabri O (2011). Impact of EEG-vigilance on brain glucose uptake measured with [(18)F]FDG and PET in patients with depressive episode or mild cognitive impairment. Neuroimage, 56(1), 93-101.
     
  478. Barthel H, Gertz HJ, Dresel S, Peters O, Bartenstein P, Buerger K, Hiemeyer F, Wittemer-Rump SM, Seibyl J, Reininger C, Sabri O (2011). Cerebral amyloid-ß PET with florbetaben (18F) in patients with Alzheimer's disease and healthy controls: a multicentre phase 2 diagnostic study. Lancet Neurol, 10(5), 424-435.
     
  479. Barthel H, Luthardt J, Becker G, Patt M, Hammerstein E, Hartwig K, Eggers B, Sattler B, Schildan A, Hesse S, Meyer PM, Wolf H, Zimmermann T, Reischl J, Rohde B, Gertz HJ, Reininger C, Sabri O (2011). Individualized quantification of brain ß-amyloid burden: results of a proof of mechanism phase 0 florbetaben PET trial in patients with Alzheimer's disease and healthy controls. Eur J Nucl Med Mol Imaging, 38(9), 1702-1714.
     
  480. Purz S, Mauz-Korholz C, Korholz D, Hasenclever D, Krausse A, Sorge I, Ruschke K, Stiefel M, Amthauer H, Schober O, Kranert WT, Weber WA, Haberkorn U, .... Sabri O, Kluge R (2011). [18F]fluorodeoxyglucose Positron Emission Tomography for Detection of Bone Marrow Involvement in Children and Adolescents With Hodgkin's Lymphoma. J Clin Oncol, 29(26), 3523-8.
     
  481. Lincke T, Orschekowski G, Singer J, Sabri O, Paschke R (2011). Increased gallium-68 DOTATOC uptake in normal thyroid glands. Horm Metab Res, 43(4), 282-286.
     
  482. Schroeter ML, Vogt B, Frisch S, Becker G, Seese A, Barthel H, Mueller K, Villringer A, Sabri O (2011). Dissociating behavioral disorders in early dementia-An FDG-PET study. Psychiatry Res, 194(3), 235-244.
     
  483. Barthel H, Sabri O (2011). Florbetaben to trace amyloid-ß in the Alzheimer brain by means of PET. J Alzheimers Dis, 26(Suppl.3), 117-121.
     
  484. Kluge R, Korholz D (2011). [Role of FDG-PET in Staging and Therapy of Children with Hodgkin Lymphoma]. Klin Padiatr, 223(6), 315-319.
     
  485. Graef S, Schonknecht P, Sabri O, Hegerl U (2011). Cholinergic receptor subtypes and their role in cognition, emotion, and vigilance control: an overview of preclinical and clinical findings. Psychopharmacology (Berl), 215(2), 205-229.
     
  486. Deuther-Conrad W, Fischer S, Hiller A, Becker G, Cumming P, Xiong G, Funke U, Sabri O, Peters D, Brust P (2011). Assessment of a7 nicotinic acetylcholine receptor availability in juvenile pig brain with [18F]NS10743. Eur J Nucl Med Mol Imaging, 38(8), 1541-1549.
     
  487. Isaias IU, Marotta G, Pezzoli G, Sabri O, Schwarz J, Crenna P, Classen J, Cavallari P (2011). Enhanced catecholamine transporter binding in the locus coeruleus of patients with early Parkinson disease. BMC Neurol, 11, e88.
     
  488. Langen KJ, Bartenstein P, Boecker H, Brust P, Coenen HH, Drzezga A, Grunwald F, Krause BJ, Kuwert T, Sabri O, Tatsch K, Weber WA, Schreckenberger M (2011). [German guidelines for brain tumour imaging by PET and SPECT using labelled amino acids]. Nuklearmedizin, 50(4), 167-173.
     
  489. Wenzel B, Hiller A, Fischer S, Sorger D, Deuther-Conrad W, Scheunemann M, Brust P, Sabri O, Steinbach J (2011). In vitro binding profile and radiosynthesis of a novel 18F-labeled azaspirovesamicol analog as potential ligand for imaging oft the vesicular acetylcholine transporter. J Labelled Compd Rad, 54(8), 426-432.
     
  490. Ashford JW, Salehi A, Furst A, Bayley P, Frisoni GB, Jack CR Jr, Sabri O, Adamson MM, Coburn KL, Olichney J, Schuff N, Spielman D, Edland SD, Black S, Rosen A, Kennedy D, Weiner M, Perry G (2011). Imaging the Alzheimer brain. J Alzheimers Dis, 26(Suppl.3), 1-27.
     
  491. Singer J, Koch CA, Kassahun W, Lamesch P, Eisenhofer G, Kluge R, Lincke T, Seiwerts M, Borte G, Schierle K, Paschke R (2011). A patient with a large recurrent pheochromocytoma demonstrating the pitfalls of diagnosis. Nat Rev Endocrinol, 7(12), 749-755.
     
  492. Braunschweig R, Bergert H, Kluge R, Tiemann AH (2011). [Imaging diagnostics of osteitis, osteomyelitis and joint infections]. Z Orthop Unfall, 149(4), 436-448.
     
  493. Barthel H (2011). Implementierung der Kleintier-PET in die präklinische Evaluierung von [18F]Fluoretanidazol, einem neuen Radiopharmakon für die nuklearmedizinische Bildgebung von Tumorhypoxie. In: Shaker Verlag, Implementierung der Kleintier-PET in die präklinische Evaluierung von [18F]Fluoretanidazol, einem neuen Radiopharmakon für die nuklearmedizinische Bildgebung von Tumorhypoxie. (S. 1-127), Aachen: Shaker Verlag.
     
  494. Ashford JW, Rosen A, Adamson M, Bayley P, Sabri O, Furst A, Black SE, Weiner M, eds (2011). Florbetaben to Trace Beta-amyloid in the Alzheimer Brain by Means of PET. In: Casadesus G, Handbook of imaging the Alzheimer Brain. (S. 247-251), Amsterdam: IOS Press.
     
  495. Handels H, Ehrhardt J, Deserno ThM, Meinzer HP, Tolxdorff Th (2011). Erweiterung einer Toolbox zur semiautomatischen Volume-of-Interest Segmentierung kortikaler Gehirnregionen. In: Tolxdroff T, Bildverarbeitung für die Medizin 2011 (S. 404-408), Berlin: Springer Verlag.
     


    496. 2010


  496. Patt M, Schildan A, Habermann B, Mishchenko O, Patt J T, Sabri O (2010). 18F- and 11C-labelling of quantum dots with n.c.a. [18F]fluoroethyltosylate and [11C]methyliodide: a feasibility study. J Radioanal Nucl Chem, 283(2), 487-491.
     
  497. Patt M, Schildan A, Barthel H, Becker G, Schultze-Mosgau MH, Rohde B, Reininger C, Sabri O (2010). Metabolite analysis of [18F]Florbetaben (BAY 94-9172) in human subjects: a substudy within a proof of mechanism clinical trial. J Radioanal Nucl Chem, 284(3), 557-562.
     
  498. Wachowiak R, Till H, Metzger R, Bierbach U, Simon T, Sattler B, Aigner T, Sabri O, Kluge R (2010). Residual lymph node metastasis in stage 4 neuroblastoma-advantage of radio-guided surgery. Paediatric Haematol Oncol, 27(6), 471-475.
     
  499. Barthel H, Sabri O (2010). "EANM 2009 pre-congress symposium on beta-amyloid PET in dementia". Eur J Nucl Med Mol Imaging, 37, 411-412.
     
  500. Sattler B, Lee JA, Lonsdale M, Coche E (2010). 2010 PET/CT (and CT) instrumentation, image reconstruction and data transfer for radiotherapy planning. Radiother Oncol, 96(3), 288-297.
     
  501. Krohmer S, Sorge I, Krausse A, Kluge R, Bierbach U, Marwede D, Kahn T, Hirsch W (2010). Whole-body MRI for primary evaluation of malignant disease in children. Eur J Radiol, 74(1), 256-261.
     
  502. Tehnert U, Schubert S, Tröltzsch M, Tchavdarova L, Mössner J, Schoppmeyer K (2010). Pitfall alveolar echinococcosis in non-endemic areas Alveolar echinococcosis migrating northward. Ann Hepatol, 9(1), 99-103.
     
  503. Derlin T, Afzal W, Wilke F, Apostolova I, Klutmann S, Meyer PT, Buhmann C, Hesse S, Buchert R (2010). IBZM SPECT and FDG PET in the differential diagnosis of Parkinsonian syndromes: comparison with respect to inter-rater agreement. Nuklearmedizin, 49(4), 139-147.
     
  504. Singer J, Werner F, Koch CA, Bartels M, Aigner T, Lincke T, Fasshauer M, Paschke R (2010). Ecotopic Cushings's syndrome caused by a well differentiated ACTH-secreting neuroendocrine carcinoma of the ileum. Exp Clin Endocrinol Diabetes, 118(8), 524-529.
     
  505. Denecke T, Hundsdorfer P, Misch D, Steffen IG, Schonberger S, Furth C, Plotkin M, Ruf J, Hautzel H, Stover B, Kluge R, Bierbach U, Otto S, Beck JF, Franzius C, Henze G, Amthauer H (2010). Assessment of histological response of paediatric bone sarcomas using FDG PET in comparison to morphological volume measurement and standardized MRI parameters. Eur J Nucl Med Mol Imaging, 37(10), 1842-1853.
     
  506. Dukart J, Müller K, Horstmann, A, Vogt B, Frisch S, Barthel H, Becker G, Möller HE, Villringer A, Sabri O, Schroeter ML (2010). Differential effects of global and cerebellar normalization on detection and differentiation of dementia in FDG-PET studies. Neuroimage, 49(2), 1490-1495.
     
  507. Raczka KA, Becker G, Seese A, Frisch S, Heiner S, Marschhauser A, Barthel H, Scheid R, Sabri O , Schroeter ML (2010). Executive and behavioral deficits share common neural substrates in frontotemporal lobar degeneration - A pilot FDG-PET study. Psychiat Res-Neuroim, 182(3), 274-280.
     
  508. Schneider R, Welt K, Aust W, Kluge R, Löster H, Fitzl G (2010). Cardiovascular autonomic neuropathy in spontaneously diabetic rats with and without application of EGb 761. Histol Histopathol, 25(12), 1581-90.
     
  509. Mauz-Körholz C, Hasenclever D, Dörffel W, Ruschke K, Pelz T, Voigt A, Stiefel M, Winkler M, Vilser C, Dieckmann K, Karlen J, Bergsträsser E, Fossa A, Mann G, ... Kluge R, Körholz D (2010). Procarbazine-free OEPA-COPDAC chemotherapy in boys and standard OPPA-COPP in girls have comparable effectiveness in pediatric Hodgkin's lymphoma: the GPOH-HD-2002 study. J Clin Oncol, 28(23), 3680-86.
     
  510. Franzius C, Stauss J, Pfluger T, Jürgens KU, Kluge R, Amthauer H, Jürgens H, Henze G, Stöver B, Hahn K (2010). Procedure guidelines for whole-body 18F-FDG PET and PET/CT in children with malignant diseases. Nuklearmedizin, 49(6), 225-233.
     
  511. Kotzerke J, Oehme L, Lindner O, Hellwig D, Bartenstein P, Baum RP, Burchert W, Dietlein M, Haberkorn U, Kuge R, Knapp WH, Kuwert T, Nitzsche E, Reske SN, Reuland P, Schicha H, Schober O, Schwaiger M, (2010). Positron emission tomography 2008 in Germany - results of the query and current status. Nuklearmedizin, 49(2), 58-64.
     
  512. Dietz A, ... Kluge R, ... et al (2010). Bildgebung Larynx/Hypopharynx – PET/CT. In: UNI-MED Bremen, Kopf-Hals-Tumoren. (S. 68-69), Bremen: UNI-MED.
     


    513. 2009


  513. Lincke Th, Singer J, Kluge R, Sabri O, Paschke R (2009). Relative quantification of indium-111 pentetreotide and gallium-68 DOTATOC uptake in the thyroid gland and association with thyroid pathologies. Thyroid, 19(4), 381-389.
     
  514. Meyer P, Strecker K, Kendziorra K, Becker G, Hesse S, Woelpl D, Hensel A, Patt M, Sorger D, Wegner F, Lobsien D, Barthel H, Brust P, Gertz HJ, Sabri O, Schwarz J (2009). Reduced alpha4ß2*Nicotinic Acetylcholine Receptor Binding and its Relationship to Cognitive and Depressive Symptoms in Parkinson's Disease. Arch Gen Psychiatry, 66(8), 866-877.
     
  515. Hesse S, Meyer P, Strecker K, Barthel H, Wegner F, Oehlwein C, Isaias IU, Schwarz J, Sabri O (2009). Monoamine transporter availability in Parkinson's disease patients with or without depression. Eur J Nucl Med Mol Imaging, 36(3), 428-435.
     
  516. Hesse S, Ballaschke O, Barthel H, Sabri O (2009). Dopamine transporter imaging in adult patients with attention-deficit hyperactivity disorder. Psychiatry Research Neuroimaging, 171(2), 120-128.
     
  517. Kendziorra K, Kluge R, Borte G, Kahn Th, Sabri O, Wirtz H (2009). PET/CT beim Lungenkarzinom Ärzteblatt Sachsen, 20(10), 544-547.
     
  518. Wilde F, Steinhoff K, Frerich B, Schulz T, Winter K, Hemprich A, Sabri O, Kluge R (2009). Positron-emission tomography imaging in the diagnosis of bisphosphonate-related osteonecrosis of the jaw Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 107(3), 412-419.
     
  519. Kendziorra K, Meyer P, Sabri O (2009). Radiotracer-Bildgebung zerebraler Azetylcholinrezeptoren bei demenziellen Erkrankungen Nervenheilkunde, 28(10), 739-744.
     
  520. Hesse S, Sabri O, Brockmann H, Biersack HJ, Boecker H (2009). Nuklearmedizinische Bildgebung bei depressiven Störungen und antidepressiver Therapie Nervenheilkunde, 28(10), 719-726.
     
  521. Sorger D, Scheunemann M, Vercouille J, Großmann U, Fischer S, Hiller A, Wenzel B, Roghani A, Schliebs R, Steinbach J, Brust P, Sabri O (2009). Neuroimaging of the vesicular acetylcholine transporter by a novel 4-[18F]fluoro-benzoyl derivative of 7-hydroxy-6-(4-phenyl-piperidin-1-yl)-octahydro-benzo[1,4]oxazines Nucl Med Biol, 36(1), 17-27.
     
  522. Lotze M, Reimold M, Heymans U, Laihinen A, Patt M, Halsband U (2009). Reduced Ventrolateral fMRI Response during Observation of Emotional Gestures Related to Reduced Dopamine in the Putamen. J Cogn Neurosci, 21(7), 1321-1331.
     
  523. Deuther-Conrad W, Fischer S, Hiller A, Ostergaard Nielsen E, Brunicardi Timmermann D, Steinbach J, Sabri O, Peters D, Brust P (2009). Molecular imaging of alpha7 nicotinic acetylcholine receptors: design and evaluation of the potent radioligand [(18)F]NS10743. Eur J Nucl Med Mol Imaging, 36(5), 791-800.
     
  524. Grunewald WA, Just G, Petzold J, von Philipsborn H (2009). [Radon transfer and intracorporal deposition of radon decay products under balneotherapeutic conditions] Z Med Phys , 19(2), 108-119.
     
  525. Schafers M, Bengel F, Bull U, Burchert W, Kies P, Kluge R, Krause BJ, Lindner O, Nienaber C, Nowak B, Schafer W, Schober O, Schwaiger M, Silber S, Vom Dahl J, Zimmermann R (2009). [Position paper nuclear cardiology: update 2008] Nuklearmedizin, 48(2), 71-78.
     
  526. Wilhelm M, Bierbach U, Kluge R, Kiess W, Christiansen H (2009). Appendixkarzinoid - der Zufallsbefund jeder 300. Appendektomie Kinder- und Jugendmedizin, 9(7), 412-417.
     
  527. Petzold J, Sattler B, Seese A, Krummeich C (2009). Lehrbriefe Physik und Technik der Nuklearmedizin MPT 0009. In: Zentrum für Fernstudien und universitäre Weiterbildung, Universität Kaiserslautern. Eigenverlag, Lehrbriefe Physik und Technik der Nuklearmedizin MPT 0009. (S. 1-240), Universität Kaiserslautern: Zentrum für Fernstudien und universitäre Weiterbil.
     


    528. 2008


  528. Baldauf D, Petzold J, Lincke T, Sattler B, Schüler W, Seese A, Winkler B, Sabri O (2008). Strahlenschutz von Patient und Personal bei der Radiojodtherapie Strahlenschutzpraxis, 1, 27-32.
     
  529. Erkwoh R, Steinmeyer EM, Döring WH, Vorländer M, Sabri O (2008). Akute psychotische Produktivität in der zerebralen Bildgebung Fortschr Neurol Psychiat, 76(Suppl 1), 40-48.
     
  530. Meyer P, Sattler B, Winz OH, Fundke R, Oehlwein C, Kendziorra K, Hesse S, Schäfer WM, Sabri O (2008). Kinetic analyses of [123-I]IBZM SPECT for quantification of striatal dopamine D2 receptor binding: A critical evaluation of single-scan approach. NeuroImage, 42(2), 548-558.
     
  531. Hesse S, Barthel H, Strecker K, Oehlwein C, Sabri O, Schwarz J (2008). Nuklearmedizinische Diagnostik beim Parkinson-Syndrom. Akt Neurol, 35(8), 389-398.
     
  532. Brust P, Patt JT, Deuther-Conrad W, Becker G, Patt M, Schildan A, Sorger D, Kendziorra K, Meyer P, Steinbach J, Sabri O (2008). In vivo measurement of nicotinic acetylcholine receptors with [18F]norchloro-fluoro-homoepibatidine (NCFHEB). Synapse, 62(3), 205-218.
     
  533. Langen KJ, Tatsch K, Grosu AL, Jacobs AH, Weckesser M, Sabri O (2008). Diagnostics of Cerebral Gliomas With Radiolabeled Amino Acids [Diagnostik von Hirntumoren mit radioaktiv markierten Aminosäuren]. Deutsches Ärzteblatt, 105(4), 55-61.
     
  534. Kendziorra K, Barthel H, Erbs S, Emmrich F, Hambrecht R, Schuler G, Sabri O, Kluge R (2008). Effect of progenitor cells on myocardial perfusion and metabolism in patients after recanalization of a chronically occluded coronary artery J Nucl Med, 49(4), 557-563.
     
  535. Sabri O, Kendziorra K, Wolf H, Gertz HJ, Brust P (2008). Acetylcholine receptors in dementia and mild cognitive impairment. Eur J Nucl Med Mol Imaging, 35(Suppl 1), 30-45.
     
  536. Marwede D, Schulz T, Kahn T (2008). Indexing thoracic CT reports using a preliminary version of a standardized radiological lexicon (RadLex). J Digit Imaging, 21(4), 363-370.
     
  537. Petzold J (2008). Bestimmung von Iod-131-Konzentrationen in der Raumluft der Patientenzimmer. Forschungsbericht Landesamt für Umwelt und Geologie, Dresden, , 1-15.
     
  538. Sorger D, Scheunemann M, Grossmann U, Fischer S, Vercouille J, Hiller A, Wenzel B, Roghani A, Schliebs R, Brust P, Sabri O, Steinbach J (2008). A new 18F-labeled fluoroacetylmorpholino derivative of vesamicol for neuroimaging of the vesicular acetylcholine transporter. Nucl Med Biol, 35(2), 185-195.
     
  539. Petzold J, Alborzi H, Keller A, Lincke T, Meyer K, Petzold L, Seese A, Schönmuth T, Sabri O (2008). Strahlenschutzmaßnahmen zur Verringerung der Inkorporation beim Personal während der Radioiodtherapie Strahlenschutzpraxis, 2, 44-52.
     
  540. Hesse S, Strecker K, Winkler D, Luthardt J, Scherfler C, Reupert A, Oehlwein C, Barthel H, Schneider JP, Wegner F, Meyer P, Meixensberger J, Sabri O, Schwarz J (2008). Effects of subthalamic nucleus stimulation on striatal dopaminergic transmission in patients with Parkinson\'s disease within one-year follow-up. J Neurol, 255(7), 1059-1066.
     
  541. Barthel H, Sabri O (2008). Neue Entwicklungen in der molekularen Bildgebung von neuropsychiatrischen Erkrankungen. MedReport, 32(11), 6-11.
     
  542. Wegner F, Strecker K, Boeckler D, Wagner A, Preul C, Lobsien D, Sabri O, Hesse S (2008). Intact serotonergic and dopaminergic systems in two cases of orthostatic tremor. J Neurol, 255(11), 1840-1842.
     
  543. Kobe C, Dietlein M, Mauz-Korholz C, Engert A, Borchmann P, Sabri O, Schober O, Schicha H, Kluge R (2008). FDG-PET in Hodgkin lymphoma. Nuklearmedizin, 47(6), 235-238.
     
  544. Kluge R, Mauz-Körholz C, Hasenclever D, Purz S, Ruschke K, Kuhnt T, Sabri O, Körholz D (2008). Einsatz von FDG-PET zur Therapiesteuerung bei Kindern mit Hodgkin-Lymphom. MedReport , 32(11), 10-11.
     
  545. Deuther-Conrad W, Patt JT, Lockmann P, Allen D, Patt M, Schildan A, Ganapathy V, Steinbach J, Sabri O, Brust P (2008). Norchloro-fluoro-homoepibatidine (NCFHEB) – A Promising Radioligand for Neuroimaging Nicotinic Acetylcholine Receptors with PET Eur Neuropsychopharm, 18(3), 222-229.
     
  546. Boltze J, Förschler A, Nitzsche B, Waldmin D, Hoffmann A, Boltze CM, Dreyer AY, Goldammer A, Reischauer A, Härtig W, Geiger KD, Barthel H, Emmrich F, Gille U (2008). Permanent middle cerebral artery occlusion in sheep - New model of focal cerebral ischemia J Cereb Blood Flow Metab, 28(12), 1951-1964.
     
  547. Busse F, Fuhrer D, Stumvoll M, Schneider JP, Neid M, Kluge R, Sterker I (2008). Metastasis of neuroendocrine colon carcinoma mimicking Graves' ophthalmopathy. Thyroid, 18(11), 1237-1238.
     
  548. Maschke J, Kluge R, Schuster V, Merkenschlager A, Neid M, Treudler R, Sabri O, Simon JC (2008). [Multilocular osteo-articular pain combined with pustular skin eruptions in an adolescent] J Dtsch Dermatol Ges, 6(8), 682-684.
     
  549. Lindner O, Burchert W, Bengel FM, Zimmermann R, Vom Dahl J, Schafer W, Schober O, Kluge R, Schafers M, Arbeitsgemeinschaft Kadiovaskuläre Nuklearmedizin der Deutschen Gesellschaft für Nuklearmedizin, (2008). [Myocardial perfusion scintigraphy 2006 in Germany. Results of the query and current status] Nuklearmedizin, 47(4), 139-145.
     
  550. Stauss J, Franzius C, Pfluger T, Juergens KU, Biassoni L, Begent J, Kluge R, Amthauer H, Voelker T, Hojgaard L, Barrington S, Hain S, Lynch T, Hahn K, European Association of Nuclear Medicine (2008). Guidelines for 18F-FDG PET and PET-CT imaging in paediatric oncology. Eur J Nucl Med Mol Imaging, 35(8), 1581-1588.
     
  551. Bockisch A, Döbert N, Eisenhut M, Fitscher T, Hellwig D, Hofmann M, Jüngling D, Knoop O, Menzel C, Mier W, Mödder G, Müller W, Reinartz P, Riemann B, Römer W, Sabri O, Schäfer A, Sonnenschein W, Wecke (2008). Lunge. In: Kuwert T, Grünwald F, Haberkorn U, Krause T, Nuklearmedizin. (S. 258-271), Stuttgart: Georg Thieme - Verlag.
     
  552. Petzold J, Krummeich C, Sattler B, Seese A (2008). Studienbrief MPT0009 Physik und Technik der Nuklearmedizin, Ergänzte Auflage 2008. In: , Studienbrief MPT0009 Physik und Technik der Nuklearmedizin, Ergänzte Auflage 2008. (S. 5 S.), Kaiserslautern: Universität Kaiserslautern Eigenverlag.
     


    553. 2007


  553. Frerich B, Forster M, Schiefke F, Wittekind C, Hemprich A, Sabri O (2007). Sentinel lymph node biopsy in squamous cell carcinomas of the lips and the oral cavity - a single center experience. J Surg Oncol, 95(2), 97-105.
     
  554. Schildan A, Patt M, Sabri O (2007). Synthesis procedure for routine production of 2-[18F]fluoro-3-(2(S)-azetidinylmethoxy)pyridine (2-[18F]F-A-85380). Appl Radiat Isot, 65(11), 1244-1248.
     
  555. Strecker K, Schneider JP, Sabri O, Wegner F, Then Bergh F, Schwarz J, Hesse S (2007). Responsiveness to a dopamine agent in Holmes tremor - case report. Eur J Neurol, 14(4), e9-e10.
     
  556. Sorger D, Becker GA, Patt M, Schildan A, Grossmann U, Schliebs R, Seese A, Kendziorra K, Kluge M, Brust P, Mukhin AG, Sabri O (2007). Measurement of the alpha4beta2* nicotinic acetylcholine receptor ligand 2-[(18)F]Fluoro-A-85380 and its metabolites in human blood during PET investigation: a methodological study. Nucl Med Biol, 34(3), 331-342.
     
  557. Patt M, Solbach C, Wullner U, Blocher A, Stahlschmidt A, Gundisch D, Kovar KA, Machulla HJ (2007). Synthetic approaches and bio-distribution studies of [11C]methyl-phenidate. J Pharm Pharm Sci, 10(2), 312-320.
     
  558. Hesse S, Barthel H, Seese A, Sabri O (2007). Dopamin-Transporter- und Dopamin-D2-Rezeptor-SPECT bei Erkrankungen der Basalganglien. Nuklearmediziner, 30(3), 195-203.
     
  559. Barthel H, Hesse S, Sabri O (2007). Nuklearmedizinische Bildgebung bei zerebrovaskulären Erkrankungen. Nuklearmediziner, 30(3), 217-221.
     
  560. Petzold J, Alborzi H, Fundke R, Petzold L, Seese A, Sabri O (2007). Verringerung der Inkorporation von 99m-Technetium beim Personal während Lungenventilationsuntersuchungen. Strahlenschutzpraxis, 3, 23-28.
     
  561. Petzold J, Alborzi H, Keller A, Lincke T, Meyer K, Petzold L, Seese A, Sabri O (2007). Bestimmung von 131-Jod-Inkorporationen beim Pflegepersonal einer nuklearmedizinischen Klinik. Strahlenschutzpraxis, 4, 50-57.
     
  562. Wegner F, Strecker K, Schwarz J, Wagner A, Heinritz W, Sommerer F, Thal DR, Schneider JP, Kendziorra K, Sabri O (2007). Vascular parkinsonism in a CADASIL case with an intact nigrostriatal dopaminergic system. J Neurol, 254(12), 1743-1745.
     
  563. Gründig M, Richter M, Seese A, Sabri O (2007). Tomographic Radiotracer Studies of the Spatial Distribution of Heterogeneous Geochemical Transport Processes. Appl Geochem, 22(11), 2334-2343.
     
  564. Strecker K, Hesse S, Wegner F, Sabri O, Schwarz J, Schneider JP (2007). Eye of the Tiger sign in multiple system atrophy. Eur J Neurol, 14(11), e1-e2.
     
  565. Solbach C, Patt M, Reimold M, Blocher A, Dohmen BM, Bares R, Zeller KP, Machulla HJ (2007). [11C]Vinblastine syntheses and preliminary imaging in cancer patients. J Pharm Pharm Sci, 10(2), 266-276.
     
  566. Lindner O, Burchert W, Bengel FM, Zimmermann R, Vom Dahl J, Schafer W, Bull U, Schober O, Schwaiger M, Kluge R, Schafers M (2007). [Myocardial perfusion scintigraphy in Germany. Results of the 2005 query and current status] Nuklearmedizin, 46(2), 49-55.
     
  567. Wagner A, Hermann W, Hesse S, Sabri O, Wagner A (2007). Einfluss der repetitiven transkraniellen Magnetstimulation (rTMS) auf motorische Störungen bei Patienten mit Morbus Parkinson und Morbus Wilson Klin Neurophysiol, 38(3), 169-178.
     
  568. Scheunemann M, Sorger D, Kouznetsova E, Sabri O, Schliebs R, Wenzel B, Steinbach J (2007). Sequential ring-opening of trans 1,4-cyclohexadiene dioxide for an expedient modular approach to 6,7-disubstituted +/--hexahydro-benzol [1,4]oxazin-3-ones. Tetrahedron Lett, 48(31), 5497-5501.
     
  569. Schiefke I, Schoppmeyer K, Kluge R, Mössner J (2007). Epidemiologie, Klinik und Diagnostik von gastrointestinalen Stromatumoren (GIST). Verdauungskrankheiten, 25(6), 266-272.
     
  570. Busse FP, Mössner J, Stumvoll M, Kluge R, Schoppmeyer K (2007). Nichtoperative Therapiemöglichkeiten gastroenteropankreatischer neuroendokriner Tumoren Chir Gastroenterol, 23(2), 158-165.
     
  571. Krummeich C, Petzold J, Sattler B, Seese A (2007). Physik und Technik der Nuklearmedizin. In: , Physik und Technik der Nuklearmedizin. Studienbrief MPT0009. (S. 1-218), Kaiserslautern: Technische Universität .
     


    572. 2006


  572. Scheid R, Preul C, Lincke T, Matthes G, Schroeter ML, Guthke T, von Cramon DY, Sabri O (2006). Correlation of cognitive status, MRI- and SPECT-imaging in CADASIL patients Eur J Neurol, 13(4), 363-370.
     
  573. Stengler-Wenzke K, Müller U, Barthel H, Angermeyer MC, Sabri O, Hesse S (2006). Serotonin transporter imaging with [123]beta-CIT SPECT before and after one year of citalprom treatment of obsessive-compulsive disorder. Neuropsychobiology, 53(1), 40-45.
     
  574. Sorger D, Becker GA, Hauber K, Schildan A, Patt M, Birkenmeier G, Otto A, Meyer P, Kluge M, Schliebs R, Sabri O (2006). Binding properties of the cerebral α4β2 nicotinic acetylcholine receptor ligand 2-[18F]Fluoro-A-85380 to plasma proteins. Nucl Med Biol, 33(7), 899-906.
     
  575. Hesse S, Oehlwein C, Barthel H, Schwarz J, Polster D, Wagner A, Sabri O (2006). Possible impact of dopamine SPECT on decision-making for drug treatment in Parkinsonian syndrome. J Neural Transm, 113(9), 1177-1190.
     
  576. Banning U, Barthel H, Mauz-Korholz C, Kluge R, Korholz D, Sabri O (2006). Effect of drug-induced cytotoxicity on glucose uptake in Hodgkins lymphoma cells. Eur J Haematol, 77(2), 102-108.
     
  577. Fasshauer M, Lincke T, Witzigmann H, Kluge R, Tannapfel A, Moche M, Buchfelder M, Petersenn S, Kratzsch J, Paschke R, Koch C (2006). Ectopic Cushing syndrome caused by a neuroendocrine carcinoma of the mesentery. BMC Cancer, 6, 108.
     
  578. Trobs RB, Heinecke K, Elouahidi T, Nounla J, Kuge R (2006). Renal fucntion and urine drainage after conservative or operative treatment of primary (obstructive) megaureter in infants and children. Int Urol Nephrol, 38(1), 141-147.
     
  579. Deuther-Conrad W, Wevers A, Becker G, Schildan A, Patt M, Sabri O, Steinbach J, Brust P (2006). Autoradiography of 2-[(18)F]F-A-85380 on nicotinic acetylcholine receptors in the porcine brain in vitro. Synapse, 59(4), 201-210.
     
  580. Kouznetsova E, Klingner M, Sorger D, Sabri O, Großmann U, Steinbach J, Scheunemann M, Schliebs R (2006). Developmental and amyloid plaque-related changes in cerebral cortical capillaries in transgenic Tg2576 Alzheimer mice. Int J Dev Neurosci, 24(2-3), 187-193.
     
  581. Brust P, Hesse S, Müller U, Szabo Z (2006). Neuroimaging of the serotonin transporter - possibilities and pitfalls. Curr Psychiat Rev, 2(1), 111-149.
     
  582. Perumal M, Pillai RG, Barthel H, Leyton J, Latigo JR, Forster M, Mitchell F, Jackman AL, Aboagye EO (2006). Redistribution of nucleoside transporters to the cell membrane provides a novel approach for imaging thymidylate synthase inhibition by positron emission tomography. Cancer Res, 66(17), 8858-8564.
     
  583. Strecker K, Schneider JP, Barthel H, Herman W, Wegner F, Wagner A, Schwarz J, Sabri O, Zimmer C (2006). Profound midbrain atrophy in patients with Wilson's disease and neurological symptoms? J Neurol, 253(8), 1024-1029.
     
  584. Faber S, Boltze J, Barthel H, Linke A, Hengstler JG (2006). Review of the First Fraunhofer Life Sciences symposium on Cell Therapy and Immunology EXCLI J, 5, 217-225.
     
  585. Beyer T, Bockisch A, Barthel H, Munz D (2006). State-of-the-art nuclear medicine: perspectives from an international symposium in Berlin. Eur J Nucl Med Mol Imag, 33(12), 1518-1521.
     
  586. Koch CA, Grimm O, Vortmeyer AO, Al-Ali HK, Lamesch P, Ott R, Kluge R, Bierbach U, Tannapfel A (2006). Does the expression of c-kit (CD117) in neuroendocrine tumors represent a target for therapy? Ann N Y Acad Sci, 1073, 517-526.
     
  587. Schulz T, Prietzel T, Kluge R, Schneider JP, Tannapfel A, Kahn T (2006). Efficient diagnosis of pathological fractures. Rontgenpraxis, 56(3), 75-92.
     
  588. Uhlmann D, Wiedmann M, Schmidt F, Kluge R, Tannapfel A, Berr F, Hauss J, Witzigmann H (2006). Management and outcome in patients with Klatskin-mimicking lesions of the biliary tree. J Gastrointest Surg, 10(8), 1144-1150.
     
  589. Scheid R, Voltz R, Briest S, Kluge R, von Cramon DY (2006). Clinical insights into paraneoplastic cerebellar degeneration. J Neurol Neurosurg Psychiatry, 77(4), 529-530.
     


    590. 2005


  590. Barthel H, Perumal M, Latigo J, He Q, Brady F, Luthra SK, Price PM, Aboagye EO (2005). The uptake of 3'-deoxy-3'-[(18)F]fluorothymidine into L5178Y tumours in vivo is dependent on thymidine kinase 1 protein levels. Eur J Nucl Med Mol Imaging, 32(3), 257-263.
     
  591. Kluge R, Barthel H, Pankau H, Seese A, Schauer J, Wirtz H, Seyfarth HJ, Steinbach J, Sabri O, Winkler J (2005). Different mechanisms for changes in glucose uptake of the right and left ventricular myocardium in pulmonary hypertension. J Nucl Med, 46(1), 25-31.
     
  592. Förster M, Conradi S, Müller D, Kluge R, Sabri O (2005). Heart abscess revealed by nuclear medicine imaging. Eur J Nucl Med Mol Imaging, 32(2), 249.
     
  593. Dannenberg C, Kluge R, Korholz D, Sabri O (2005). Simultaneous osteosarcoma and papillary thyroid carcinoma. Lancet Oncol, 6(2), 126-127.
     
  594. Muller D, Wiedmann M, Kluge R, Berr F, Mossner J, Sabri O, Caca K (2005). [Is 18F-FDG-PET Suitable for Therapy Monitoring after Palliative Photodynamic Therapy of Non-Resectable Hilar Cholangiocarcinoma?] Z Gastroenterol, 43(5), 439-443.
     
  595. Hesse S, Barthel H, Becker G, Patt M, Brust P, Sabri O, Müller U (2005). Imaging of Serotonin Transporters. Neurosci Imag, 1, 19-47.
     
  596. Hesse S, Müller U, Lincke T, Barthel H, Villmann T, Angermeyer MC, Sabri O, Stengler-Wenzke K (2005). Serotonin and dopamine transporter imaging in patients with obsessive-compulsive disorder. Psychiatry Res, 140(1), 63-72.
     
  597. Kendziorra K, Walther C, Förster M, Möbius-Winkler S, Conradi K, Schuler G,Sabri O, Hambrecht R, Kluge R (2005). Changes in myocardial perfusion due to physical exercise in patients with stable coronary artery disease (CAD). Eur J Nucl Med Mol Imaging, 32(7), 813-819.
     
  598. Richter M, Gründig M, Zieger K, Seese A, Sabri O (2005). Positron emission tomography for modelling of geochemical transport processes in clay. Radiochim Acta, 93, 643-651.
     
  599. Becker GA, Müller-Schauenburg W, Spilker ME, Machulla HJ, Piert M (2005). A priori identifiability of a one-compartment model with two input functions for liver blood flow measurements. Phys Med Biol, 50(7), 1393-1404.
     
  600. Wenzel B, Sorger D, Heinitz K, Scheunemann M, Schliebs R, Steinbach J, Sabri O (2005). Structural changes of benzylether derivatives of vesamicol and their influence on the binding selectivity to the vesicular acetylcholine transporter. Eur J Med Chem, 40(12), 1197-1205.
     
  601. Regenthal R, Kunstler U, Hesse S, Sabri O, Preiss R (2005). D2 dopamine receptor occupancy, risperidone plasma level and extrapyramidal motor symptoms in previously drug-free schizophrenic patients. Int J Clin Pharmacol Ther, 43(8), 370-378.
     
  602. Kratzsch J, Fiedler GM, Leichtle A, Brügel M, Buchbinder S, Otto L, Sabri O, Matthes G, Thiery J (2005). New Reference Intervals for Thyrotropin and Thyroid Hormones Based on National Academy of Clinical Biochemistry Criteria and Regular Ultrasonography of the Thyroid. Clin Chem, 51(8), 1480-1486.
     
  603. Erbs S, Linke A, Adams V, Lenk K, Thiele H, Diederich KW, Emmrich F, Kluge R, Kendziorra K, Sabri O, Schuler G, Hambrecht R (2005). Transplantation of blood-derived progenitor cells after recanalization of chronic coronary artery occlusion: first randomized and placebo-controlled study. Circ Res, 97(8), 756-762.
     
  604. Scheid R, Voltz R, Vetter T, Sabri O, von Cramon DY (2005). Neurosyphilis and paraneoplastic limbic encephalitis: important differential diagnoses. J Neurol, 252(9), 1129-1132.
     
  605. Barthel H, Kendziorra K, Hesse S, Kluge R , Gertz HJ, Hambrecht R, Sabri O (2005). Positron emission tomography for monitoring regenerative therapies. In: Braun JM, Braun A, Emmrich F, Poster Abstract Booklet - Regenerative Medicine Network Leipzig-Halle (S. P 25), Leipzig: Springer Verlag.
     
  606. Petzold J, Sattler B (2005). Physikalisch-technische Grundlagen der Nuklearmedizin. In: Angerstein W, Grundlagen der Strahlenphysik und Radiologischen Technik in der Medizin. (S. 441-495), Berlin: H. Hoffmann Verlag.
     


    607. 2004


  607. Barthel H, Hesse S, Sabri O (2004). I-123-beta-CIT SPECT for imaging serotonin transporters in Parkinson's disease. J Nucl Med, 45, 923-924.
     
  608. Wagenknecht G, Kaiser HJ, Buell U, Sabri O (2004). MRI-based Individual 3D Region-of-interest Atlases of the Human Brain Method sInf Med, 43(4), 383-390.
     
  609. Günther P, Storch A, Schwarz J, Sabri O, Steinbach P, Wagner A, Hesse S (2004). Basal ganglia involvement of a patient with SCA 17. J Neurol, 251(7), 896-897.
     
  610. Stengler-Wenzke K, Müller U, Angermeyer MC, Sabri O, Hesse S (2004). Reduced serotonin transporter-availability in obsessive-compulsive disorder (OCD). Eur Arch Psy Clin N, 254(4), 252-255.
     
  611. Scheid R, Lincke T, Voltz R, von Cramon DY, Sabri O (2004). Serial 18-F-fluoro-2-deoxy-D-glucose Positron Emission Tomography and Magnetic Resonance Imaging of Paraneoplastic Limbic Encephalitis. Arch Neurol, 61(11), 1785-1789.
     
  612. Korholz D, Claviez A, Hasenclever D, Kluge R, Hirsch W, Kamprad F, Dorffel W, Wickmann L, Papsdorf K, Dieckmann K, Kahn T, Mauz-Korholz C, Dannenberg C, Potter R, Brosteanu O, Schellong G, Sabri O (2004). The Concept of the GPOH-HD 2003 Therapy Study for Pediatric Hodgkin's Disease: Evolution in the Tradition of the DAL/GPOH Studies. Klin Padiatr, 216(3), 150-156.
     
  613. Hesse, S, Barthel, H, Schwarz J, Sabri O, Müller U (2004). Advances in vivo imging of serotonergic neurons in neuropsychiatric disorders. Neurosci Biobehav Rev, 28(6), 547-563.
     
  614. Kendziorra K, Barthel H, Winkler D, Schober R, Zimmer C, Meixensberger J, Sabri O (2004). Intracranial germinoma diagnosed by Fluorine-18-FDG-PET-guided stereotactic biopsy. Nuklearmedizin, 43(6), N80-N83.
     
  615. Hesse S, Barthel H, Sabri O (2004). Nuklearmedizinische Frühdiagnostik des Schlaganfalls. MTA Dialog, 4, 274-277.
     
  616. Barthel H, Wilson H, Collingridge DR, Brown G, Osman S, Luthra SK, Brady F, Workman P, Price P, Aboagye EO (2004). In vivo evaluation of [18F]fluoroetanidazole as a new marker for imaging tumor hypoxia with positron emission tomography Br J Cancer, 90(11), 2232-2242.
     
  617. Barthel H, Price P, Aboagye EO (2004). Small-animal imaging of tumour proliferation with PET. Lancet Oncol, 5, 100.
     
  618. Feisthammel J, Caca K, Mössner J, Kahn T, Kluge R (2004). An important pitfall in diagnosing gall bladder cancer. GUT, 53(11), 1651.
     
  619. Kluge R (2004). Positronenemissionstomographie zur Diagnostik von Gallenblasen- und Gallenwegkarzinomen Chir Gastroenterol, 20(4), 260-264.
     
  620. Koerholz D, Kluge R, Kahn T, Kamprad F, Papsdorf K, Dörffel W, Wickmann L, Claviez A, Schellong G, Hasenclever D, Brosteanu O, Dieckmann K, Pötter R, Hirsch W, Sorge I, Dannenberg C, Mauz-Koerholz C, (2004). Behandlung des Morbus Hodgkin im Kindes- und Jugendalter. Journal Onkologie, 8, 4-9.
     
  621. Scheunemann M, Sorger D, Wenzel B, Heinitz K, Schliebs R, Klingner M, Sabri O, Steinbach J (2004). Synthesis of novel 4-and 5-substituted benzyl ether derivatives of vesamicol and in vitro evaluation of their binding properties to the vesicular acetylcholine transporter site Bioorg Med Chem, 12(6), 1459-1465.
     
  622. Reinges MHT, Krings T, Meyer PT, Schreckenberger M, Rohde V, Weidemann J, Sabri O, Mulders EJ, Buell U, Thron A, Gilsbach JM (2004). Preoperative mapping of cortical motor function: prospective comparison of functional magnetic resonance imaging and [O-15]-H2O-positron emission tomography in the same co-ordinate system. Nucl Med Communications, 25, 987-997.
     
  623. Hambrecht R, Walther C, Mobius-Winkler S, Gielen S, Linke A, Conradi K, Erbs S, Kluge R, Kendziorra K, Sabri O, Schuler G (2004). Percutaneous coronary angioplasty compared with excercise training in patients with stable coronary artery disease - A randomized trial. Circulation, 109(11), 1371-1378.
     
  624. Winkler D, Strauss G, Hesse S, Goldammer A, Hund-Georgiadis M, Richter A, Sabri O, Kahn T, Meixensberger J (2004). Preoperative imaging as the basis for image-guided neurosurgery. Radiologe, 44(7), 723-732.
     
  625. Franke K, Patt JT, Patt M, Kupsch H, Steinbach J (2004). A new technique for radiolabelling of humic substances. Radiochimica Acta, 92(4-6), 359-362.
     
  626. Miehle K, Tannapfel A, Lamesch P, Borte G, Schenker E, Kluge R, Ott RA, Wiechmann V, Koch M, Kassahun W, Paschke R, Koch CA (2004). Pancreatic neuroendocrine tumor with ectopic ACTH-production upon second recurrence. J Clin Endocrinol Metab, 89(8), 3731-3736.
     
  627. Briest S, Pawelka MK, Leinung S, Horn LC (2004). Die Sentinel-Lymphknoten-Biopsie beim Mammakarzinom Konzept und Management Ärzteblatt Sachsen, 15(10), 480-483.
     
  628. Patt JT, Deuther-Conrad W, Brust P, Patt M, Schildan A, Feuerbach D, Sabri O, Steinbach J (2004). [18F]Norchlorofluorohomoepibatidine: Synthesis, radiosynthesis, evaluation in vitro and comparison with 2-[18]fluoro-A-85380 in mice. Sixth International Conference on Nuclear and Radi, 3, 395-397.
     
  629. Reimold M, Mueller-Schauenburg W, Becker GA, Reisch G, Dohmen BM, Bares R (2004). Noninvasive assessment of distribution volume ratios and binding potential: tissue heterogeneity and interindividually averaged time-activity curves. Eur J Nucl Med Mol Imaging, 31(4), 564-577.
     
  630. Barthel H (2004). Präklinische Evaluierung neuer Marker zur PET-Bildgebung von Tumorhypoxie und -proliferation. In: Fischer GS, Clausing A, Ter Meulen V, Ergebnisse des Leopoldina-Förderprogramms IV (S. 27-28), Stuttgart: Wiss. Verlagsgesellschaft mbH.